Dopamine	HMDB_SMPDB	Samples:	61	Pathways:	96	Tyrosinemia Type I	Levomethadyl Acetate Action Action Pathway	Ethylmorphine Action Pathway	3-Methylthiofentanyl Action Pathway	Levorphanol Action Pathway	Heroin Pathway	Dibucaine Action Pathway	Prilocaine Pathway	Proparacaine Pathway	Oxycodone Pathway	Carfentanil Pathway	Disulfiram Pathway	Bupivacaine Action Pathway	Fentanyl Pathway	Ropivacaine Action Pathway	Procaine Action Pathway	Procaine Pathway	Benzocaine Action Pathway	Buprenorphine Action Pathway	Nicotine Action Pathway	Tyrosine hydroxylase deficiency	Heroin Action Pathway	Mepivacaine Action Pathway	Cocaine Pathway	Dihydromorphine Action Pathway	Sufentanil Pathway	Alvimopan Action Pathway	Alfentanil Action Pathway	Fentanyl Action Pathway	Dezocine Action Pathway	Levobupivacaine Pathway	Naloxone Action Pathway	Levallorphan Action Pathway	Methadone Action Pathway	Ropivacaine Pathway	Prilocaine Action Pathway	Citalopram Pathway	Hawkinsinuria	Tyrosine Metabolism	Oxybuprocaine Pathway	Nalbuphine Action Pathway	Fluoxetine Action Pathway	Monoamine oxidase-a deficiency (MAO-A)	Benzocaine Pathway	Hydrocodone Action Pathway	Aromatic L-Aminoacid Decarboxylase Deficiency	Hydromorphone Action Pathway	Propoxyphene Action Pathway	Imipramine Action Pathway	Citalopram Action Pathway	Disulfiram Action Pathway	Dibucaine Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Proparacaine Action Pathway	Desipramine Pathway	Alkaptonuria	Lidocaine (Local Anaesthetic) Pathway	Sufentanil Action Pathway	Oxycodone Action Pathway	Escitalopram Action Pathway	Mepivacaine Pathway	Nicotine Pathway	Codeine Pathway	Dopamine beta-hydroxylase deficiency	Chloroprocaine Action Pathway	Pentazocine Action Pathway	Catecholamine Biosynthesis	Oxymorphone Pathway	Dimethylthiambutene Action Pathway	Oxybuprocaine Action Pathway	Remifentanil Pathway	Desipramine Action Pathway	Codeine Action Pathway	Imipramine Pathway	Remifentanil Action Pathway	Tyrosinemia, transient, of the newborn	Ketobemidone  Action Pathway	Naltrexone Action Pathway	Tramadol Action Action Pathway	Morphine Action Pathway	Hydromorphone Pathway	Chloroprocaine Pathway	Hydrocodone Pathway	Levobupivacaine Action Pathway	Bupivacaine Pathway	Fluoxetine Pathway	Escitalopram Pathway	Morphine Pathway	Oxymorphone Action Pathway	Alfentanil Pathway	Methadone Pathway	Carfentanil Action Pathway	Diphenoxylate Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Cocaine Action Pathway
Norepinephrine	HMDB_SMPDB	Samples:	59	Pathways:	63	Nalbuphine Action Pathway	Tyrosinemia Type I	Levomethadyl Acetate Action Action Pathway	Monoamine oxidase-a deficiency (MAO-A)	Ethylmorphine Action Pathway	Benzocaine Pathway	Aromatic L-Aminoacid Decarboxylase Deficiency	Propoxyphene Action Pathway	3-Methylthiofentanyl Action Pathway	Levorphanol Action Pathway	Dibucaine Pathway	Heroin Pathway	Anileridine Action Pathway	Methadyl Acetate Action Pathway	Desipramine Pathway	Alkaptonuria	Prilocaine Pathway	Lidocaine (Local Anaesthetic) Pathway	Proparacaine Pathway	Mepivacaine Pathway	Oxycodone Pathway	Nicotine Pathway	Carfentanil Pathway	Codeine Pathway	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosine Metabolism	Pentazocine Action Pathway	Catecholamine Biosynthesis	Fentanyl Pathway	Procaine Pathway	Buprenorphine Action Pathway	Dimethylthiambutene Action Pathway	Oxymorphone Pathway	Remifentanil Pathway	Tyrosine hydroxylase deficiency	Imipramine Pathway	Tyrosinemia, transient, of the newborn	Cocaine Pathway	Ketobemidone  Action Pathway	Naltrexone Action Pathway	Dihydromorphine Action Pathway	Tramadol Action Action Pathway	Sufentanil Pathway	Dezocine Action Pathway	Alvimopan Action Pathway	Levobupivacaine Pathway	Naloxone Action Pathway	Levallorphan Action Pathway	Chloroprocaine Pathway	Hydromorphone Pathway	Hydrocodone Pathway	Ropivacaine Pathway	Citalopram Pathway	Bupivacaine Pathway	Fluoxetine Pathway	Escitalopram Pathway	Morphine Pathway	Hawkinsinuria	Alfentanil Pathway	Methadone Pathway	Diphenoxylate Action Pathway	Oxybuprocaine Pathway
Serotonin	HMDB_SMPDB	Samples:	56	Pathways:	85	Levomethadyl Acetate Action Action Pathway	Ethylmorphine Action Pathway	3-Methylthiofentanyl Action Pathway	Levorphanol Action Pathway	Heroin Pathway	Dibucaine Action Pathway	Prilocaine Pathway	Proparacaine Pathway	Oxycodone Pathway	Carfentanil Pathway	Bupivacaine Action Pathway	Fentanyl Pathway	Ropivacaine Action Pathway	Procaine Action Pathway	Procaine Pathway	Benzocaine Action Pathway	Buprenorphine Action Pathway	Nicotine Action Pathway	Heroin Action Pathway	Mepivacaine Action Pathway	Cocaine Pathway	Dihydromorphine Action Pathway	Sufentanil Pathway	Alvimopan Action Pathway	Alfentanil Action Pathway	Fentanyl Action Pathway	Dezocine Action Pathway	Levobupivacaine Pathway	Naloxone Action Pathway	Levallorphan Action Pathway	Methadone Action Pathway	Ropivacaine Pathway	Prilocaine Action Pathway	Citalopram Pathway	Oxybuprocaine Pathway	Nalbuphine Action Pathway	Fluoxetine Action Pathway	Benzocaine Pathway	Hydrocodone Action Pathway	Hydromorphone Action Pathway	Propoxyphene Action Pathway	Imipramine Action Pathway	Citalopram Action Pathway	Dibucaine Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Proparacaine Action Pathway	Desipramine Pathway	Lidocaine (Local Anaesthetic) Pathway	Sufentanil Action Pathway	Oxycodone Action Pathway	Escitalopram Action Pathway	Mepivacaine Pathway	Nicotine Pathway	Codeine Pathway	Chloroprocaine Action Pathway	Pentazocine Action Pathway	Oxymorphone Pathway	Dimethylthiambutene Action Pathway	Oxybuprocaine Action Pathway	Remifentanil Pathway	Desipramine Action Pathway	Codeine Action Pathway	Imipramine Pathway	Remifentanil Action Pathway	Ketobemidone  Action Pathway	Naltrexone Action Pathway	Tramadol Action Action Pathway	Morphine Action Pathway	Tryptophan Metabolism	Hydromorphone Pathway	Chloroprocaine Pathway	Hydrocodone Pathway	Levobupivacaine Action Pathway	Bupivacaine Pathway	Fluoxetine Pathway	Escitalopram Pathway	Morphine Pathway	Oxymorphone Action Pathway	Alfentanil Pathway	Methadone Pathway	Carfentanil Action Pathway	Diphenoxylate Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Cocaine Action Pathway
Calcium	HMDB_SMPDB	Samples:	93	Pathways:	168	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Levomethadyl Acetate Action Action Pathway	Ureidopropionase deficiency	Lidocaine (Antiarrhythmic) Pathway	Phenindione Action Pathway	Ardeparin Pathway	Dicumarol Pathway	Levorphanol Action Pathway	Clopidogrel Pathway	Proparacaine Pathway	Nisoldipine Pathway	Phenylalanine and Tyrosine Metabolism	Oxycodone Pathway	Teniposide Pathway	Fentanyl Pathway	Pindolol Pathway	Buprenorphine Action Pathway	Citrullinemia Type I	Ibuprofen Pathway	Aminocaproic Acid Pathway	Arbutamine Action Pathway	Esmolol Pathway	Anistreplase Pathway	Dihydromorphine Action Pathway	Sufentanil Pathway	Alvimopan Action Pathway	Coagulation 	Pantothenate and CoA Biosynthesis	Ropivacaine Pathway	Citalopram Pathway	Alprenolol Pathway	Hawkinsinuria	Oxybuprocaine Pathway	Nalbuphine Action Pathway	Atenolol Pathway	Carvedilol Pathway	Teniposide Metabolism Pathway	Benzocaine Pathway	Felodipine Pathway	Aprotinin Pathway	Tranexamic Acid Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Methotrexate Pathway	Desipramine Pathway	Lidocaine (Local Anaesthetic) Pathway	Etoposide Metabolism Pathway	Nicotine Pathway	Codeine Pathway	Dopamine beta-hydroxylase deficiency	Quinidine Pathway	Practolol Action Pathway	Dicoumarol Action Pathway	Propranolol Pathway	Phenprocoumon Pathway	Pentazocine Action Pathway	Epinephrine Action Pathway	Lepirudin Pathway	Oxymorphone Pathway	Dimethylthiambutene Action Pathway	Celecoxib Pathway	Timolol Action Pathway	Streptokinase Pathway	Nadolol Pathway	Imipramine Pathway	Penbutolol Pathway	Phenytoin (Antiarrhythmic) Pathway	Heparin Pathway	Isoprenaline Action Pathway	Ketobemidone  Action Pathway	Argininosuccinic Aciduria	Procainamide (Antiarrhythmic) Pathway	Enoxaparin Pathway	Hydromorphone Pathway	Clopidogrel Metabolism Pathway	Flecainide Pathway	Glibenclamide Pathway	Hydrocodone Pathway	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	Escitalopram Pathway	Alfentanil Pathway	Methadone Pathway	Diphenoxylate Action Pathway	Labetalol Pathway	Tyrosinemia Type I	Warfarin Pathway	Beta-Alanine Metabolism	Ethylmorphine Action Pathway	Verapamil Pathway	Disopyramide Pathway	Folate Metabolism	3-Methylthiofentanyl Action Pathway	Ibutilide Pathway	Nitrendipine Pathway	Heroin Pathway	Prilocaine Pathway	Alteplase Pathway	Nebivolol Pathway	Levobunolol Action Pathway	Carfentanil Pathway	Muscle/Heart Contraction	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Betaxolol Pathway	Procaine Pathway	Bupranolol Action Pathway	Urokinase Pathway	Amlodipine Pathway	Nateglinide Pathway	Carteolol Action Pathway	Carnosinuria, carnosinemia	Nifedipine Pathway	Cocaine Pathway	Urea Cycle	Phenylketonuria	Dezocine Action Pathway	Levobupivacaine Pathway	Naloxone Action Pathway	Levallorphan Action Pathway	Pancreas Function	Isradipine Pathway	Ximelagatran Pathway	Metoprolol Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Nimodipine Pathway	Diltiazem Pathway	Argatroban Pathway	Tyrosine Metabolism	Thyroid hormone synthesis	Monoamine oxidase-a deficiency (MAO-A)	Tenecteplase Pathway	Carbamoyl Phosphate Synthetase Deficiency	Reteplase Pathway	Histidinemia	Propoxyphene Action Pathway	Oxprenolol Pathway	Dibucaine Pathway	Acenocoumarol Pathway	Alkaptonuria	Bivalirudin Pathway	Mepivacaine Pathway	Argininemia	Amiodarone Action Pathway	Gliclazide Pathway	Remifentanil Pathway	Repaglinide Pathway	Mexiletine Pathway	Acebutolol Pathway	Malate-Aspartate Shuttle	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Bevantolol Action Pathway	Naltrexone Action Pathway	Tramadol Action Action Pathway	Chloroprocaine Pathway	Bupivacaine Pathway	Fluoxetine Pathway	Morphine Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Tocainide Pathway	Fondaparinux Pathway	Bisoprolol Pathway	Dobutamine Action Pathway	Folate malabsorption, hereditary	Metipranolol Action Pathway
Adenosine triphosphate	HMDB_SMPDB	Samples:	85	Pathways:	290	Lidocaine (Antiarrhythmic) Pathway	Levomethadyl Acetate Action Action Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Butyrate Metabolism	Beta-Ketothiolase Deficiency	Proparacaine Pathway	Nisoldipine Pathway	Oxycodone Pathway	Mitochondrial Electron Transport Chain	Carnitine-acylcarnitine translocase deficiency	Aspartate Metabolism	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	Fentanyl Pathway	Gastric Acid Production	Carnitine palmitoyl transferase deficiency (I)	Citrullinemia Type I	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Ethylmalonic Encephalopathy	Arbutamine Action Pathway	Malonic Aciduria	Dihydromorphine Action Pathway	Adrenoleukodystrophy, X-linked	Alvimopan Action Pathway	Sufentanil Pathway	Transfer of Acetyl Groups into Mitochondria	Sarcosinemia	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Pantothenate and CoA Biosynthesis	Ropivacaine Pathway	Citalopram Pathway	Succinic semialdehyde dehydrogenase deficiency	Alprenolol Pathway	Sulfite oxidase deficiency	Pyruvate dehydrogenase deficiency (E3)	Fructosuria	Nalbuphine Action Pathway	Congenital Bile Acid Synthesis Defect Type III	Benzocaine Pathway	Arginine and Proline Metabolism	The oncogenic action of Succinate	Felodipine Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Desipramine Pathway	Lidocaine (Local Anaesthetic) Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Etoposide Metabolism Pathway	Codeine Pathway	Quinidine Pathway	sarcosine oncometabolite pathway 	Practolol Action Pathway	Threonine and 2-Oxobutanoate Degradation	Pentazocine Action Pathway	Epinephrine Action Pathway	Familial lipoprotein lipase deficiency	Oxymorphone Pathway	Timolol Action Pathway	Nadolol Pathway	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Acetaminophen Metabolism Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Flecainide Pathway	Glibenclamide Pathway	Hydrocodone Pathway	Alfentanil Pathway	Selenoamino Acid Metabolism	Ranitidine Pathway	Hyperprolinemia Type I	Disopyramide Pathway	Trifunctional protein deficiency	Folate Metabolism	Ibutilide Pathway	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Nitrendipine Pathway	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Prilocaine Pathway	Nebivolol Pathway	Carfentanil Pathway	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Muscle/Heart Contraction	Disulfiram Pathway	Trehalose Degradation	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Beta Oxidation of Very Long Chain Fatty Acids	Betaxolol Pathway	Irinotecan Metabolism Pathway	Hyperglycinemia, non-ketotic	Gemcitabine Metabolism Pathway	Nateglinide Pathway	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Nifedipine Pathway	Cocaine Pathway	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Dezocine Action Pathway	Omeprazole Pathway	Levallorphan Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Metoprolol Pathway	Nimodipine Pathway	Pirenzepine Pathway	Phenylacetate Metabolism	Diltiazem Pathway	Leigh Syndrome	Cerebrotendinous Xanthomatosis (CTX)	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	27-Hydroxylase Deficiency	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Amiodarone Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Fructose intolerance, hereditary	Methylmalonic Aciduria	Isovaleric acidemia	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Glutathione Metabolism	Remifentanil Pathway	Repaglinide Pathway	Congenital Bile Acid Synthesis Defect Type II	Mexiletine Pathway	Acebutolol Pathway	Prolinemia Type II	D-glyceric acidura	Nizatidine Pathway	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Famotidine Pathway	Chloroprocaine Pathway	Glycerolipid Metabolism	Morphine Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Tocainide Pathway	Esomeprazole Pathway	Glycine and Serine Metabolism	Folate malabsorption, hereditary	Metipranolol Action Pathway	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Levorphanol Action Pathway	Homocarnosinosis	Oxidation of Branched Chain Fatty Acids	Clopidogrel Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Gamma-Glutamyltransferase Deficiency	Glutathione Synthetase Deficiency	Nucleotide Sugars Metabolism	3-Methylglutaconic Aciduria Type I	Pindolol Pathway	Canavan Disease	Methionine Metabolism	Buprenorphine Action Pathway	Glycerol Kinase Deficiency	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Lansoprazole Pathway	Esmolol Pathway	Fructose and Mannose Degradation	Metiamide Action Pathway	3-Methylglutaconic Aciduria Type III	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	Pyruvate Metabolism	Oxybuprocaine Pathway	Atenolol Pathway	Carvedilol Pathway	Lactose Intolerance	Primary hyperoxaluria II, PH2	Pantoprazole Pathway	Tramadol Metabolism Pathway	Anileridine Action Pathway	Methotrexate Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Galactosemia II (GALK)	Zellweger Syndrome	Nicotine Pathway	Propranolol Pathway	Betaine Metabolism	Dimethylthiambutene Action Pathway	Carnitine palmitoyl transferase deficiency (II)	Primary Hyperoxaluria Type I	Imipramine Pathway	Penbutolol Pathway	The oncogenic action of Fumarate	Isoprenaline Action Pathway	3-Methylglutaconic Aciduria Type IV	Hypermethioninemia	Ketobemidone  Action Pathway	Argininosuccinic Aciduria	Tryptophan Metabolism	Procainamide (Antiarrhythmic) Pathway	Hydromorphone Pathway	Clopidogrel Metabolism Pathway	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Maple Syrup Urine Disease	Tyrosinemia Type 3 (TYRO3)	Escitalopram Pathway	Methadone Pathway	Diphenoxylate Action Pathway	Labetalol Pathway	Rabeprazole Pathway	Lactic Acidemia	Congenital lactic acidosis	Ethylmorphine Action Pathway	Verapamil Pathway	3-Methylthiofentanyl Action Pathway	Glycine N-methyltransferase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Heroin Pathway	Levobunolol Action Pathway	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Gemcitabine Pathway	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Procaine Pathway	Non Ketotic Hyperglycinemia	Bupranolol Action Pathway	Galactosemia III	Amlodipine Pathway	Gamma-glutamyl-transpeptidase deficiency	Carteolol Action Pathway	Sulfate/Sulfite Metabolism	Fatty acid Metabolism	Fumarase deficiency	Phenylketonuria	Hypoacetylaspartia	Levobupivacaine Pathway	Naloxone Action Pathway	Lactose Degradation	Pancreas Function	Isradipine Pathway	Prolidase Deficiency (PD)	Betazole Action Pathway	Roxatidine acetate Action Pathway	5-Oxoprolinuria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	5-oxoprolinase deficiency	Lamivudine Metabolism Pathway	Cystathionine Beta-Synthase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Glutamate Metabolism	Warburg Effect	Glycolysis	Alanine Metabolism	Familial Hypercholanemia (FHCA)	Carbamoyl Phosphate Synthetase Deficiency	Propoxyphene Action Pathway	Oxprenolol Pathway	Dibucaine Pathway	Cimetidine Pathway	Bile Acid Biosynthesis	Mepivacaine Pathway	Argininemia	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Gliclazide Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	Methionine Adenosyltransferase Deficiency	Histidine Metabolism	Bevantolol Action Pathway	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Naltrexone Action Pathway	Tramadol Action Action Pathway	Ammonia Recycling	Bupivacaine Pathway	Fluoxetine Pathway	L-arginine:glycine amidinotransferase deficiency	Bisoprolol Pathway	Dobutamine Action Pathway
Potassium	HMDB_SMPDB	Samples:	76	Pathways:	171	Lidocaine (Antiarrhythmic) Pathway	Levomethadyl Acetate Action Action Pathway	Indapamide Pathway	Levorphanol Action Pathway	Lysinuric Protein Intolerance	Proparacaine Pathway	Nisoldipine Pathway	Oxycodone Pathway	Fentanyl Pathway	Pindolol Pathway	Gastric Acid Production	Methionine Metabolism	Buprenorphine Action Pathway	Arbutamine Action Pathway	Lansoprazole Pathway	Esmolol Pathway	Chlorthalidone Pathway	Dihydromorphine Action Pathway	Metiamide Action Pathway	Sufentanil Pathway	Alvimopan Action Pathway	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Methyclothiazide Pathway	Ropivacaine Pathway	Citalopram Pathway	Blue diaper syndrome	Iminoglycinuria	Alprenolol Pathway	Amiloride Pathway	Pyruvate Metabolism	Bendroflumethiazide Pathway	Oxybuprocaine Pathway	Nalbuphine Action Pathway	Atenolol Pathway	Carvedilol Pathway	Lactose Intolerance	Benzocaine Pathway	Primary hyperoxaluria II, PH2	Felodipine Pathway	Pantoprazole Pathway	Spironolactone Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Desipramine Pathway	Lidocaine (Local Anaesthetic) Pathway	Nicotine Pathway	Codeine Pathway	Polythiazide Pathway	Quinidine Pathway	sarcosine oncometabolite pathway 	Practolol Action Pathway	Propranolol Pathway	Betaine Metabolism	Pentazocine Action Pathway	Epinephrine Action Pathway	Oxymorphone Pathway	Dimethylthiambutene Action Pathway	Chlorothiazide Pathway	Furosemide Pathway	Timolol Action Pathway	Nadolol Pathway	Eplerenone Pathway	Imipramine Pathway	Penbutolol Pathway	Phenytoin (Antiarrhythmic) Pathway	Isoprenaline Action Pathway	Hypermethioninemia	Ketobemidone  Action Pathway	Triamterene Pathway	Procainamide (Antiarrhythmic) Pathway	Hydromorphone Pathway	Flecainide Pathway	Glibenclamide Pathway	Hydrocodone Pathway	Escitalopram Pathway	Quinethazone Pathway	Alfentanil Pathway	Methadone Pathway	Ranitidine Pathway	Diphenoxylate Action Pathway	Labetalol Pathway	Rabeprazole Pathway	Kidney Function	Ethylmorphine Action Pathway	Verapamil Pathway	Disopyramide Pathway	3-Methylthiofentanyl Action Pathway	Glycine N-methyltransferase Deficiency	Ibutilide Pathway	Nitrendipine Pathway	Heroin Pathway	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Cyclothiazide Pathway	Prilocaine Pathway	Nebivolol Pathway	Levobunolol Action Pathway	Carfentanil Pathway	Muscle/Heart Contraction	Trehalose Degradation	Betaxolol Pathway	Procaine Pathway	Bupranolol Action Pathway	Glucose Transporter Defect (SGLT2)	Amlodipine Pathway	Nateglinide Pathway	Carteolol Action Pathway	Ethacrynic Acid pathway	Nifedipine Pathway	Cocaine Pathway	Cystinuria	Dezocine Action Pathway	Levobupivacaine Pathway	Naloxone Action Pathway	Lactose Degradation	Omeprazole Pathway	Levallorphan Action Pathway	Pancreas Function	Isradipine Pathway	Betazole Action Pathway	Roxatidine acetate Action Pathway	Hydrochlorothiazide Pathway	Metoprolol Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Nimodipine Pathway	Cystathionine Beta-Synthase Deficiency	Pirenzepine Pathway	Diltiazem Pathway	Warburg Effect	Glycolysis	Leigh Syndrome	Lysinuric protein intolerance (LPI)	Propoxyphene Action Pathway	Oxprenolol Pathway	Trichlormethiazide Pathway	Dibucaine Pathway	Hydroflumethiazide Pathway	Pyruvate kinase deficiency	Cimetidine Pathway	Mepivacaine Pathway	Amiodarone Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Bumetanide Pathway	Gliclazide Pathway	Remifentanil Pathway	Repaglinide Pathway	Torsemide Pathway	Mexiletine Pathway	Acebutolol Pathway	Methionine Adenosyltransferase Deficiency	Bevantolol Action Pathway	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Hartnup Disorder	Naltrexone Action Pathway	Nizatidine Pathway	Tramadol Action Action Pathway	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Famotidine Pathway	Chloroprocaine Pathway	Bupivacaine Pathway	Fluoxetine Pathway	Morphine Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Tocainide Pathway	Esomeprazole Pathway	Bisoprolol Pathway	Metolazone Pathway	Dobutamine Action Pathway	Metipranolol Action Pathway
Sodium	HMDB_SMPDB	Samples:	76	Pathways:	135	Lidocaine (Antiarrhythmic) Pathway	Levomethadyl Acetate Action Action Pathway	Indapamide Pathway	Levorphanol Action Pathway	Lysinuric Protein Intolerance	Proparacaine Pathway	Nisoldipine Pathway	Oxycodone Pathway	Fentanyl Pathway	Pindolol Pathway	Buprenorphine Action Pathway	Capecitabine Pathway	Arbutamine Action Pathway	Esmolol Pathway	Chlorthalidone Pathway	Dihydromorphine Action Pathway	Sufentanil Pathway	Alvimopan Action Pathway	Methyclothiazide Pathway	Ropivacaine Pathway	Citalopram Pathway	Blue diaper syndrome	Iminoglycinuria	Alprenolol Pathway	Amiloride Pathway	Bendroflumethiazide Pathway	Oxybuprocaine Pathway	Nalbuphine Action Pathway	Atenolol Pathway	Carvedilol Pathway	Lactose Intolerance	Benzocaine Pathway	Felodipine Pathway	Spironolactone Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Desipramine Pathway	Lidocaine (Local Anaesthetic) Pathway	Nicotine Pathway	Codeine Pathway	Polythiazide Pathway	Quinidine Pathway	Practolol Action Pathway	Propranolol Pathway	Pentazocine Action Pathway	Epinephrine Action Pathway	Oxymorphone Pathway	Dimethylthiambutene Action Pathway	Chlorothiazide Pathway	Furosemide Pathway	Timolol Action Pathway	Nadolol Pathway	Eplerenone Pathway	Imipramine Pathway	Penbutolol Pathway	Phenytoin (Antiarrhythmic) Pathway	Isoprenaline Action Pathway	Triamterene Pathway	Ketobemidone  Action Pathway	Procainamide (Antiarrhythmic) Pathway	Hydromorphone Pathway	Flecainide Pathway	Hydrocodone Pathway	Escitalopram Pathway	Quinethazone Pathway	Capecitabine Metabolism Pathway	Alfentanil Pathway	Methadone Pathway	Diphenoxylate Action Pathway	Labetalol Pathway	Kidney Function	Ethylmorphine Action Pathway	Verapamil Pathway	Disopyramide Pathway	3-Methylthiofentanyl Action Pathway	Ibutilide Pathway	Nitrendipine Pathway	Heroin Pathway	Cyclothiazide Pathway	Prilocaine Pathway	Nebivolol Pathway	Levobunolol Action Pathway	Carfentanil Pathway	Muscle/Heart Contraction	Trehalose Degradation	Betaxolol Pathway	Procaine Pathway	Bupranolol Action Pathway	Glucose Transporter Defect (SGLT2)	Amlodipine Pathway	Carteolol Action Pathway	Ethacrynic Acid pathway	Nifedipine Pathway	Cocaine Pathway	Cystinuria	Dezocine Action Pathway	Levobupivacaine Pathway	Naloxone Action Pathway	Lactose Degradation	Levallorphan Action Pathway	Isradipine Pathway	Hydrochlorothiazide Pathway	Metoprolol Pathway	Nimodipine Pathway	Diltiazem Pathway	Lysinuric protein intolerance (LPI)	Thyroid hormone synthesis	Propoxyphene Action Pathway	Oxprenolol Pathway	Trichlormethiazide Pathway	Dibucaine Pathway	Hydroflumethiazide Pathway	Mepivacaine Pathway	Amiodarone Action Pathway	Bumetanide Pathway	Remifentanil Pathway	Torsemide Pathway	Mexiletine Pathway	Acebutolol Pathway	Bevantolol Action Pathway	Hartnup Disorder	Naltrexone Action Pathway	Tramadol Action Action Pathway	Chloroprocaine Pathway	Bupivacaine Pathway	Fluoxetine Pathway	Morphine Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Tocainide Pathway	Bisoprolol Pathway	Metolazone Pathway	Dobutamine Action Pathway	Metipranolol Action Pathway
ADP	HMDB_SMPDB	Samples:	83	Pathways:	330	Alprenolol Action Pathway	Levomethadyl Acetate Action Action Pathway	Lidocaine (Antiarrhythmic) Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Bisoprolol Action Pathway	Beta-Ketothiolase Deficiency	Proparacaine Pathway	Nisoldipine Pathway	Oxycodone Pathway	Mitochondrial Electron Transport Chain	Carnitine-acylcarnitine translocase deficiency	Bupivacaine Action Pathway	Malonyl-coa decarboxylase deficiency	Fentanyl Pathway	Gastric Acid Production	Citrullinemia Type I	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Arbutamine Action Pathway	Heroin Action Pathway	Malonic Aciduria	Dihydromorphine Action Pathway	Mexiletine Action Pathway	Adrenoleukodystrophy, X-linked	Alvimopan Action Pathway	Sufentanil Pathway	Fentanyl Action Pathway	Transfer of Acetyl Groups into Mitochondria	Methadone Action Pathway	Sarcosinemia	Phenytoin (Antiarrhythmic) Action Pathway	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Labetalol Action Pathway	Ropivacaine Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Pantothenate and CoA Biosynthesis	Citalopram Pathway	Succinic semialdehyde dehydrogenase deficiency	Alprenolol Pathway	Sulfite oxidase deficiency	Pyruvate dehydrogenase deficiency (E3)	Fructosuria	Disopyramide Action Pathway	Nalbuphine Action Pathway	Fluoxetine Action Pathway	Congenital Bile Acid Synthesis Defect Type III	Benzocaine Pathway	Arginine and Proline Metabolism	Hydrocodone Action Pathway	The oncogenic action of Succinate	Felodipine Pathway	Procainamide (Antiarrhythmic) Action Pathway	Tocainide Action Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Proparacaine Action Pathway	Desipramine Pathway	Lidocaine (Local Anaesthetic) Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Sufentanil Action Pathway	Etoposide Metabolism Pathway	Codeine Pathway	Quinidine Pathway	Practolol Action Pathway	Chloroprocaine Action Pathway	Threonine and 2-Oxobutanoate Degradation	Pentazocine Action Pathway	Epinephrine Action Pathway	Familial lipoprotein lipase deficiency	Oxymorphone Pathway	Timolol Action Pathway	Oxprenolol Action Pathway	Nadolol Pathway	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Remifentanil Action Pathway	Isobutyryl-coa dehydrogenase deficiency	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Esmolol Action Pathway	Acetaminophen Metabolism Pathway	Morphine Action Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Acebutolol Action Pathway	Flecainide Pathway	Hydrocodone Pathway	Omeprazole Action Pathway	Alfentanil Pathway	Selenoamino Acid Metabolism	Ranitidine Pathway	Cocaine Action Pathway	Ibutilide Action Pathway	Hyperprolinemia Type I	Disopyramide Pathway	Folate Metabolism	Ibutilide Pathway	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Nitrendipine Pathway	Dibucaine Action Pathway	Prilocaine Pathway	Nebivolol Pathway	Carfentanil Pathway	Muscle/Heart Contraction	Trehalose Degradation	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Beta Oxidation of Very Long Chain Fatty Acids	Betaxolol Pathway	Irinotecan Metabolism Pathway	Hyperglycinemia, non-ketotic	Ranitidine Action Pathway	Nicotine Action Pathway	Gemcitabine Metabolism Pathway	Etoposide Action Pathway	Propranolol Action Pathway	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Nifedipine Pathway	Cocaine Pathway	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Alfentanil Action Pathway	Dezocine Action Pathway	Omeprazole Pathway	Levallorphan Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Fosphenytoin (Antiarrhythmic) Action Pathway	Metoprolol Pathway	Nimodipine Pathway	Famotidine Action Pathway	Pirenzepine Pathway	Diltiazem Pathway	Leigh Syndrome	Atenolol Action Pathway	Cerebrotendinous Xanthomatosis (CTX)	Diltiazem Action Pathway	Citric Acid Cycle	Histidinemia	Imipramine Action Pathway	27-Hydroxylase Deficiency	Betaxolol Action Pathway	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Oxycodone Action Pathway	Amiodarone Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Methotrexate Action Pathway	Nebivolol Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Fructose intolerance, hereditary	Methylmalonic Aciduria	Isovaleric acidemia	Oxybuprocaine Action Pathway	Glutathione Metabolism	Remifentanil Pathway	Codeine Action Pathway	Clopidogrel Action Pathway	Congenital Bile Acid Synthesis Defect Type II	Mexiletine Pathway	Acebutolol Pathway	Prolinemia Type II	D-glyceric acidura	Nizatidine Pathway	Glutaminolysis and Cancer	Quinidine Action Pathway	Amlodipine Action Pathway	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pirenzepine Action Pathway	Famotidine Pathway	Chloroprocaine Pathway	Glycerolipid Metabolism	Esomeprazole Pathway	Morphine Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Tocainide Pathway	Glycine and Serine Metabolism	Carfentanil Action Pathway	Folate malabsorption, hereditary	Metipranolol Action Pathway	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Levorphanol Action Pathway	Homocarnosinosis	Oxidation of Branched Chain Fatty Acids	Clopidogrel Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Felodipine Action Pathway	Gamma-Glutamyltransferase Deficiency	Glutathione Synthetase Deficiency	Nucleotide Sugars Metabolism	3-Methylglutaconic Aciduria Type I	Isradipine Action Pathway	Nizatidine Action Pathway	Pindolol Pathway	Ropivacaine Action Pathway	Buprenorphine Action Pathway	Glycerol Kinase Deficiency	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Lansoprazole Pathway	Esmolol Pathway	Fructose and Mannose Degradation	Nisoldipine Action Pathway	Verapamil Action Pathway	Metiamide Action Pathway	3-Methylglutaconic Aciduria Type III	Irinotecan Action Pathway	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	Pyruvate Metabolism	Oxybuprocaine Pathway	Atenolol Pathway	Carvedilol Pathway	Lactose Intolerance	Primary hyperoxaluria II, PH2	Lansoprazole Action Pathway	Pantoprazole Pathway	Tramadol Metabolism Pathway	Anileridine Action Pathway	Methotrexate Pathway	Gemcitabine Action Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Galactosemia II (GALK)	Escitalopram Action Pathway	Zellweger Syndrome	Nicotine Pathway	Propranolol Pathway	Dimethylthiambutene Action Pathway	Primary Hyperoxaluria Type I	Desipramine Action Pathway	Pantoprazole Action Pathway	Cimetidine Action Pathway	Imipramine Pathway	Penbutolol Pathway	The oncogenic action of Fumarate	Isoprenaline Action Pathway	3-Methylglutaconic Aciduria Type IV	Ketobemidone  Action Pathway	Argininosuccinic Aciduria	Penbutolol Action Pathway	Procainamide (Antiarrhythmic) Pathway	Hydromorphone Pathway	Clopidogrel Metabolism Pathway	Hyperinsulinism-Hyperammonemia Syndrome	Nitrendipine Action Pathway	Maple Syrup Urine Disease	Levobupivacaine Action Pathway	Escitalopram Pathway	Methadone Pathway	Diphenoxylate Action Pathway	Labetalol Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Rabeprazole Action Pathway	Rabeprazole Pathway	Lactic Acidemia	Congenital lactic acidosis	Ethylmorphine Action Pathway	Verapamil Pathway	3-Methylthiofentanyl Action Pathway	Heroin Pathway	Levobunolol Action Pathway	Hyperprolinemia Type II	Gemcitabine Pathway	Procaine Action Pathway	Procaine Pathway	Benzocaine Action Pathway	Non Ketotic Hyperglycinemia	Bupranolol Action Pathway	Galactosemia III	Amlodipine Pathway	Gamma-glutamyl-transpeptidase deficiency	Carteolol Action Pathway	Mepivacaine Action Pathway	Nifedipine Action Pathway	Sulfate/Sulfite Metabolism	Fumarase deficiency	Metoprolol Action Pathway	Levobupivacaine Pathway	Naloxone Action Pathway	Lactose Degradation	Isradipine Pathway	Prolidase Deficiency (PD)	Betazole Action Pathway	Roxatidine acetate Action Pathway	5-Oxoprolinuria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	5-oxoprolinase deficiency	Prilocaine Action Pathway	Lamivudine Metabolism Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Glutamate Metabolism	Warburg Effect	Glycolysis	Alanine Metabolism	Familial Hypercholanemia (FHCA)	Carbamoyl Phosphate Synthetase Deficiency	Hydromorphone Action Pathway	Propoxyphene Action Pathway	Oxprenolol Pathway	Citalopram Action Pathway	Dibucaine Pathway	Cimetidine Pathway	Bile Acid Biosynthesis	Mepivacaine Pathway	Argininemia	Carvedilol Action Pathway	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Histidine Metabolism	Bevantolol Action Pathway	Flecainide Action Pathway	Naltrexone Action Pathway	Nimodipine Action Pathway	Tramadol Action Action Pathway	Nadolol Action Pathway	Esomeprazole Action Pathway	Ammonia Recycling	Bupivacaine Pathway	Fluoxetine Pathway	L-arginine:glycine amidinotransferase deficiency	Oxymorphone Action Pathway	Pindolol Action Pathway	Bisoprolol Pathway	Dobutamine Action Pathway
Phosphate	HMDB_SMPDB	Samples:	87	Pathways:	231	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Levomethadyl Acetate Action Action Pathway	Lidocaine (Antiarrhythmic) Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Levorphanol Action Pathway	Homocarnosinosis	Beta-Ketothiolase Deficiency	Clopidogrel Pathway	Proparacaine Pathway	Nisoldipine Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Oxycodone Pathway	Mitochondrial Electron Transport Chain	Aspartate Metabolism	3-Methylglutaconic Aciduria Type I	Fentanyl Pathway	Pindolol Pathway	Gastric Acid Production	Canavan Disease	Methionine Metabolism	Buprenorphine Action Pathway	Citrullinemia Type I	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Glycerol Kinase Deficiency	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Capecitabine Pathway	Arbutamine Action Pathway	Lansoprazole Pathway	Esmolol Pathway	Fructose and Mannose Degradation	Dihydromorphine Action Pathway	Metiamide Action Pathway	Sufentanil Pathway	Alvimopan Action Pathway	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Sarcosinemia	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Propionic Acidemia	Ropivacaine Pathway	Citalopram Pathway	Valine, Leucine and Isoleucine Degradation	Succinic semialdehyde dehydrogenase deficiency	Alprenolol Pathway	Sulfite oxidase deficiency	Pyruvate dehydrogenase deficiency (E3)	Pyruvate Metabolism	Fructosuria	Oxybuprocaine Pathway	Nalbuphine Action Pathway	Atenolol Pathway	Carvedilol Pathway	Lactose Intolerance	Benzocaine Pathway	Arginine and Proline Metabolism	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Felodipine Pathway	Pantoprazole Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Methotrexate Pathway	Desipramine Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Lidocaine (Local Anaesthetic) Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Etoposide Metabolism Pathway	Nicotine Pathway	Codeine Pathway	Quinidine Pathway	sarcosine oncometabolite pathway 	Practolol Action Pathway	Propranolol Pathway	Betaine Metabolism	Pentazocine Action Pathway	Epinephrine Action Pathway	Familial lipoprotein lipase deficiency	Oxymorphone Pathway	Dimethylthiambutene Action Pathway	Primary Hyperoxaluria Type I	Timolol Action Pathway	Nadolol Pathway	Imipramine Pathway	Penbutolol Pathway	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	Isoprenaline Action Pathway	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hypermethioninemia	Ketobemidone  Action Pathway	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Acetaminophen Metabolism Pathway	Procainamide (Antiarrhythmic) Pathway	Hydromorphone Pathway	Clopidogrel Metabolism Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Flecainide Pathway	Hydrocodone Pathway	Maple Syrup Urine Disease	Escitalopram Pathway	Capecitabine Metabolism Pathway	Alfentanil Pathway	Methadone Pathway	Ranitidine Pathway	Diphenoxylate Action Pathway	Labetalol Pathway	Rabeprazole Pathway	Hyperprolinemia Type I	Lactic Acidemia	Congenital lactic acidosis	Ethylmorphine Action Pathway	Verapamil Pathway	Disopyramide Pathway	Folate Metabolism	3-Methylthiofentanyl Action Pathway	Glycine N-methyltransferase Deficiency	Ibutilide Pathway	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Heroin Pathway	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Nitrendipine Pathway	Prilocaine Pathway	Nebivolol Pathway	Levobunolol Action Pathway	Carfentanil Pathway	Hyperprolinemia Type II	Muscle/Heart Contraction	Trehalose Degradation	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Betaxolol Pathway	Procaine Pathway	Non Ketotic Hyperglycinemia	Irinotecan Metabolism Pathway	Hyperglycinemia, non-ketotic	Bupranolol Action Pathway	Amlodipine Pathway	Carteolol Action Pathway	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Nifedipine Pathway	Cocaine Pathway	Sulfate/Sulfite Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Fumarase deficiency	Hypoacetylaspartia	Dezocine Action Pathway	Levobupivacaine Pathway	Naloxone Action Pathway	Lactose Degradation	Omeprazole Pathway	Levallorphan Action Pathway	Isradipine Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Betazole Action Pathway	Roxatidine acetate Action Pathway	Metoprolol Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Lamivudine Metabolism Pathway	Nimodipine Pathway	Cystathionine Beta-Synthase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Pirenzepine Pathway	Diltiazem Pathway	Glutamate Metabolism	Warburg Effect	Glycolysis	Leigh Syndrome	Alanine Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Citric Acid Cycle	Histidinemia	Propoxyphene Action Pathway	Oxprenolol Pathway	Dibucaine Pathway	Pyruvate kinase deficiency	Cimetidine Pathway	Mepivacaine Pathway	Argininemia	Amiodarone Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Fructose intolerance, hereditary	Methylmalonic Aciduria	Isovaleric acidemia	Remifentanil Pathway	Mexiletine Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	Methionine Adenosyltransferase Deficiency	Prolinemia Type II	Histidine Metabolism	Acebutolol Pathway	D-glyceric acidura	Bevantolol Action Pathway	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Naltrexone Action Pathway	Nizatidine Pathway	Glutaminolysis and Cancer	Tramadol Action Action Pathway	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Famotidine Pathway	Chloroprocaine Pathway	Glycerolipid Metabolism	Ammonia Recycling	Bupivacaine Pathway	Fluoxetine Pathway	L-arginine:glycine amidinotransferase deficiency	Morphine Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Tocainide Pathway	Bisoprolol Pathway	Esomeprazole Pathway	Glycine and Serine Metabolism	Dobutamine Action Pathway	Folate malabsorption, hereditary	Metipranolol Action Pathway
Water	HMDB_SMPDB	Samples:	103	Pathways:	370	Ureidopropionase deficiency	Levomethadyl Acetate Action Action Pathway	Lidocaine (Antiarrhythmic) Pathway	Indapamide Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Butyrate Metabolism	Beta-Ketothiolase Deficiency	Lysinuric Protein Intolerance	Proparacaine Pathway	Nisoldipine Pathway	Nicotine Metabolism Pathway	Oxycodone Pathway	Mitochondrial Electron Transport Chain	Aspartate Metabolism	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	Teniposide Pathway	Fentanyl Pathway	Gastric Acid Production	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Citrullinemia Type I	Pyridoxine dependency with seizures	Ethylmalonic Encephalopathy	Tyrosine hydroxylase deficiency	Arbutamine Action Pathway	Malonic Aciduria	Dihydromorphine Action Pathway	Sufentanil Pathway	Alvimopan Action Pathway	Transfer of Acetyl Groups into Mitochondria	Sarcosinemia	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Methyclothiazide Pathway	Pyruvate dehydrogenase deficiency (E2)	Ropivacaine Pathway	Pantothenate and CoA Biosynthesis	Citalopram Pathway	Blue diaper syndrome	Succinic semialdehyde dehydrogenase deficiency	Alprenolol Pathway	Amiloride Pathway	Sulfite oxidase deficiency	Pyruvate dehydrogenase deficiency (E3)	Segawa syndrome	Hawkinsinuria	Fructosuria	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Nalbuphine Action Pathway	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Felodipine Pathway	Arginine and Proline Metabolism	Benzocaine Pathway	The oncogenic action of Succinate	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Desipramine Pathway	Lidocaine (Local Anaesthetic) Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Etoposide Metabolism Pathway	Polythiazide Pathway	Codeine Pathway	Quinidine Pathway	sarcosine oncometabolite pathway 	Practolol Action Pathway	Pentazocine Action Pathway	Catecholamine Biosynthesis	Epinephrine Action Pathway	Familial lipoprotein lipase deficiency	Oxymorphone Pathway	Chlorothiazide Pathway	Timolol Action Pathway	Furosemide Pathway	Nadolol Pathway	Eplerenone Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Acetaminophen Metabolism Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Flecainide Pathway	Hydrocodone Pathway	GABA-Transaminase Deficiency	Quinethazone Pathway	Alfentanil Pathway	Selenoamino Acid Metabolism	Ranitidine Pathway	Retinol Metabolism	Tyrosinemia Type I	Hyperprolinemia Type I	Venlafaxine Metabolism Pathway	Disopyramide Pathway	Trifunctional protein deficiency	Folate Metabolism	Ibutilide Pathway	Nitrendipine Pathway	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Cyclothiazide Pathway	Prilocaine Pathway	Nebivolol Pathway	Carfentanil Pathway	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Muscle/Heart Contraction	Disulfiram Pathway	Trehalose Degradation	Sorafenib Metabolism Pathway	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Betaxolol Pathway	Celecoxib Metabolism Pathway	Irinotecan Metabolism Pathway	Hyperglycinemia, non-ketotic	Corticosterone methyl oxidase I deficiency (CMO I)	Glucose Transporter Defect (SGLT2)	Gemcitabine Metabolism Pathway	Ethacrynic Acid pathway	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Nifedipine Pathway	Cocaine Pathway	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Cystinuria	Dezocine Action Pathway	Omeprazole Pathway	Levallorphan Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Hydrochlorothiazide Pathway	Metoprolol Pathway	Nimodipine Pathway	Pirenzepine Pathway	Diltiazem Pathway	Tyrosine Metabolism	Leigh Syndrome	Lysinuric protein intolerance (LPI)	Cerebrotendinous Xanthomatosis (CTX)	Thyroid hormone synthesis	Carnitine Synthesis	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Artemether Metabolism Pathway	27-Hydroxylase Deficiency	Vitamin B6 Metabolism	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Steroidogenesis	Ibuprofen Metabolism Pathway	Amiodarone Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Fructose intolerance, hereditary	Bumetanide Pathway	Methylmalonic Aciduria	Isovaleric acidemia	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Glutathione Metabolism	Remifentanil Pathway	Congenital Bile Acid Synthesis Defect Type II	Torsemide Pathway	Mexiletine Pathway	Acebutolol Pathway	Prolinemia Type II	Ubiquinone Biosynthesis	D-glyceric acidura	Nizatidine Pathway	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Famotidine Pathway	Chloroprocaine Pathway	Glycerolipid Metabolism	Esomeprazole Pathway	Morphine Pathway	Tocainide Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Pterine Biosynthesis	Glycine and Serine Metabolism	Folate malabsorption, hereditary	Metipranolol Action Pathway	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Levorphanol Action Pathway	Clopidogrel Pathway	Homocarnosinosis	Phenylalanine and Tyrosine Metabolism	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Gamma-Glutamyltransferase Deficiency	Glutathione Synthetase Deficiency	Nucleotide Sugars Metabolism	3-Methylglutaconic Aciduria Type I	Pindolol Pathway	Canavan Disease	Methionine Metabolism	Buprenorphine Action Pathway	Glycerol Kinase Deficiency	Ibuprofen Pathway	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Capecitabine Pathway	Lansoprazole Pathway	Esmolol Pathway	Fructose and Mannose Degradation	21-hydroxylase deficiency (CYP21)	Chlorthalidone Pathway	Hypophosphatasia	Glucose-Alanine Cycle	Metiamide Action Pathway	3-Methylglutaconic Aciduria Type III	Tamoxifen Pathway	Propanoate Metabolism	Propionic Acidemia	Iminoglycinuria	Valine, Leucine and Isoleucine Degradation	Pyruvate Metabolism	Bendroflumethiazide Pathway	Oxybuprocaine Pathway	Atenolol Pathway	Lactose Intolerance	Carvedilol Pathway	Teniposide Metabolism Pathway	Primary hyperoxaluria II, PH2	Pantoprazole Pathway	Spironolactone Pathway	Tramadol Metabolism Pathway	Anileridine Action Pathway	Methotrexate Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Galactosemia II (GALK)	Zellweger Syndrome	Nicotine Pathway	Dopamine beta-hydroxylase deficiency	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Propranolol Pathway	Betaine Metabolism	17-alpha-hydroxylase deficiency (CYP17)	Dimethylthiambutene Action Pathway	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Celecoxib Pathway	Imipramine Pathway	Penbutolol Pathway	The oncogenic action of Fumarate	Isoprenaline Action Pathway	3-Methylglutaconic Aciduria Type IV	Hypermethioninemia	Ketobemidone  Action Pathway	Triamterene Pathway	Argininosuccinic Aciduria	Procainamide (Antiarrhythmic) Pathway	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Tryptophan Metabolism	Hydromorphone Pathway	Clopidogrel Metabolism Pathway	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Maple Syrup Urine Disease	Tyrosinemia Type 3 (TYRO3)	Escitalopram Pathway	Capecitabine Metabolism Pathway	Methadone Pathway	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Diphenoxylate Action Pathway	Labetalol Pathway	Rabeprazole Pathway	Kidney Function	Congenital lactic acidosis	Degradation of Superoxides	Beta-Alanine Metabolism	Ethylmorphine Action Pathway	Ketone Body Metabolism	Verapamil Pathway	3-Methylthiofentanyl Action Pathway	Glycine N-methyltransferase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Heroin Pathway	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Levobunolol Action Pathway	Sepiapterin reductase deficiency	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dopa-responsive dystonia	Gemcitabine Pathway	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Procaine Pathway	Non Ketotic Hyperglycinemia	Corticosterone methyl oxidase II deficiency - CMO II	Bupranolol Action Pathway	Galactosemia III	Amlodipine Pathway	Gamma-glutamyl-transpeptidase deficiency	Carteolol Action Pathway	Carnosinuria, carnosinemia	Sulfate/Sulfite Metabolism	Fatty acid Metabolism	Hyperphenylalaninemia due to dhpr-deficiency	Phenylketonuria	Fumarase deficiency	Hypoacetylaspartia	Naloxone Action Pathway	Levobupivacaine Pathway	Lactose Degradation	Isradipine Pathway	Prolidase Deficiency (PD)	Betazole Action Pathway	Roxatidine acetate Action Pathway	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	5-Oxoprolinuria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Lamivudine Metabolism Pathway	5-oxoprolinase deficiency	Cystathionine Beta-Synthase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Glutamate Metabolism	Warburg Effect	Glycolysis	Citalopram Metabolism Pathway	Monoamine oxidase-a deficiency (MAO-A)	Familial Hypercholanemia (FHCA)	Carbamoyl Phosphate Synthetase Deficiency	Aromatic L-Aminoacid Decarboxylase Deficiency	Propoxyphene Action Pathway	Oxprenolol Pathway	Trichlormethiazide Pathway	Dibucaine Pathway	Hydroflumethiazide Pathway	Cimetidine Pathway	Bile Acid Biosynthesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mepivacaine Pathway	Argininemia	Vitamin A Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Codeine Metabolism Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	Methionine Adenosyltransferase Deficiency	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Apparent mineralocorticoid excess syndrome	Bevantolol Action Pathway	Hyperlysinemia I, Familial	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Hartnup Disorder	Naltrexone Action Pathway	Tramadol Action Action Pathway	Tamoxifen Metabolism Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Ammonia Recycling	Bupivacaine Pathway	Fluoxetine Pathway	L-arginine:glycine amidinotransferase deficiency	Bisoprolol Pathway	Metolazone Pathway	Dobutamine Action Pathway
Levobupivacaine	HMDB_SMPDB	Samples:	28	Pathways:	1	Levobupivacaine Pathway
Alpha-ketoisovaleric acid	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
(S)-3-Hydroxyisobutyric acid	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Biotin	HMDB_SMPDB	Samples:	62	Pathways:	54	Alanine Metabolism	Congenital lactic acidosis	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Lactic Acidemia	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Citric Acid Cycle	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Homocarnosinosis	Beta-Ketothiolase Deficiency	Pyruvate kinase deficiency	2-Hydroxyglutric Aciduria (D And L Form)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Malonyl-coa decarboxylase deficiency	The oncogenic action of 2-hydroxyglutarate	3-Methylglutaconic Aciduria Type I	Threonine and 2-Oxobutanoate Degradation	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Primary Hyperoxaluria Type I	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Malonic Aciduria	Fumarase deficiency	Glutaminolysis and Cancer	3-Methylglutaconic Aciduria Type III	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Transfer of Acetyl Groups into Mitochondria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Pyruvate dehydrogenase deficiency (E2)	Ammonia Recycling	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome
Acetoacetic acid	HMDB_SMPDB	Samples:	59	Pathways:	32	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Ketone Body Metabolism	Butyrate Metabolism	Beta-Ketothiolase Deficiency	Alkaptonuria	Phenylalanine and Tyrosine Metabolism	Dopamine beta-hydroxylase deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	3-Methylglutaconic Aciduria Type I	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria	3-hydroxyisobutyric acid dehydrogenase deficiency	Tyrosinemia, transient, of the newborn	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Phenylketonuria	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Maple Syrup Urine Disease	Propionic Acidemia	Tyrosinemia Type 3 (TYRO3)	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Hawkinsinuria	Tyrosine Metabolism	Succinyl CoA: 3-ketoacid CoA transferase deficiency
L-Glutamic acid	HMDB_SMPDB	Samples:	62	Pathways:	105	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Ureidopropionase deficiency	Tyrosinemia Type I	Hyperprolinemia Type I	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Lactic Acidemia	Beta-Alanine Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Folate Metabolism	Homocarnosinosis	Beta-Ketothiolase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Gamma-Glutamyltransferase Deficiency	Hyperprolinemia Type II	Glutathione Synthetase Deficiency	Aspartate Metabolism	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	The oncogenic action of 2-hydroxyglutarate	Canavan Disease	Non Ketotic Hyperglycinemia	Citrullinemia Type I	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Hyperglycinemia, non-ketotic	Ibuprofen Pathway	Pyridoxine dependency with seizures	Isovaleric Aciduria	Gamma-glutamyl-transpeptidase deficiency	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	3-Phosphoglycerate dehydrogenase deficiency	Glucose-Alanine Cycle	Malonic Aciduria	Urea Cycle	Phenylketonuria	Hypoacetylaspartia	3-Methylglutaconic Aciduria Type III	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Propanoate Metabolism	Propionic Acidemia	5-Oxoprolinuria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Valine, Leucine and Isoleucine Degradation	5-oxoprolinase deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Hawkinsinuria	Glutamate Metabolism	Warburg Effect	Tyrosine Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Monoamine oxidase-a deficiency (MAO-A)	2-aminoadipic 2-oxoadipic aciduria	Alanine Metabolism	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Histidinemia	Methotrexate Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Alkaptonuria	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Argininemia	Dopamine beta-hydroxylase deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Saccharopinuria/Hyperlysinemia II	Primary Hyperoxaluria Type I	Celecoxib Pathway	Glutathione Metabolism	3-hydroxyisobutyric acid dehydrogenase deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Malate-Aspartate Shuttle	Histidine Metabolism	Tyrosinemia, transient, of the newborn	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Glutaminolysis and Cancer	Tryptophan Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Folate malabsorption, hereditary
L-Isoleucine	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Methylmalonic acid	HMDB_SMPDB	Samples:	57	Pathways:	21	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Oxoglutaric acid	HMDB_SMPDB	Samples:	62	Pathways:	104	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Ureidopropionase deficiency	Tyrosinemia Type I	Hyperprolinemia Type I	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Lactic Acidemia	Beta-Alanine Metabolism	Congenital lactic acidosis	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Homocarnosinosis	Beta-Ketothiolase Deficiency	Oxidation of Branched Chain Fatty Acids	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Hyperprolinemia Type II	Disulfiram Pathway	Aspartate Metabolism	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	The oncogenic action of 2-hydroxyglutarate	Canavan Disease	Non Ketotic Hyperglycinemia	Citrullinemia Type I	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Hyperglycinemia, non-ketotic	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Pyridoxine dependency with seizures	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	3-Phosphoglycerate dehydrogenase deficiency	Glucose-Alanine Cycle	Malonic Aciduria	Urea Cycle	Fumarase deficiency	Phenylketonuria	Hypoacetylaspartia	3-Methylglutaconic Aciduria Type III	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Glutamate Metabolism	Warburg Effect	Tyrosine Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Monoamine oxidase-a deficiency (MAO-A)	2-aminoadipic 2-oxoadipic aciduria	Alanine Metabolism	Carnitine Synthesis	Arginine and Proline Metabolism	The oncogenic action of Succinate	Carbamoyl Phosphate Synthetase Deficiency	Citric Acid Cycle	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Argininemia	Dopamine beta-hydroxylase deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Saccharopinuria/Hyperlysinemia II	Primary Hyperoxaluria Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	Prolinemia Type II	Malate-Aspartate Shuttle	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Tyrosinemia, transient, of the newborn	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Glutaminolysis and Cancer	Tryptophan Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism
Succinic acid	HMDB_SMPDB	Samples:	62	Pathways:	57	Hyperprolinemia Type I	Congenital lactic acidosis	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Carnitine Synthesis	Arginine and Proline Metabolism	The oncogenic action of Succinate	Ketone Body Metabolism	Citric Acid Cycle	Butyrate Metabolism	Homocarnosinosis	Beta-Ketothiolase Deficiency	Oxidation of Branched Chain Fatty Acids	Phytanic Acid Peroxisomal Oxidation	2-Hydroxyglutric Aciduria (D And L Form)	Refsum Disease	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Mitochondrial Electron Transport Chain	Hyperprolinemia Type II	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	The oncogenic action of 2-hydroxyglutarate	3-Methylglutaconic Aciduria Type I	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	3-hydroxyisobutyric acid dehydrogenase deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	The oncogenic action of Fumarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Fumarase deficiency	Glutaminolysis and Cancer	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Maple Syrup Urine Disease	Pyruvate dehydrogenase deficiency (E2)	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	L-arginine:glycine amidinotransferase deficiency	3-hydroxyisobutyric aciduria	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Succinyl CoA: 3-ketoacid CoA transferase deficiency
3-Methyl-2-oxovaleric acid	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Hydrogen carbonate	HMDB_SMPDB	Samples:	70	Pathways:	90	Rabeprazole Pathway	Kidney Function	Lactic Acidemia	Indapamide Pathway	Congenital lactic acidosis	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Beta-Ketothiolase Deficiency	Lysinuric Protein Intolerance	Cyclothiazide Pathway	Malonyl-coa decarboxylase deficiency	The oncogenic action of 2-hydroxyglutarate	3-Methylglutaconic Aciduria Type I	Gastric Acid Production	Methylmalonate Semialdehyde Dehydrogenase Deficiency	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Glucose Transporter Defect (SGLT2)	Ethacrynic Acid pathway	Lansoprazole Pathway	Chlorthalidone Pathway	Urea Cycle	Malonic Aciduria	Cystinuria	Metiamide Action Pathway	Fumarase deficiency	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Omeprazole Pathway	Betazole Action Pathway	Roxatidine acetate Action Pathway	Methyclothiazide Pathway	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Hydrochlorothiazide Pathway	Iminoglycinuria	Blue diaper syndrome	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Amiloride Pathway	Pirenzepine Pathway	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Bendroflumethiazide Pathway	Leigh Syndrome	Lysinuric protein intolerance (LPI)	Alanine Metabolism	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Pantoprazole Pathway	Citric Acid Cycle	Spironolactone Pathway	Trichlormethiazide Pathway	Hydroflumethiazide Pathway	Pyruvate kinase deficiency	Cimetidine Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Polythiazide Pathway	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Threonine and 2-Oxobutanoate Degradation	Bumetanide Pathway	Methylmalonic Aciduria	Isovaleric acidemia	Chlorothiazide Pathway	Primary Hyperoxaluria Type I	Furosemide Pathway	Eplerenone Pathway	Torsemide Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Triamterene Pathway	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Hartnup Disorder	Nizatidine Pathway	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Famotidine Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Maple Syrup Urine Disease	Esomeprazole Pathway	Quinethazone Pathway	Metolazone Pathway	Ranitidine Pathway
L-Leucine	HMDB_SMPDB	Samples:	59	Pathways:	18	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	Glutaminolysis and Cancer	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Ketoleucine	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
L-Valine	HMDB_SMPDB	Samples:	57	Pathways:	21	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
NAD	HMDB_SMPDB	Samples:	80	Pathways:	195	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Ureidopropionase deficiency	Lidocaine (Antiarrhythmic) Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Homocarnosinosis	Beta-Ketothiolase Deficiency	Nicotine Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Mitochondrial Electron Transport Chain	Nucleotide Sugars Metabolism	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Teniposide Pathway	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Methionine Metabolism	Citrullinemia Type I	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Glycerol Kinase Deficiency	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Pyridoxine dependency with seizures	Fructose and Mannose Degradation	21-hydroxylase deficiency (CYP21)	Glucose-Alanine Cycle	Malonic Aciduria	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Sarcosinemia	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Citalopram Pathway	Valine, Leucine and Isoleucine Degradation	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Segawa syndrome	Pyruvate Metabolism	Fructosuria	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Teniposide Metabolism Pathway	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Tramadol Metabolism Pathway	Methotrexate Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Lidocaine (Local Anaesthetic) Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Etoposide Metabolism Pathway	Galactosemia II (GALK)	Zellweger Syndrome	Nicotine Pathway	Codeine Pathway	Dopamine beta-hydroxylase deficiency	sarcosine oncometabolite pathway 	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Threonine and 2-Oxobutanoate Degradation	Betaine Metabolism	Familial lipoprotein lipase deficiency	17-alpha-hydroxylase deficiency (CYP17)	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	11-beta-hydroxylase deficiency (CYP11B1)	Imipramine Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hypermethioninemia	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Acetaminophen Metabolism Pathway	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Maple Syrup Urine Disease	GABA-Transaminase Deficiency	Selenoamino Acid Metabolism	Methadone Pathway	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Retinol Metabolism	Tyrosinemia Type I	Hyperprolinemia Type I	Venlafaxine Metabolism Pathway	Beta-Alanine Metabolism	Congenital lactic acidosis	Ketone Body Metabolism	Trifunctional protein deficiency	Folate Metabolism	Glycine N-methyltransferase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Sepiapterin reductase deficiency	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Disulfiram Pathway	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	The oncogenic action of 2-hydroxyglutarate	Dopa-responsive dystonia	Non Ketotic Hyperglycinemia	Corticosterone methyl oxidase II deficiency - CMO II	Hyperglycinemia, non-ketotic	Galactosemia III	Corticosterone methyl oxidase I deficiency (CMO I)	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Hyperphenylalaninemia due to dhpr-deficiency	Urea Cycle	Fumarase deficiency	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Glutamate Metabolism	Warburg Effect	Tyrosine Metabolism	Glycolysis	Leigh Syndrome	Citalopram Metabolism Pathway	Cerebrotendinous Xanthomatosis (CTX)	Monoamine oxidase-a deficiency (MAO-A)	Familial Hypercholanemia (FHCA)	Carnitine Synthesis	Carbamoyl Phosphate Synthetase Deficiency	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	Artemether Metabolism Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	27-Hydroxylase Deficiency	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Bile Acid Biosynthesis	Steroidogenesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Argininemia	Vitamin A Deficiency	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Fructose intolerance, hereditary	Methylmalonic Aciduria	Isovaleric acidemia	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Codeine Metabolism Pathway	Congenital Bile Acid Synthesis Defect Type II	3-hydroxyisobutyric acid dehydrogenase deficiency	Methionine Adenosyltransferase Deficiency	Malate-Aspartate Shuttle	Histidine Metabolism	Prolinemia Type II	Tyrosinemia, transient, of the newborn	D-glyceric acidura	Apparent mineralocorticoid excess syndrome	Hyperlysinemia I, Familial	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Glutaminolysis and Cancer	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Glycerolipid Metabolism	Ammonia Recycling	Fluoxetine Pathway	L-arginine:glycine amidinotransferase deficiency	Pterine Biosynthesis	Glycine and Serine Metabolism	Folate malabsorption, hereditary
Lipoamide	HMDB_SMPDB	Samples:	62	Pathways:	44	2-aminoadipic 2-oxoadipic aciduria	Congenital lactic acidosis	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Citric Acid Cycle	Beta-Ketothiolase Deficiency	Pyruvate kinase deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	The oncogenic action of 2-hydroxyglutarate	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Lysine Degradation	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Saccharopinuria/Hyperlysinemia II	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Pyridoxine dependency with seizures	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Fumarase deficiency	Glutaminolysis and Cancer	3-Methylglutaconic Aciduria Type III	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Maple Syrup Urine Disease	Pyruvate dehydrogenase deficiency (E2)	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome	Hyperlysinemia II or Saccharopinuria
Dihydrolipoamide	HMDB_SMPDB	Samples:	58	Pathways:	23	3-hydroxyisobutyric acid dehydrogenase deficiency	Primary hyperoxaluria II, PH2	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	Pyruvate kinase deficiency	3-Methylglutaconic Aciduria Type III	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Pyruvate Metabolism	Leigh Syndrome	Isovaleric Aciduria
Methacrylyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Succinyl-CoA	HMDB_SMPDB	Samples:	62	Pathways:	46	Congenital lactic acidosis	Ketone Body Metabolism	The oncogenic action of Succinate	Citric Acid Cycle	Butyrate Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Beta-Ketothiolase Deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	The oncogenic action of 2-hydroxyglutarate	3-Methylglutaconic Aciduria Type I	Threonine and 2-Oxobutanoate Degradation	Non Ketotic Hyperglycinemia	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Hyperglycinemia, non-ketotic	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	3-Phosphoglycerate dehydrogenase deficiency	Malonic Aciduria	Fumarase deficiency	Glutaminolysis and Cancer	3-Methylglutaconic Aciduria Type III	Sarcosinemia	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Maple Syrup Urine Disease	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Glycine and Serine Metabolism	Succinyl CoA: 3-ketoacid CoA transferase deficiency
2-Methylbutyryl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
(S)-3-Hydroxyisobutyryl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
3-Methylglutaconyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Isovaleryl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
2-Methylacetoacetyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Acetyl-CoA	HMDB_SMPDB	Samples:	64	Pathways:	96	Ureidopropionase deficiency	Beta-Alanine Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Congenital lactic acidosis	Ketone Body Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Trifunctional protein deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Homocarnosinosis	Beta-Ketothiolase Deficiency	Oxidation of Branched Chain Fatty Acids	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Carnitine-acylcarnitine translocase deficiency	Disulfiram Pathway	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Beta Oxidation of Very Long Chain Fatty Acids	The oncogenic action of 2-hydroxyglutarate	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Non Ketotic Hyperglycinemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Hyperglycinemia, non-ketotic	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Pyridoxine dependency with seizures	Carnosinuria, carnosinemia	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Malonic Aciduria	Fumarase deficiency	Adrenoleukodystrophy, X-linked	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Sarcosinemia	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Succinic semialdehyde dehydrogenase deficiency	3-hydroxyisobutyric aciduria	Pyruvate dehydrogenase deficiency (E3)	Glutamate Metabolism	Warburg Effect	Pyruvate Metabolism	Lysine Degradation	Leigh Syndrome	Hyperlysinemia II or Saccharopinuria	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Disulfiram Action Pathway	Pyruvate kinase deficiency	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Phytanic Acid Peroxisomal Oxidation	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Vitamin A Deficiency	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Methylmalonic Aciduria	Isovaleric acidemia	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Glutaminolysis and Cancer	Tryptophan Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Maple Syrup Urine Disease	GABA-Transaminase Deficiency	Glycine and Serine Metabolism	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Retinol Metabolism
Isobutyryl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	19	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	Refsum Disease	Phytanic Acid Peroxisomal Oxidation	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
FAD	HMDB_SMPDB	Samples:	82	Pathways:	162	Ureidopropionase deficiency	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Capecitabine Action Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Homocarnosinosis	Beta-Ketothiolase Deficiency	Nicotine Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Gamma-Glutamyltransferase Deficiency	Mitochondrial Electron Transport Chain	Glutathione Synthetase Deficiency	Aspartate Metabolism	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Canavan Disease	Methionine Metabolism	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Glycerol Kinase Deficiency	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Pyridoxine dependency with seizures	Capecitabine Pathway	Hypophosphatasia	Malonic Aciduria	3-Methylglutaconic Aciduria Type III	Sarcosinemia	Phenytoin (Antiarrhythmic) Action Pathway	Pyruvate dehydrogenase deficiency (E2)	Tamoxifen Pathway	Propanoate Metabolism	Propionic Acidemia	Citalopram Pathway	Valine, Leucine and Isoleucine Degradation	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Pyruvate Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Methotrexate Pathway	2-Hydroxyglutric Aciduria (D And L Form)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Zellweger Syndrome	Nicotine Pathway	Dopamine beta-hydroxylase deficiency	sarcosine oncometabolite pathway 	Threonine and 2-Oxobutanoate Degradation	Betaine Metabolism	Familial lipoprotein lipase deficiency	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hypermethioninemia	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Tryptophan Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	Capecitabine Metabolism Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Beta-Alanine Metabolism	Congenital lactic acidosis	Trifunctional protein deficiency	Folate Metabolism	Glycine N-methyltransferase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Disulfiram Pathway	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	The oncogenic action of 2-hydroxyglutarate	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Nicotine Action Pathway	Gamma-glutamyl-transpeptidase deficiency	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Fumarase deficiency	Phenylketonuria	Hypoacetylaspartia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	5-Oxoprolinuria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	5-oxoprolinase deficiency	Tamoxifen Action Pathway	Cystathionine Beta-Synthase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Glutamate Metabolism	Warburg Effect	Tyrosine Metabolism	Leigh Syndrome	Citalopram Metabolism Pathway	Cerebrotendinous Xanthomatosis (CTX)	Thyroid hormone synthesis	Monoamine oxidase-a deficiency (MAO-A)	Familial Hypercholanemia (FHCA)	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	Citalopram Action Pathway	27-Hydroxylase Deficiency	Disulfiram Action Pathway	Vitamin B6 Metabolism	Pyruvate kinase deficiency	Alkaptonuria	Bile Acid Biosynthesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Methotrexate Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Glutathione Metabolism	Congenital Bile Acid Synthesis Defect Type II	3-hydroxyisobutyric acid dehydrogenase deficiency	Methionine Adenosyltransferase Deficiency	Prolinemia Type II	Histidine Metabolism	Tyrosinemia, transient, of the newborn	D-glyceric acidura	Hyperlysinemia I, Familial	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Glutaminolysis and Cancer	Tamoxifen Metabolism Pathway	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Glycerolipid Metabolism	Ammonia Recycling	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Folate malabsorption, hereditary
Propionyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	33	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type III	Familial Hypercholanemia (FHCA)	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	27-Hydroxylase Deficiency	Oxidation of Branched Chain Fatty Acids	Beta-Ketothiolase Deficiency	Phytanic Acid Peroxisomal Oxidation	Refsum Disease	Bile Acid Biosynthesis	Zellweger Syndrome	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Malonyl-coa decarboxylase deficiency	Threonine and 2-Oxobutanoate Degradation	3-Methylglutaconic Aciduria Type I	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria	Congenital Bile Acid Synthesis Defect Type II	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria
2-Methyl-3-hydroxybutyryl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Thiamine pyrophosphate	HMDB_SMPDB	Samples:	62	Pathways:	49	2-aminoadipic 2-oxoadipic aciduria	Congenital lactic acidosis	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Citric Acid Cycle	Oxidation of Branched Chain Fatty Acids	Beta-Ketothiolase Deficiency	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Refsum Disease	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	The oncogenic action of 2-hydroxyglutarate	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Threonine and 2-Oxobutanoate Degradation	Lysine Degradation	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Saccharopinuria/Hyperlysinemia II	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Pyridoxine dependency with seizures	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Fumarase deficiency	Glutaminolysis and Cancer	3-Methylglutaconic Aciduria Type III	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Transfer of Acetyl Groups into Mitochondria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Maple Syrup Urine Disease	Pyruvate dehydrogenase deficiency (E2)	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome	Hyperlysinemia II or Saccharopinuria
3-Hydroxy-3-methylglutaryl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	20	3-hydroxyisobutyric acid dehydrogenase deficiency	Ketone Body Metabolism	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Butyrate Metabolism	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Isovaleric Aciduria
Oxygen	HMDB_SMPDB	Samples:	80	Pathways:	158	Ureidopropionase deficiency	Lidocaine (Antiarrhythmic) Pathway	Valproic Acid Metabolism Pathway	Oxidation of Branched Chain Fatty Acids	Beta-Ketothiolase Deficiency	Clopidogrel Pathway	Nicotine Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Mitochondrial Electron Transport Chain	Aspartate Metabolism	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Teniposide Pathway	Canavan Disease	Methionine Metabolism	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Ibuprofen Pathway	Pyridoxine dependency with seizures	Isovaleric Aciduria	Celecoxib Action Pathway	Tyrosine hydroxylase deficiency	21-hydroxylase deficiency (CYP21)	Hypophosphatasia	3-Methylglutaconic Aciduria Type III	Methadone Action Pathway	Sarcosinemia	Phenytoin (Antiarrhythmic) Action Pathway	Tamoxifen Pathway	Propionic Acidemia	Lidocaine (Antiarrhythmic) Action Pathway	Citalopram Pathway	Valine, Leucine and Isoleucine Degradation	Sulfite oxidase deficiency	Hawkinsinuria	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Fluoxetine Action Pathway	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Teniposide Metabolism Pathway	Arginine and Proline Metabolism	The oncogenic action of Succinate	Tramadol Metabolism Pathway	Desipramine Pathway	Refsum Disease	Lidocaine (Local Anaesthetic) Pathway	Etoposide Metabolism Pathway	Zellweger Syndrome	Nicotine Pathway	Codeine Pathway	Dopamine beta-hydroxylase deficiency	Catecholamine Biosynthesis	17-alpha-hydroxylase deficiency (CYP17)	Saccharopinuria/Hyperlysinemia II	Celecoxib Pathway	Desipramine Action Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Imipramine Pathway	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	The oncogenic action of Fumarate	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hypermethioninemia	Ibuprofen Action Pathway	Tryptophan Metabolism	Clopidogrel Metabolism Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Ethanol Degradation	Maple Syrup Urine Disease	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	Methadone Pathway	Retinol Metabolism	Lidocaine (Local Anaesthetic) Action Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Venlafaxine Metabolism Pathway	Beta-Alanine Metabolism	Degradation of Superoxides	Glycine N-methyltransferase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Hyperprolinemia Type II	Disulfiram Pathway	Sorafenib Metabolism Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Celecoxib Metabolism Pathway	Teniposide Action Pathway	Non Ketotic Hyperglycinemia	Corticosterone methyl oxidase II deficiency - CMO II	Hyperglycinemia, non-ketotic	Nicotine Action Pathway	Corticosterone methyl oxidase I deficiency (CMO I)	Etoposide Action Pathway	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Sulfate/Sulfite Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Phenylketonuria	Hypoacetylaspartia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Tamoxifen Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Lamivudine Metabolism Pathway	Cystathionine Beta-Synthase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Tyrosine Metabolism	Citalopram Metabolism Pathway	Cerebrotendinous Xanthomatosis (CTX)	Monoamine oxidase-a deficiency (MAO-A)	Familial Hypercholanemia (FHCA)	Carnitine Synthesis	Aromatic L-Aminoacid Decarboxylase Deficiency	Histidinemia	Imipramine Action Pathway	Artemether Metabolism Pathway	Citalopram Action Pathway	27-Hydroxylase Deficiency	Disulfiram Action Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Vitamin B6 Metabolism	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Bile Acid Biosynthesis	Steroidogenesis	Ibuprofen Metabolism Pathway	Vitamin A Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Clopidogrel Action Pathway	Codeine Metabolism Pathway	Codeine Action Pathway	Congenital Bile Acid Synthesis Defect Type II	Ubiquinone Biosynthesis	3-hydroxyisobutyric acid dehydrogenase deficiency	Methionine Adenosyltransferase Deficiency	Prolinemia Type II	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Apparent mineralocorticoid excess syndrome	Hyperlysinemia I, Familial	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Glutaminolysis and Cancer	Tamoxifen Metabolism Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Fluoxetine Pathway	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism
Coenzyme A	HMDB_SMPDB	Samples:	64	Pathways:	110	Ureidopropionase deficiency	Beta-Alanine Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Congenital lactic acidosis	Valproic Acid Metabolism Pathway	Ketone Body Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Trifunctional protein deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Homocarnosinosis	Beta-Ketothiolase Deficiency	Oxidation of Branched Chain Fatty Acids	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Carnitine-acylcarnitine translocase deficiency	Disulfiram Pathway	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Beta Oxidation of Very Long Chain Fatty Acids	The oncogenic action of 2-hydroxyglutarate	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Non Ketotic Hyperglycinemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Glycerol Kinase Deficiency	Hyperglycinemia, non-ketotic	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Pyridoxine dependency with seizures	Carnosinuria, carnosinemia	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Malonic Aciduria	Fumarase deficiency	Adrenoleukodystrophy, X-linked	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Sarcosinemia	Pyruvate dehydrogenase deficiency (E2)	Pantothenate and CoA Biosynthesis	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Succinic semialdehyde dehydrogenase deficiency	3-hydroxyisobutyric aciduria	Phenylacetate Metabolism	Pyruvate dehydrogenase deficiency (E3)	Glutamate Metabolism	Warburg Effect	Pyruvate Metabolism	Lysine Degradation	Leigh Syndrome	Hyperlysinemia II or Saccharopinuria	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Familial Hypercholanemia (FHCA)	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	27-Hydroxylase Deficiency	Pyruvate kinase deficiency	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Phytanic Acid Peroxisomal Oxidation	Bile Acid Biosynthesis	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Zellweger Syndrome	Vitamin A Deficiency	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Threonine and 2-Oxobutanoate Degradation	Familial lipoprotein lipase deficiency	Methylmalonic Aciduria	Isovaleric acidemia	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Congenital Bile Acid Synthesis Defect Type II	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	D-glyceric acidura	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Glutaminolysis and Cancer	Tryptophan Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Glycerolipid Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Maple Syrup Urine Disease	GABA-Transaminase Deficiency	Glycine and Serine Metabolism	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Retinol Metabolism
Acetoacetyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	48	2-aminoadipic 2-oxoadipic aciduria	Ketone Body Metabolism	Primary hyperoxaluria II, PH2	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Trifunctional protein deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Beta-Ketothiolase Deficiency	Pyruvate kinase deficiency	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Malonyl-coa decarboxylase deficiency	Lysine Degradation	Carnitine palmitoyl transferase deficiency (I)	Methylmalonic Aciduria	Isovaleric acidemia	Carnitine palmitoyl transferase deficiency (II)	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Saccharopinuria/Hyperlysinemia II	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Pyridoxine dependency with seizures	Isovaleric Aciduria	Ethylmalonic Encephalopathy	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Hyperlysinemia I, Familial	Fatty acid Metabolism	Malonic Aciduria	3-Methylglutaconic Aciduria Type III	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Pyruvate Metabolism	Leigh Syndrome	Hyperlysinemia II or Saccharopinuria
NADH	HMDB_SMPDB	Samples:	80	Pathways:	206	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Ureidopropionase deficiency	Lidocaine (Antiarrhythmic) Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Homocarnosinosis	Beta-Ketothiolase Deficiency	Nicotine Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Mitochondrial Electron Transport Chain	Nucleotide Sugars Metabolism	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Teniposide Pathway	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Methionine Metabolism	Citrullinemia Type I	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Glycerol Kinase Deficiency	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Pyridoxine dependency with seizures	Fructose and Mannose Degradation	21-hydroxylase deficiency (CYP21)	Glucose-Alanine Cycle	Malonic Aciduria	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Methadone Action Pathway	Sarcosinemia	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Lidocaine (Antiarrhythmic) Action Pathway	Citalopram Pathway	Valine, Leucine and Isoleucine Degradation	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Segawa syndrome	Pyruvate Metabolism	Fructosuria	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Fluoxetine Action Pathway	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Teniposide Metabolism Pathway	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Tramadol Metabolism Pathway	Methotrexate Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Lidocaine (Local Anaesthetic) Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Etoposide Metabolism Pathway	Galactosemia II (GALK)	Zellweger Syndrome	Nicotine Pathway	Codeine Pathway	Dopamine beta-hydroxylase deficiency	sarcosine oncometabolite pathway 	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Threonine and 2-Oxobutanoate Degradation	Betaine Metabolism	Familial lipoprotein lipase deficiency	17-alpha-hydroxylase deficiency (CYP17)	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	11-beta-hydroxylase deficiency (CYP11B1)	Imipramine Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hypermethioninemia	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Acetaminophen Metabolism Pathway	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Maple Syrup Urine Disease	GABA-Transaminase Deficiency	Methadone Pathway	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Retinol Metabolism	Lidocaine (Local Anaesthetic) Action Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Venlafaxine Metabolism Pathway	Beta-Alanine Metabolism	Congenital lactic acidosis	Ketone Body Metabolism	Trifunctional protein deficiency	Folate Metabolism	Glycine N-methyltransferase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Sepiapterin reductase deficiency	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Disulfiram Pathway	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	The oncogenic action of 2-hydroxyglutarate	Dopa-responsive dystonia	Teniposide Action Pathway	Non Ketotic Hyperglycinemia	Corticosterone methyl oxidase II deficiency - CMO II	Hyperglycinemia, non-ketotic	Nicotine Action Pathway	Galactosemia III	Corticosterone methyl oxidase I deficiency (CMO I)	Etoposide Action Pathway	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Hyperphenylalaninemia due to dhpr-deficiency	Urea Cycle	Fumarase deficiency	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Glutamate Metabolism	Warburg Effect	Tyrosine Metabolism	Glycolysis	Leigh Syndrome	Citalopram Metabolism Pathway	Cerebrotendinous Xanthomatosis (CTX)	Monoamine oxidase-a deficiency (MAO-A)	Familial Hypercholanemia (FHCA)	Carnitine Synthesis	Carbamoyl Phosphate Synthetase Deficiency	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	Imipramine Action Pathway	Artemether Metabolism Pathway	Citalopram Action Pathway	27-Hydroxylase Deficiency	Disulfiram Action Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Bile Acid Biosynthesis	Steroidogenesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Argininemia	Vitamin A Deficiency	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Methotrexate Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Fructose intolerance, hereditary	Methylmalonic Aciduria	Isovaleric acidemia	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Codeine Metabolism Pathway	Codeine Action Pathway	Congenital Bile Acid Synthesis Defect Type II	3-hydroxyisobutyric acid dehydrogenase deficiency	Methionine Adenosyltransferase Deficiency	Malate-Aspartate Shuttle	Histidine Metabolism	Prolinemia Type II	Tyrosinemia, transient, of the newborn	D-glyceric acidura	Apparent mineralocorticoid excess syndrome	Hyperlysinemia I, Familial	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Glutaminolysis and Cancer	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Glycerolipid Metabolism	Ammonia Recycling	Fluoxetine Pathway	L-arginine:glycine amidinotransferase deficiency	Pterine Biosynthesis	Glycine and Serine Metabolism	Folate malabsorption, hereditary
Pyridoxal 5'-phosphate	HMDB_SMPDB	Samples:	60	Pathways:	109	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Ureidopropionase deficiency	Tyrosinemia Type I	Hyperprolinemia Type I	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Lactic Acidemia	Beta-Alanine Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Folate Metabolism	Glycine N-methyltransferase Deficiency	Homocarnosinosis	Beta-Ketothiolase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Hyperprolinemia Type II	Disulfiram Pathway	Aspartate Metabolism	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Canavan Disease	Non Ketotic Hyperglycinemia	Methionine Metabolism	Citrullinemia Type I	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Hyperglycinemia, non-ketotic	Pyridoxine dependency with seizures	Isovaleric Aciduria	Tyrosine hydroxylase deficiency	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Hypophosphatasia	3-Phosphoglycerate dehydrogenase deficiency	Glucose-Alanine Cycle	Malonic Aciduria	Urea Cycle	Phenylketonuria	Hypoacetylaspartia	3-Methylglutaconic Aciduria Type III	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Propanoate Metabolism	Propionic Acidemia	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Valine, Leucine and Isoleucine Degradation	Cystathionine Beta-Synthase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Hawkinsinuria	Glutamate Metabolism	Tyrosine Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Monoamine oxidase-a deficiency (MAO-A)	2-aminoadipic 2-oxoadipic aciduria	Alanine Metabolism	Carnitine Synthesis	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Aromatic L-Aminoacid Decarboxylase Deficiency	Histidinemia	Vitamin B6 Metabolism	Methotrexate Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Alkaptonuria	Argininemia	Dopamine beta-hydroxylase deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	sarcosine oncometabolite pathway 	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Threonine and 2-Oxobutanoate Degradation	Catecholamine Biosynthesis	Methylmalonic Aciduria	Isovaleric acidemia	Saccharopinuria/Hyperlysinemia II	Primary Hyperoxaluria Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Methionine Adenosyltransferase Deficiency	Malate-Aspartate Shuttle	Histidine Metabolism	Prolinemia Type II	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hypermethioninemia	Tyrosinemia, transient, of the newborn	Hyperlysinemia I, Familial	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Argininosuccinic Aciduria	Glutaminolysis and Cancer	Tryptophan Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Selenoamino Acid Metabolism	Folate malabsorption, hereditary
3-Methylcrotonyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Pyridoxal	HMDB_SMPDB	Samples:	57	Pathways:	19	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hypophosphatasia	Vitamin B6 Metabolism	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Carbon dioxide	HMDB_SMPDB	Samples:	68	Pathways:	151	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Ureidopropionase deficiency	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Homocarnosinosis	Beta-Ketothiolase Deficiency	Oxidation of Branched Chain Fatty Acids	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Nucleotide Sugars Metabolism	Aspartate Metabolism	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Gastric Acid Production	Carnitine palmitoyl transferase deficiency (I)	Canavan Disease	Methionine Metabolism	Citrullinemia Type I	Methylmalonate Semialdehyde Dehydrogenase Deficiency	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Pyridoxine dependency with seizures	Tyrosine hydroxylase deficiency	Lansoprazole Pathway	Malonic Aciduria	Metiamide Action Pathway	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Sarcosinemia	Pyruvate dehydrogenase deficiency (E2)	Pantothenate and CoA Biosynthesis	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Pyruvate Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	2-aminoadipic 2-oxoadipic aciduria	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Pantoprazole Pathway	Methotrexate Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Galactosemia II (GALK)	Dopamine beta-hydroxylase deficiency	Threonine and 2-Oxobutanoate Degradation	Catecholamine Biosynthesis	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hypermethioninemia	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Tryptophan Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Ranitidine Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Rabeprazole Pathway	Beta-Alanine Metabolism	Congenital lactic acidosis	Ketone Body Metabolism	Trifunctional protein deficiency	Folate Metabolism	Glycine N-methyltransferase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Hyperprolinemia Type II	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	The oncogenic action of 2-hydroxyglutarate	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Galactosemia III	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Fumarase deficiency	Phenylketonuria	Hypoacetylaspartia	Omeprazole Pathway	Betazole Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Roxatidine acetate Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Pirenzepine Pathway	Glutamate Metabolism	Warburg Effect	Tyrosine Metabolism	Leigh Syndrome	Monoamine oxidase-a deficiency (MAO-A)	Carnitine Synthesis	Carbamoyl Phosphate Synthetase Deficiency	Aromatic L-Aminoacid Decarboxylase Deficiency	Citric Acid Cycle	Histidinemia	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Cimetidine Pathway	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Methionine Adenosyltransferase Deficiency	Prolinemia Type II	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Hyperlysinemia I, Familial	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Nizatidine Pathway	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Famotidine Pathway	Ammonia Recycling	Esomeprazole Pathway	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Folate malabsorption, hereditary
Tiglyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Adenosylcobalamin	HMDB_SMPDB	Samples:	57	Pathways:	22	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	Threonine and 2-Oxobutanoate Degradation	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
(S)-b-aminoisobutyric acid	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Molybdopterin	HMDB_SMPDB	Samples:	59	Pathways:	27	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hypophosphatasia	Citalopram Action Pathway	Vitamin B6 Metabolism	Beta-Ketothiolase Deficiency	Tryptophan Metabolism	3-Methylglutaconic Aciduria Type III	Nicotine Metabolism Pathway	Nicotine Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Citalopram Metabolism Pathway	Propionic Acidemia	Citalopram Pathway	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Pterine Biosynthesis	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Nicotine Action Pathway	Isovaleric Aciduria
(S)-Methylmalonic acid semialdehyde	HMDB_SMPDB	Samples:	57	Pathways:	21	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
R-Methylmalonyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	22	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	Threonine and 2-Oxobutanoate Degradation	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
S-Methylmalonyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	22	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	Threonine and 2-Oxobutanoate Degradation	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Hydrogen peroxide	HMDB_SMPDB	Samples:	75	Pathways:	101	Ureidopropionase deficiency	Tyrosinemia Type I	Hyperprolinemia Type I	Beta-Alanine Metabolism	Degradation of Superoxides	Glycine N-methyltransferase Deficiency	Clopidogrel Pathway	Beta-Ketothiolase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Nicotine Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Gamma-Glutamyltransferase Deficiency	Hyperprolinemia Type II	Glutathione Synthetase Deficiency	Aspartate Metabolism	Disulfiram Pathway	Sorafenib Metabolism Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Canavan Disease	Non Ketotic Hyperglycinemia	Methionine Metabolism	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Hyperglycinemia, non-ketotic	Ibuprofen Pathway	Nicotine Action Pathway	Pyridoxine dependency with seizures	Isovaleric Aciduria	Gamma-glutamyl-transpeptidase deficiency	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Hypophosphatasia	Sulfate/Sulfite Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Phenylketonuria	Hypoacetylaspartia	3-Methylglutaconic Aciduria Type III	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Propionic Acidemia	5-Oxoprolinuria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Citalopram Pathway	Valine, Leucine and Isoleucine Degradation	5-oxoprolinase deficiency	Lamivudine Metabolism Pathway	Cystathionine Beta-Synthase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Sulfite oxidase deficiency	Hawkinsinuria	Tyrosine Metabolism	Lysine Degradation	Citalopram Metabolism Pathway	Hyperlysinemia II or Saccharopinuria	Thyroid hormone synthesis	Monoamine oxidase-a deficiency (MAO-A)	2-aminoadipic 2-oxoadipic aciduria	Arginine and Proline Metabolism	Histidinemia	Citalopram Action Pathway	Disulfiram Action Pathway	Vitamin B6 Metabolism	Alkaptonuria	Ibuprofen Metabolism Pathway	Nicotine Pathway	Dopamine beta-hydroxylase deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Saccharopinuria/Hyperlysinemia II	Glutathione Metabolism	Clopidogrel Action Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Methionine Adenosyltransferase Deficiency	Prolinemia Type II	Histidine Metabolism	Tyrosinemia, transient, of the newborn	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hypermethioninemia	Hyperlysinemia I, Familial	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Ibuprofen Action Pathway	Tryptophan Metabolism	Clopidogrel Metabolism Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Ethanol Degradation	Maple Syrup Urine Disease	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism
3-Methyl-1-hydroxybutyl-ThPP	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
2-Methyl-1-hydroxypropyl-ThPP 	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
S-(3-Methylbutanoyl)-dihydrolipoamide-E	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
S-(2-Methylpropionyl)-dihydrolipoamide-E	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
S-(2-Methylbutanoyl)-dihydrolipoamide	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
3-Hydroxyisovaleryl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Lipoyl-GMP	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Hydrogen Ion	HMDB_SMPDB	Samples:	77	Pathways:	137	Ureidopropionase deficiency	Lidocaine (Antiarrhythmic) Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Homocarnosinosis	Beta-Ketothiolase Deficiency	Nicotine Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Mitochondrial Electron Transport Chain	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Gastric Acid Production	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Ibuprofen Pathway	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Lansoprazole Pathway	21-hydroxylase deficiency (CYP21)	Glucose-Alanine Cycle	Metiamide Action Pathway	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Pyruvate dehydrogenase deficiency (E2)	Tamoxifen Pathway	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Pyruvate Metabolism	Fatty Acid Elongation In Mitochondria	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Pantoprazole Pathway	Tramadol Metabolism Pathway	Methotrexate Pathway	Desipramine Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Lidocaine (Local Anaesthetic) Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Nicotine Pathway	Dopamine beta-hydroxylase deficiency	17-alpha-hydroxylase deficiency (CYP17)	Carnitine palmitoyl transferase deficiency (II)	Celecoxib Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Imipramine Pathway	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Maple Syrup Urine Disease	GABA-Transaminase Deficiency	Ranitidine Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Rabeprazole Pathway	Beta-Alanine Metabolism	Congenital lactic acidosis	Degradation of Superoxides	Trifunctional protein deficiency	Folate Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Disulfiram Pathway	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	The oncogenic action of 2-hydroxyglutarate	Celecoxib Metabolism Pathway	Corticosterone methyl oxidase II deficiency - CMO II	Corticosterone methyl oxidase I deficiency (CMO I)	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fatty acid Metabolism	Fumarase deficiency	Omeprazole Pathway	Betazole Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Roxatidine acetate Action Pathway	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Pirenzepine Pathway	Glutamate Metabolism	Warburg Effect	Tyrosine Metabolism	Leigh Syndrome	Monoamine oxidase-a deficiency (MAO-A)	Carnitine Synthesis	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Pyruvate kinase deficiency	Cimetidine Pathway	Alkaptonuria	Steroidogenesis	Ibuprofen Metabolism Pathway	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Ubiquinone Biosynthesis	3-hydroxyisobutyric acid dehydrogenase deficiency	Prolinemia Type II	Malate-Aspartate Shuttle	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Apparent mineralocorticoid excess syndrome	Nizatidine Pathway	Glutaminolysis and Cancer	Tamoxifen Metabolism Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Famotidine Pathway	Esomeprazole Pathway	L-arginine:glycine amidinotransferase deficiency	Folate malabsorption, hereditary
(2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
(R)-Methylmalonyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	22	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	Threonine and 2-Oxobutanoate Degradation	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
(S)-3-Hydroxy-3-methylglutaryl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	20	3-hydroxyisobutyric acid dehydrogenase deficiency	Ketone Body Metabolism	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Butyrate Metabolism	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Isovaleric Aciduria
(S)-3-Hydroxyisobutyrate	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
(S)-Methylmalonate semialdehyde	HMDB_SMPDB	Samples:	57	Pathways:	21	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
(S)-Methylmalonyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	22	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	Threonine and 2-Oxobutanoate Degradation	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
2-Methyl-1-hydroxypropyl-ThPP	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
2-Methylbut-2-enoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
2-Methylbutanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
2-Methylprop-2-enoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
2-Methylpropanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	19	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	Refsum Disease	Phytanic Acid Peroxisomal Oxidation	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
2-Oxoglutarate	HMDB_SMPDB	Samples:	62	Pathways:	102	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Ureidopropionase deficiency	Tyrosinemia Type I	Hyperprolinemia Type I	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Lactic Acidemia	Beta-Alanine Metabolism	Congenital lactic acidosis	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Homocarnosinosis	Beta-Ketothiolase Deficiency	Oxidation of Branched Chain Fatty Acids	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Hyperprolinemia Type II	Aspartate Metabolism	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	The oncogenic action of 2-hydroxyglutarate	3-Methylglutaconic Aciduria Type I	Canavan Disease	Non Ketotic Hyperglycinemia	Citrullinemia Type I	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Hyperglycinemia, non-ketotic	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Pyridoxine dependency with seizures	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	3-Phosphoglycerate dehydrogenase deficiency	Glucose-Alanine Cycle	Malonic Aciduria	Urea Cycle	Fumarase deficiency	Phenylketonuria	Hypoacetylaspartia	3-Methylglutaconic Aciduria Type III	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Glutamate Metabolism	Warburg Effect	Tyrosine Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Monoamine oxidase-a deficiency (MAO-A)	2-aminoadipic 2-oxoadipic aciduria	Alanine Metabolism	Carnitine Synthesis	Arginine and Proline Metabolism	The oncogenic action of Succinate	Carbamoyl Phosphate Synthetase Deficiency	Citric Acid Cycle	Disulfiram Action Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Argininemia	Dopamine beta-hydroxylase deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Saccharopinuria/Hyperlysinemia II	Primary Hyperoxaluria Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Prolinemia Type II	Malate-Aspartate Shuttle	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Tyrosinemia, transient, of the newborn	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Glutaminolysis and Cancer	Tryptophan Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism
3-Methyl-2-oxobutanoic acid	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
3-Methyl-2-oxopentanoate	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
3-Methylbutanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
4-Methyl-2-oxopentanoate	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Acetoacetate	HMDB_SMPDB	Samples:	59	Pathways:	32	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Ketone Body Metabolism	Butyrate Metabolism	Disulfiram Action Pathway	Beta-Ketothiolase Deficiency	Alkaptonuria	Phenylalanine and Tyrosine Metabolism	Dopamine beta-hydroxylase deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	3-Methylglutaconic Aciduria Type I	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria	3-hydroxyisobutyric acid dehydrogenase deficiency	Tyrosinemia, transient, of the newborn	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Phenylketonuria	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Maple Syrup Urine Disease	Propionic Acidemia	Tyrosinemia Type 3 (TYRO3)	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Hawkinsinuria	Tyrosine Metabolism	Succinyl CoA: 3-ketoacid CoA transferase deficiency
ATP	HMDB_SMPDB	Samples:	85	Pathways:	285	Alprenolol Action Pathway	Levomethadyl Acetate Action Action Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Butyrate Metabolism	Bisoprolol Action Pathway	Beta-Ketothiolase Deficiency	Mitochondrial Electron Transport Chain	Carnitine-acylcarnitine translocase deficiency	Aspartate Metabolism	Bupivacaine Action Pathway	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	Gastric Acid Production	Carnitine palmitoyl transferase deficiency (I)	Citrullinemia Type I	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Ethylmalonic Encephalopathy	Arbutamine Action Pathway	Heroin Action Pathway	Malonic Aciduria	Dihydromorphine Action Pathway	Mexiletine Action Pathway	Adrenoleukodystrophy, X-linked	Alvimopan Action Pathway	Fentanyl Action Pathway	Transfer of Acetyl Groups into Mitochondria	Methadone Action Pathway	Sarcosinemia	Phenytoin (Antiarrhythmic) Action Pathway	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Labetalol Action Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Pantothenate and CoA Biosynthesis	Succinic semialdehyde dehydrogenase deficiency	Sulfite oxidase deficiency	Pyruvate dehydrogenase deficiency (E3)	Fructosuria	Disopyramide Action Pathway	Nalbuphine Action Pathway	Fluoxetine Action Pathway	Congenital Bile Acid Synthesis Defect Type III	Glibenclamide Action Pathway	Repaglinide Action Pathway	Hydrocodone Action Pathway	Arginine and Proline Metabolism	The oncogenic action of Succinate	Procainamide (Antiarrhythmic) Action Pathway	Tocainide Action Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Proparacaine Action Pathway	Sufentanil Action Pathway	Practolol Action Pathway	Chloroprocaine Action Pathway	Threonine and 2-Oxobutanoate Degradation	Pentazocine Action Pathway	Epinephrine Action Pathway	Familial lipoprotein lipase deficiency	Timolol Action Pathway	Oxprenolol Action Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Remifentanil Action Pathway	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Esmolol Action Pathway	Acetaminophen Metabolism Pathway	Nateglinide Action Pathway	Morphine Action Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Acebutolol Action Pathway	Omeprazole Action Pathway	Selenoamino Acid Metabolism	Cocaine Action Pathway	Ibutilide Action Pathway	Hyperprolinemia Type I	Trifunctional protein deficiency	Folate Metabolism	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Dibucaine Action Pathway	Trehalose Degradation	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Muscle/Heart Contraction	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Beta Oxidation of Very Long Chain Fatty Acids	Hyperglycinemia, non-ketotic	Ranitidine Action Pathway	Nicotine Action Pathway	Etoposide Action Pathway	Propranolol Action Pathway	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Alfentanil Action Pathway	Dezocine Action Pathway	Levallorphan Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Fosphenytoin (Antiarrhythmic) Action Pathway	Famotidine Action Pathway	Phenylacetate Metabolism	Leigh Syndrome	Atenolol Action Pathway	Cerebrotendinous Xanthomatosis (CTX)	Diltiazem Action Pathway	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	Imipramine Action Pathway	27-Hydroxylase Deficiency	Disulfiram Action Pathway	Betaxolol Action Pathway	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Oxycodone Action Pathway	Amiodarone Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Methotrexate Action Pathway	Nebivolol Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Fructose intolerance, hereditary	Methylmalonic Aciduria	Isovaleric acidemia	Oxybuprocaine Action Pathway	Glutathione Metabolism	Clopidogrel Action Pathway	Codeine Action Pathway	Congenital Bile Acid Synthesis Defect Type II	Prolinemia Type II	D-glyceric acidura	Glutaminolysis and Cancer	Quinidine Action Pathway	Amlodipine Action Pathway	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pirenzepine Action Pathway	Glycerolipid Metabolism	Glycine and Serine Metabolism	Carfentanil Action Pathway	Folate malabsorption, hereditary	Metipranolol Action Pathway	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Gliclazide Action Pathway	Levorphanol Action Pathway	Homocarnosinosis	Oxidation of Branched Chain Fatty Acids	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Felodipine Action Pathway	Gamma-Glutamyltransferase Deficiency	Glutathione Synthetase Deficiency	Nucleotide Sugars Metabolism	3-Methylglutaconic Aciduria Type I	Isradipine Action Pathway	Nizatidine Action Pathway	Ropivacaine Action Pathway	Canavan Disease	Methionine Metabolism	Buprenorphine Action Pathway	Glycerol Kinase Deficiency	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Fructose and Mannose Degradation	Nisoldipine Action Pathway	Verapamil Action Pathway	Metiamide Action Pathway	3-Methylglutaconic Aciduria Type III	Irinotecan Action Pathway	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	Pyruvate Metabolism	Lactose Intolerance	Primary hyperoxaluria II, PH2	Lansoprazole Action Pathway	Tramadol Metabolism Pathway	Anileridine Action Pathway	Gemcitabine Action Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Galactosemia II (GALK)	Escitalopram Action Pathway	Zellweger Syndrome	Betaine Metabolism	Dimethylthiambutene Action Pathway	Carnitine palmitoyl transferase deficiency (II)	Primary Hyperoxaluria Type I	Desipramine Action Pathway	Pantoprazole Action Pathway	Cimetidine Action Pathway	The oncogenic action of Fumarate	Isoprenaline Action Pathway	3-Methylglutaconic Aciduria Type IV	Hypermethioninemia	Ketobemidone  Action Pathway	Argininosuccinic Aciduria	Penbutolol Action Pathway	Tryptophan Metabolism	Hyperinsulinism-Hyperammonemia Syndrome	Nitrendipine Action Pathway	Ethanol Degradation	Maple Syrup Urine Disease	Levobupivacaine Action Pathway	Tyrosinemia Type 3 (TYRO3)	Diphenoxylate Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Rabeprazole Action Pathway	Lactic Acidemia	Congenital lactic acidosis	Ethylmorphine Action Pathway	3-Methylthiofentanyl Action Pathway	Glycine N-methyltransferase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Levobunolol Action Pathway	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Procaine Action Pathway	Benzocaine Action Pathway	Non Ketotic Hyperglycinemia	Bupranolol Action Pathway	Galactosemia III	Gamma-glutamyl-transpeptidase deficiency	Carteolol Action Pathway	Mepivacaine Action Pathway	Nifedipine Action Pathway	Sulfate/Sulfite Metabolism	Fatty acid Metabolism	Fumarase deficiency	Phenylketonuria	Metoprolol Action Pathway	Hypoacetylaspartia	Naloxone Action Pathway	Lactose Degradation	Pancreas Function	Betazole Action Pathway	Prolidase Deficiency (PD)	Roxatidine acetate Action Pathway	5-Oxoprolinuria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	5-oxoprolinase deficiency	Prilocaine Action Pathway	Lamivudine Metabolism Pathway	Cystathionine Beta-Synthase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Glutamate Metabolism	Warburg Effect	Glycolysis	Alanine Metabolism	Familial Hypercholanemia (FHCA)	Carbamoyl Phosphate Synthetase Deficiency	Hydromorphone Action Pathway	Propoxyphene Action Pathway	Citalopram Action Pathway	Bile Acid Biosynthesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Argininemia	Carvedilol Action Pathway	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Methionine Adenosyltransferase Deficiency	Histidine Metabolism	Bevantolol Action Pathway	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Flecainide Action Pathway	Naltrexone Action Pathway	Nimodipine Action Pathway	Tramadol Action Action Pathway	Nadolol Action Pathway	Esomeprazole Action Pathway	Ammonia Recycling	L-arginine:glycine amidinotransferase deficiency	Oxymorphone Action Pathway	Pindolol Action Pathway	Dobutamine Action Pathway
CO2	HMDB_SMPDB	Samples:	68	Pathways:	149	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Ureidopropionase deficiency	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Homocarnosinosis	Beta-Ketothiolase Deficiency	Oxidation of Branched Chain Fatty Acids	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Nucleotide Sugars Metabolism	Aspartate Metabolism	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Nizatidine Action Pathway	Gastric Acid Production	Carnitine palmitoyl transferase deficiency (I)	Canavan Disease	Methionine Metabolism	Citrullinemia Type I	Methylmalonate Semialdehyde Dehydrogenase Deficiency	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Pyridoxine dependency with seizures	Tyrosine hydroxylase deficiency	Malonic Aciduria	Metiamide Action Pathway	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Sarcosinemia	Pyruvate dehydrogenase deficiency (E2)	Pantothenate and CoA Biosynthesis	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Pyruvate Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	2-aminoadipic 2-oxoadipic aciduria	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Lansoprazole Action Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Galactosemia II (GALK)	Dopamine beta-hydroxylase deficiency	Catecholamine Biosynthesis	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Pantoprazole Action Pathway	Cimetidine Action Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hypermethioninemia	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Tryptophan Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	Omeprazole Action Pathway	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Rabeprazole Action Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Beta-Alanine Metabolism	Congenital lactic acidosis	Ketone Body Metabolism	Trifunctional protein deficiency	Folate Metabolism	Glycine N-methyltransferase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Hyperprolinemia Type II	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	The oncogenic action of 2-hydroxyglutarate	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Ranitidine Action Pathway	Galactosemia III	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Fumarase deficiency	Phenylketonuria	Hypoacetylaspartia	Betazole Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Roxatidine acetate Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Famotidine Action Pathway	3-hydroxyisobutyric aciduria	Glutamate Metabolism	Warburg Effect	Tyrosine Metabolism	Leigh Syndrome	Monoamine oxidase-a deficiency (MAO-A)	Carnitine Synthesis	Carbamoyl Phosphate Synthetase Deficiency	Aromatic L-Aminoacid Decarboxylase Deficiency	Citric Acid Cycle	Histidinemia	Disulfiram Action Pathway	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Methotrexate Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	3-hydroxyisobutyric acid dehydrogenase deficiency	Methionine Adenosyltransferase Deficiency	Prolinemia Type II	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Hyperlysinemia I, Familial	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pirenzepine Action Pathway	Esomeprazole Action Pathway	Ammonia Recycling	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Folate malabsorption, hereditary
CoA	HMDB_SMPDB	Samples:	64	Pathways:	108	Ureidopropionase deficiency	Beta-Alanine Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Congenital lactic acidosis	Valproic Acid Metabolism Pathway	Ketone Body Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Trifunctional protein deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Homocarnosinosis	Beta-Ketothiolase Deficiency	Oxidation of Branched Chain Fatty Acids	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Carnitine-acylcarnitine translocase deficiency	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Beta Oxidation of Very Long Chain Fatty Acids	The oncogenic action of 2-hydroxyglutarate	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Non Ketotic Hyperglycinemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Glycerol Kinase Deficiency	Hyperglycinemia, non-ketotic	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Pyridoxine dependency with seizures	Carnosinuria, carnosinemia	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Malonic Aciduria	Fumarase deficiency	Adrenoleukodystrophy, X-linked	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Sarcosinemia	Pyruvate dehydrogenase deficiency (E2)	Pantothenate and CoA Biosynthesis	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Succinic semialdehyde dehydrogenase deficiency	3-hydroxyisobutyric aciduria	Phenylacetate Metabolism	Pyruvate dehydrogenase deficiency (E3)	Glutamate Metabolism	Warburg Effect	Pyruvate Metabolism	Lysine Degradation	Leigh Syndrome	Hyperlysinemia II or Saccharopinuria	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Familial Hypercholanemia (FHCA)	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	27-Hydroxylase Deficiency	Disulfiram Action Pathway	Pyruvate kinase deficiency	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Phytanic Acid Peroxisomal Oxidation	Bile Acid Biosynthesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Zellweger Syndrome	Vitamin A Deficiency	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Threonine and 2-Oxobutanoate Degradation	Familial lipoprotein lipase deficiency	Methylmalonic Aciduria	Isovaleric acidemia	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Congenital Bile Acid Synthesis Defect Type II	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	D-glyceric acidura	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Glutaminolysis and Cancer	Tryptophan Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Glycerolipid Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Maple Syrup Urine Disease	GABA-Transaminase Deficiency	Glycine and Serine Metabolism	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Retinol Metabolism
Cobamide coenzyme	HMDB_SMPDB	Samples:	57	Pathways:	22	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	Threonine and 2-Oxobutanoate Degradation	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
H+	HMDB_SMPDB	Samples:	75	Pathways:	136	Ureidopropionase deficiency	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Homocarnosinosis	Beta-Ketothiolase Deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Mitochondrial Electron Transport Chain	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Nizatidine Action Pathway	Gastric Acid Production	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Methylmalonate Semialdehyde Dehydrogenase Deficiency	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Celecoxib Action Pathway	21-hydroxylase deficiency (CYP21)	Glucose-Alanine Cycle	Malonic Aciduria	Metiamide Action Pathway	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Phenytoin (Antiarrhythmic) Action Pathway	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Lidocaine (Antiarrhythmic) Action Pathway	Valine, Leucine and Isoleucine Degradation	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Pyruvate Metabolism	Fatty Acid Elongation In Mitochondria	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Lansoprazole Action Pathway	Tramadol Metabolism Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Dopamine beta-hydroxylase deficiency	17-alpha-hydroxylase deficiency (CYP17)	Carnitine palmitoyl transferase deficiency (II)	Desipramine Action Pathway	Pantoprazole Action Pathway	Cimetidine Action Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Ibuprofen Action Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Maple Syrup Urine Disease	GABA-Transaminase Deficiency	Omeprazole Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Rabeprazole Action Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Beta-Alanine Metabolism	Congenital lactic acidosis	Degradation of Superoxides	Trifunctional protein deficiency	Folate Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	The oncogenic action of 2-hydroxyglutarate	Corticosterone methyl oxidase II deficiency - CMO II	Ranitidine Action Pathway	Nicotine Action Pathway	Corticosterone methyl oxidase I deficiency (CMO I)	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fatty acid Metabolism	Fumarase deficiency	Betazole Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Roxatidine acetate Action Pathway	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Tamoxifen Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Famotidine Action Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Glutamate Metabolism	Warburg Effect	Tyrosine Metabolism	Leigh Syndrome	Monoamine oxidase-a deficiency (MAO-A)	Carnitine Synthesis	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	Imipramine Action Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Disulfiram Action Pathway	Pyruvate kinase deficiency	Alkaptonuria	Steroidogenesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Methotrexate Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Ubiquinone Biosynthesis	3-hydroxyisobutyric acid dehydrogenase deficiency	Prolinemia Type II	Malate-Aspartate Shuttle	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Apparent mineralocorticoid excess syndrome	Glutaminolysis and Cancer	Tamoxifen Metabolism Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pirenzepine Action Pathway	Esomeprazole Action Pathway	L-arginine:glycine amidinotransferase deficiency	Folate malabsorption, hereditary
H2O	HMDB_SMPDB	Samples:	102	Pathways:	360	Ureidopropionase deficiency	Levomethadyl Acetate Action Action Pathway	Alprenolol Action Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Butyrate Metabolism	Bisoprolol Action Pathway	Beta-Ketothiolase Deficiency	Lysinuric Protein Intolerance	Mitochondrial Electron Transport Chain	Aspartate Metabolism	Bupivacaine Action Pathway	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	Gastric Acid Production	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Citrullinemia Type I	Eplerenone Action Pathway	Pyridoxine dependency with seizures	Celecoxib Action Pathway	Ethylmalonic Encephalopathy	Tyrosine hydroxylase deficiency	Arbutamine Action Pathway	Heroin Action Pathway	Malonic Aciduria	Dihydromorphine Action Pathway	Mexiletine Action Pathway	Alvimopan Action Pathway	Fentanyl Action Pathway	Transfer of Acetyl Groups into Mitochondria	Sarcosinemia	Methadone Action Pathway	Phenytoin (Antiarrhythmic) Action Pathway	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Labetalol Action Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Pantothenate and CoA Biosynthesis	Blue diaper syndrome	Ethacrynic Acid Action Pathway	Succinic semialdehyde dehydrogenase deficiency	Sulfite oxidase deficiency	Pyruvate dehydrogenase deficiency (E3)	Segawa syndrome	Hawkinsinuria	Fructosuria	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Disopyramide Action Pathway	Nalbuphine Action Pathway	Fluoxetine Action Pathway	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Hydrocodone Action Pathway	Arginine and Proline Metabolism	Tocainide Action Pathway	The oncogenic action of Succinate	Procainamide (Antiarrhythmic) Action Pathway	Spironolactone Action Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Proparacaine Action Pathway	Sufentanil Action Pathway	Practolol Action Pathway	Chloroprocaine Action Pathway	Pentazocine Action Pathway	Catecholamine Biosynthesis	Epinephrine Action Pathway	Familial lipoprotein lipase deficiency	Trichlormethiazide Action Pathway	Timolol Action Pathway	Oxprenolol Action Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Remifentanil Action Pathway	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Chlorthalidone Action Pathway	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Esmolol Action Pathway	Acetaminophen Metabolism Pathway	Morphine Action Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Acebutolol Action Pathway	GABA-Transaminase Deficiency	Omeprazole Action Pathway	Selenoamino Acid Metabolism	Retinol Metabolism	Cocaine Action Pathway	Ibutilide Action Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Venlafaxine Metabolism Pathway	Trifunctional protein deficiency	Folate Metabolism	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Dibucaine Action Pathway	Trehalose Degradation	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Muscle/Heart Contraction	Sorafenib Metabolism Pathway	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Quinethazone Action Pathway	Hyperglycinemia, non-ketotic	Ranitidine Action Pathway	Nicotine Action Pathway	Corticosterone methyl oxidase I deficiency (CMO I)	Glucose Transporter Defect (SGLT2)	Etoposide Action Pathway	Propranolol Action Pathway	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Cystinuria	Alfentanil Action Pathway	Dezocine Action Pathway	Levallorphan Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Fosphenytoin (Antiarrhythmic) Action Pathway	Hydroflumethiazide Action Pathway	Tamoxifen Action Pathway	Famotidine Action Pathway	Tyrosine Metabolism	Leigh Syndrome	Atenolol Action Pathway	Lysinuric protein intolerance (LPI)	Cerebrotendinous Xanthomatosis (CTX)	Cyclothiazide Action Pathway	Thyroid hormone synthesis	Diltiazem Action Pathway	Carnitine Synthesis	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	Imipramine Action Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Artemether Metabolism Pathway	27-Hydroxylase Deficiency	Betaxolol Action Pathway	Disulfiram Action Pathway	Vitamin B6 Metabolism	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Steroidogenesis	Oxycodone Action Pathway	Amiodarone Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Methotrexate Action Pathway	Nebivolol Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Fructose intolerance, hereditary	Chlorothiazide Action Pathway	Methylmalonic Aciduria	Isovaleric acidemia	Oxybuprocaine Action Pathway	Clopidogrel Action Pathway	Glutathione Metabolism	Codeine Action Pathway	Congenital Bile Acid Synthesis Defect Type II	Ubiquinone Biosynthesis	Prolinemia Type II	D-glyceric acidura	Glutaminolysis and Cancer	Quinidine Action Pathway	Amlodipine Action Pathway	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pirenzepine Action Pathway	Glycerolipid Metabolism	Pterine Biosynthesis	Glycine and Serine Metabolism	Carfentanil Action Pathway	Folate malabsorption, hereditary	Metipranolol Action Pathway	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Valproic Acid Metabolism Pathway	Capecitabine Action Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Levorphanol Action Pathway	Homocarnosinosis	Phenylalanine and Tyrosine Metabolism	Felodipine Action Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Gamma-Glutamyltransferase Deficiency	Triamterene Action Pathway	Furosemide Action Pathway	Glutathione Synthetase Deficiency	Nucleotide Sugars Metabolism	3-Methylglutaconic Aciduria Type I	Isradipine Action Pathway	Nizatidine Action Pathway	Ropivacaine Action Pathway	Canavan Disease	Methionine Metabolism	Buprenorphine Action Pathway	Glycerol Kinase Deficiency	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Fructose and Mannose Degradation	21-hydroxylase deficiency (CYP21)	Hypophosphatasia	Nisoldipine Action Pathway	Polythiazide Action Pathway	Verapamil Action Pathway	Glucose-Alanine Cycle	Metiamide Action Pathway	3-Methylglutaconic Aciduria Type III	Irinotecan Action Pathway	Methyclothiazide Action Pathway	Propanoate Metabolism	Propionic Acidemia	Iminoglycinuria	Valine, Leucine and Isoleucine Degradation	Pyruvate Metabolism	Lactose Intolerance	Teniposide Metabolism Pathway	Primary hyperoxaluria II, PH2	Bendroflumethiazide Action Pathway	Lansoprazole Action Pathway	Tramadol Metabolism Pathway	Anileridine Action Pathway	Gemcitabine Action Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Galactosemia II (GALK)	Escitalopram Action Pathway	Hydrochlorothiazide Action Pathway	Zellweger Syndrome	Dopamine beta-hydroxylase deficiency	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Betaine Metabolism	17-alpha-hydroxylase deficiency (CYP17)	Dimethylthiambutene Action Pathway	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Desipramine Action Pathway	Pantoprazole Action Pathway	Cimetidine Action Pathway	The oncogenic action of Fumarate	Isoprenaline Action Pathway	3-Methylglutaconic Aciduria Type IV	Hypermethioninemia	Ketobemidone  Action Pathway	Argininosuccinic Aciduria	Ibuprofen Action Pathway	Penbutolol Action Pathway	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Nitrendipine Action Pathway	Ethanol Degradation	Amiloride Action Pathway	Maple Syrup Urine Disease	Levobupivacaine Action Pathway	Tyrosinemia Type 3 (TYRO3)	Capecitabine Metabolism Pathway	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Diphenoxylate Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Rabeprazole Action Pathway	Kidney Function	Congenital lactic acidosis	Degradation of Superoxides	Beta-Alanine Metabolism	Ethylmorphine Action Pathway	Ketone Body Metabolism	3-Methylthiofentanyl Action Pathway	Glycine N-methyltransferase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Bumetanide Action Pathway	Levobunolol Action Pathway	Sepiapterin reductase deficiency	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dopa-responsive dystonia	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Teniposide Action Pathway	Procaine Action Pathway	Benzocaine Action Pathway	Non Ketotic Hyperglycinemia	Corticosterone methyl oxidase II deficiency - CMO II	Bupranolol Action Pathway	Galactosemia III	Gamma-glutamyl-transpeptidase deficiency	Torsemide Action Pathway	Carteolol Action Pathway	Carnosinuria, carnosinemia	Mepivacaine Action Pathway	Nifedipine Action Pathway	Sulfate/Sulfite Metabolism	Fatty acid Metabolism	Hyperphenylalaninemia due to dhpr-deficiency	Phenylketonuria	Metoprolol Action Pathway	Fumarase deficiency	Hypoacetylaspartia	Naloxone Action Pathway	Lactose Degradation	Betazole Action Pathway	Prolidase Deficiency (PD)	Roxatidine acetate Action Pathway	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	5-Oxoprolinuria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Lamivudine Metabolism Pathway	5-oxoprolinase deficiency	Prilocaine Action Pathway	Cystathionine Beta-Synthase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Glutamate Metabolism	Warburg Effect	Glycolysis	Monoamine oxidase-a deficiency (MAO-A)	Familial Hypercholanemia (FHCA)	Carbamoyl Phosphate Synthetase Deficiency	Aromatic L-Aminoacid Decarboxylase Deficiency	Propoxyphene Action Pathway	Hydromorphone Action Pathway	Citalopram Action Pathway	Metolazone Action Pathway	Bile Acid Biosynthesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Argininemia	Carvedilol Action Pathway	Vitamin A Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Indapamide Action Pathway	Methionine Adenosyltransferase Deficiency	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Apparent mineralocorticoid excess syndrome	Bevantolol Action Pathway	Hyperlysinemia I, Familial	Flecainide Action Pathway	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Hartnup Disorder	Naltrexone Action Pathway	Nimodipine Action Pathway	Nadolol Action Pathway	Tramadol Action Action Pathway	Tamoxifen Metabolism Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Esomeprazole Action Pathway	Ammonia Recycling	L-arginine:glycine amidinotransferase deficiency	Oxymorphone Action Pathway	Pindolol Action Pathway	Dobutamine Action Pathway
HCO3-	HMDB_SMPDB	Samples:	70	Pathways:	88	Kidney Function	Lactic Acidemia	Congenital lactic acidosis	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Beta-Ketothiolase Deficiency	Bumetanide Action Pathway	Lysinuric Protein Intolerance	Triamterene Action Pathway	Furosemide Action Pathway	Malonyl-coa decarboxylase deficiency	The oncogenic action of 2-hydroxyglutarate	3-Methylglutaconic Aciduria Type I	Nizatidine Action Pathway	Gastric Acid Production	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Quinethazone Action Pathway	Ranitidine Action Pathway	Eplerenone Action Pathway	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Glucose Transporter Defect (SGLT2)	Torsemide Action Pathway	Polythiazide Action Pathway	Malonic Aciduria	Cystinuria	Metiamide Action Pathway	Fumarase deficiency	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Betazole Action Pathway	Roxatidine acetate Action Pathway	Methyclothiazide Action Pathway	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Hydroflumethiazide Action Pathway	Iminoglycinuria	Blue diaper syndrome	Valine, Leucine and Isoleucine Degradation	Famotidine Action Pathway	Ethacrynic Acid Action Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome	Lysinuric protein intolerance (LPI)	Cyclothiazide Action Pathway	Alanine Metabolism	Primary hyperoxaluria II, PH2	Bendroflumethiazide Action Pathway	The oncogenic action of Succinate	Lansoprazole Action Pathway	Citric Acid Cycle	Spironolactone Action Pathway	Pyruvate kinase deficiency	Metolazone Action Pathway	Hydrochlorothiazide Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Threonine and 2-Oxobutanoate Degradation	Trichlormethiazide Action Pathway	Chlorothiazide Action Pathway	Methylmalonic Aciduria	Isovaleric acidemia	Primary Hyperoxaluria Type I	Pantoprazole Action Pathway	Cimetidine Action Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Indapamide Action Pathway	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Chlorthalidone Action Pathway	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Hartnup Disorder	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pirenzepine Action Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Esomeprazole Action Pathway	Amiloride Action Pathway	Maple Syrup Urine Disease	Omeprazole Action Pathway	Rabeprazole Action Pathway
L-3-Aminoisobutanoate	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
L-Glutamate	HMDB_SMPDB	Samples:	69	Pathways:	104	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Ureidopropionase deficiency	Tyrosinemia Type I	Hyperprolinemia Type I	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Lactic Acidemia	Beta-Alanine Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Folate Metabolism	Homocarnosinosis	Beta-Ketothiolase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Gamma-Glutamyltransferase Deficiency	Hyperprolinemia Type II	Glutathione Synthetase Deficiency	Aspartate Metabolism	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	The oncogenic action of 2-hydroxyglutarate	3-Methylglutaconic Aciduria Type I	Canavan Disease	Non Ketotic Hyperglycinemia	Citrullinemia Type I	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Hyperglycinemia, non-ketotic	Pyridoxine dependency with seizures	Isovaleric Aciduria	Celecoxib Action Pathway	Gamma-glutamyl-transpeptidase deficiency	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	3-Phosphoglycerate dehydrogenase deficiency	Glucose-Alanine Cycle	Malonic Aciduria	Urea Cycle	Phenylketonuria	Hypoacetylaspartia	3-Methylglutaconic Aciduria Type III	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Propanoate Metabolism	Propionic Acidemia	5-Oxoprolinuria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Valine, Leucine and Isoleucine Degradation	5-oxoprolinase deficiency	Famotidine Action Pathway	Succinic semialdehyde dehydrogenase deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Hawkinsinuria	Glutamate Metabolism	Warburg Effect	Tyrosine Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Monoamine oxidase-a deficiency (MAO-A)	2-aminoadipic 2-oxoadipic aciduria	Alanine Metabolism	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Histidinemia	Disulfiram Action Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Alkaptonuria	Argininemia	Dopamine beta-hydroxylase deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Methotrexate Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Saccharopinuria/Hyperlysinemia II	Primary Hyperoxaluria Type I	Glutathione Metabolism	3-hydroxyisobutyric acid dehydrogenase deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Malate-Aspartate Shuttle	Histidine Metabolism	Tyrosinemia, transient, of the newborn	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Ibuprofen Action Pathway	Glutaminolysis and Cancer	Tryptophan Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Folate malabsorption, hereditary
Methylmalonate	HMDB_SMPDB	Samples:	57	Pathways:	21	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
NAD+	HMDB_SMPDB	Samples:	80	Pathways:	189	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Ureidopropionase deficiency	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Homocarnosinosis	Beta-Ketothiolase Deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Mitochondrial Electron Transport Chain	Nucleotide Sugars Metabolism	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Methionine Metabolism	Citrullinemia Type I	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Glycerol Kinase Deficiency	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Pyridoxine dependency with seizures	Fructose and Mannose Degradation	21-hydroxylase deficiency (CYP21)	Glucose-Alanine Cycle	Malonic Aciduria	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Methadone Action Pathway	Sarcosinemia	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Lidocaine (Antiarrhythmic) Action Pathway	Valine, Leucine and Isoleucine Degradation	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Segawa syndrome	Pyruvate Metabolism	Fructosuria	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Fluoxetine Action Pathway	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Teniposide Metabolism Pathway	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Tramadol Metabolism Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Galactosemia II (GALK)	Zellweger Syndrome	Dopamine beta-hydroxylase deficiency	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Threonine and 2-Oxobutanoate Degradation	Betaine Metabolism	Familial lipoprotein lipase deficiency	17-alpha-hydroxylase deficiency (CYP17)	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	11-beta-hydroxylase deficiency (CYP11B1)	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hypermethioninemia	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Acetaminophen Metabolism Pathway	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Maple Syrup Urine Disease	GABA-Transaminase Deficiency	Selenoamino Acid Metabolism	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Retinol Metabolism	Lidocaine (Local Anaesthetic) Action Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Venlafaxine Metabolism Pathway	Beta-Alanine Metabolism	Congenital lactic acidosis	Ketone Body Metabolism	Trifunctional protein deficiency	Folate Metabolism	Glycine N-methyltransferase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Sepiapterin reductase deficiency	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	The oncogenic action of 2-hydroxyglutarate	Dopa-responsive dystonia	Teniposide Action Pathway	Non Ketotic Hyperglycinemia	Corticosterone methyl oxidase II deficiency - CMO II	Hyperglycinemia, non-ketotic	Nicotine Action Pathway	Galactosemia III	Corticosterone methyl oxidase I deficiency (CMO I)	Etoposide Action Pathway	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Hyperphenylalaninemia due to dhpr-deficiency	Urea Cycle	Fumarase deficiency	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Glutamate Metabolism	Warburg Effect	Tyrosine Metabolism	Glycolysis	Leigh Syndrome	Cerebrotendinous Xanthomatosis (CTX)	Monoamine oxidase-a deficiency (MAO-A)	Familial Hypercholanemia (FHCA)	Carnitine Synthesis	Carbamoyl Phosphate Synthetase Deficiency	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	Imipramine Action Pathway	Artemether Metabolism Pathway	Citalopram Action Pathway	27-Hydroxylase Deficiency	Disulfiram Action Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Bile Acid Biosynthesis	Steroidogenesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Argininemia	Vitamin A Deficiency	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Methotrexate Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Fructose intolerance, hereditary	Methylmalonic Aciduria	Isovaleric acidemia	Codeine Action Pathway	Congenital Bile Acid Synthesis Defect Type II	3-hydroxyisobutyric acid dehydrogenase deficiency	Methionine Adenosyltransferase Deficiency	Malate-Aspartate Shuttle	Histidine Metabolism	Prolinemia Type II	Tyrosinemia, transient, of the newborn	D-glyceric acidura	Apparent mineralocorticoid excess syndrome	Hyperlysinemia I, Familial	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Glutaminolysis and Cancer	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Glycerolipid Metabolism	Ammonia Recycling	L-arginine:glycine amidinotransferase deficiency	Pterine Biosynthesis	Glycine and Serine Metabolism	Folate malabsorption, hereditary
Orthophosphate	HMDB_SMPDB	Samples:	87	Pathways:	241	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Levomethadyl Acetate Action Action Pathway	Alprenolol Action Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Capecitabine Action Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Bisoprolol Action Pathway	Levorphanol Action Pathway	Homocarnosinosis	Beta-Ketothiolase Deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Felodipine Action Pathway	Gamma-Glutamyltransferase Deficiency	Mitochondrial Electron Transport Chain	Glutathione Synthetase Deficiency	Aspartate Metabolism	Bupivacaine Action Pathway	Malonyl-coa decarboxylase deficiency	3-Methylglutaconic Aciduria Type I	Isradipine Action Pathway	Nizatidine Action Pathway	Ropivacaine Action Pathway	Gastric Acid Production	Canavan Disease	Methionine Metabolism	Buprenorphine Action Pathway	Citrullinemia Type I	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Glycerol Kinase Deficiency	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Arbutamine Action Pathway	Fructose and Mannose Degradation	Heroin Action Pathway	Hypophosphatasia	Nisoldipine Action Pathway	Verapamil Action Pathway	Malonic Aciduria	Dihydromorphine Action Pathway	Metiamide Action Pathway	Mexiletine Action Pathway	Alvimopan Action Pathway	3-Methylglutaconic Aciduria Type III	Fentanyl Action Pathway	Transfer of Acetyl Groups into Mitochondria	Irinotecan Action Pathway	Methadone Action Pathway	Sarcosinemia	Phenytoin (Antiarrhythmic) Action Pathway	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Labetalol Action Pathway	Propanoate Metabolism	Propionic Acidemia	Lidocaine (Antiarrhythmic) Action Pathway	Valine, Leucine and Isoleucine Degradation	Succinic semialdehyde dehydrogenase deficiency	Sulfite oxidase deficiency	Pyruvate dehydrogenase deficiency (E3)	Pyruvate Metabolism	Fructosuria	Disopyramide Action Pathway	Nalbuphine Action Pathway	Fluoxetine Action Pathway	Lactose Intolerance	Hydrocodone Action Pathway	Arginine and Proline Metabolism	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Procainamide (Antiarrhythmic) Action Pathway	Tocainide Action Pathway	Lansoprazole Action Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Proparacaine Action Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Sufentanil Action Pathway	Escitalopram Action Pathway	Practolol Action Pathway	Chloroprocaine Action Pathway	Betaine Metabolism	Pentazocine Action Pathway	Epinephrine Action Pathway	Familial lipoprotein lipase deficiency	Dimethylthiambutene Action Pathway	Primary Hyperoxaluria Type I	Timolol Action Pathway	Desipramine Action Pathway	Oxprenolol Action Pathway	Pantoprazole Action Pathway	Cimetidine Action Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Remifentanil Action Pathway	The oncogenic action of Fumarate	Isoprenaline Action Pathway	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hypermethioninemia	Ketobemidone  Action Pathway	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Acetaminophen Metabolism Pathway	Esmolol Action Pathway	Penbutolol Action Pathway	Morphine Action Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Nitrendipine Action Pathway	Acebutolol Action Pathway	Maple Syrup Urine Disease	Levobupivacaine Action Pathway	Omeprazole Action Pathway	Capecitabine Metabolism Pathway	Selenoamino Acid Metabolism	Diphenoxylate Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Cocaine Action Pathway	Ibutilide Action Pathway	Rabeprazole Action Pathway	Hyperprolinemia Type I	Lactic Acidemia	Congenital lactic acidosis	Ethylmorphine Action Pathway	Folate Metabolism	3-Methylthiofentanyl Action Pathway	Glycine N-methyltransferase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Dibucaine Action Pathway	Levobunolol Action Pathway	Trehalose Degradation	Hyperprolinemia Type II	Muscle/Heart Contraction	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Procaine Action Pathway	Benzocaine Action Pathway	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Ranitidine Action Pathway	Nicotine Action Pathway	Bupranolol Action Pathway	Gamma-glutamyl-transpeptidase deficiency	Etoposide Action Pathway	Carteolol Action Pathway	Propranolol Action Pathway	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Mepivacaine Action Pathway	Nifedipine Action Pathway	Sulfate/Sulfite Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Fumarase deficiency	Metoprolol Action Pathway	Hypoacetylaspartia	Alfentanil Action Pathway	Dezocine Action Pathway	Naloxone Action Pathway	Lactose Degradation	Levallorphan Action Pathway	Betazole Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Fosphenytoin (Antiarrhythmic) Action Pathway	Roxatidine acetate Action Pathway	5-Oxoprolinuria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	5-oxoprolinase deficiency	Prilocaine Action Pathway	Lamivudine Metabolism Pathway	Cystathionine Beta-Synthase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Famotidine Action Pathway	Glutamate Metabolism	Warburg Effect	Glycolysis	Leigh Syndrome	Atenolol Action Pathway	Alanine Metabolism	Diltiazem Action Pathway	Carbamoyl Phosphate Synthetase Deficiency	Hydromorphone Action Pathway	Citric Acid Cycle	Histidinemia	Imipramine Action Pathway	Citalopram Action Pathway	Propoxyphene Action Pathway	Betaxolol Action Pathway	Vitamin B6 Metabolism	Pyruvate kinase deficiency	Oxycodone Action Pathway	Amiodarone Action Pathway	Argininemia	Carvedilol Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Methotrexate Action Pathway	Nebivolol Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Fructose intolerance, hereditary	Methylmalonic Aciduria	Isovaleric acidemia	Oxybuprocaine Action Pathway	Glutathione Metabolism	Clopidogrel Action Pathway	Codeine Action Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	Methionine Adenosyltransferase Deficiency	Prolinemia Type II	Histidine Metabolism	D-glyceric acidura	Bevantolol Action Pathway	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Flecainide Action Pathway	Naltrexone Action Pathway	Nimodipine Action Pathway	Glutaminolysis and Cancer	Tramadol Action Action Pathway	Amlodipine Action Pathway	Nadolol Action Pathway	Quinidine Action Pathway	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pirenzepine Action Pathway	Glycerolipid Metabolism	Esomeprazole Action Pathway	Ammonia Recycling	L-arginine:glycine amidinotransferase deficiency	Oxymorphone Action Pathway	Pindolol Action Pathway	Glycine and Serine Metabolism	Carfentanil Action Pathway	Dobutamine Action Pathway	Folate malabsorption, hereditary	Metipranolol Action Pathway
Propanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	33	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type III	Familial Hypercholanemia (FHCA)	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	27-Hydroxylase Deficiency	Oxidation of Branched Chain Fatty Acids	Beta-Ketothiolase Deficiency	Phytanic Acid Peroxisomal Oxidation	Refsum Disease	Bile Acid Biosynthesis	Zellweger Syndrome	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Malonyl-coa decarboxylase deficiency	Threonine and 2-Oxobutanoate Degradation	3-Methylglutaconic Aciduria Type I	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria	Congenital Bile Acid Synthesis Defect Type II	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria
Pyridoxal phosphate	HMDB_SMPDB	Samples:	60	Pathways:	107	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Ureidopropionase deficiency	Tyrosinemia Type I	Hyperprolinemia Type I	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Lactic Acidemia	Beta-Alanine Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Folate Metabolism	Glycine N-methyltransferase Deficiency	Homocarnosinosis	Beta-Ketothiolase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Hyperprolinemia Type II	Aspartate Metabolism	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	3-Methylglutaconic Aciduria Type I	Canavan Disease	Non Ketotic Hyperglycinemia	Methionine Metabolism	Citrullinemia Type I	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Hyperglycinemia, non-ketotic	Pyridoxine dependency with seizures	Isovaleric Aciduria	Tyrosine hydroxylase deficiency	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Hypophosphatasia	3-Phosphoglycerate dehydrogenase deficiency	Glucose-Alanine Cycle	Malonic Aciduria	Urea Cycle	Phenylketonuria	Hypoacetylaspartia	3-Methylglutaconic Aciduria Type III	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Propanoate Metabolism	Propionic Acidemia	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Valine, Leucine and Isoleucine Degradation	Cystathionine Beta-Synthase Deficiency	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Hawkinsinuria	Glutamate Metabolism	Tyrosine Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Monoamine oxidase-a deficiency (MAO-A)	2-aminoadipic 2-oxoadipic aciduria	Alanine Metabolism	Carnitine Synthesis	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Aromatic L-Aminoacid Decarboxylase Deficiency	Histidinemia	Disulfiram Action Pathway	Vitamin B6 Metabolism	2-Hydroxyglutric Aciduria (D And L Form)	Alkaptonuria	Argininemia	Dopamine beta-hydroxylase deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Methotrexate Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Threonine and 2-Oxobutanoate Degradation	Catecholamine Biosynthesis	Methylmalonic Aciduria	Isovaleric acidemia	Saccharopinuria/Hyperlysinemia II	Primary Hyperoxaluria Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Methionine Adenosyltransferase Deficiency	Malate-Aspartate Shuttle	Histidine Metabolism	Prolinemia Type II	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hypermethioninemia	Tyrosinemia, transient, of the newborn	Hyperlysinemia I, Familial	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Argininosuccinic Aciduria	Glutaminolysis and Cancer	Tryptophan Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Selenoamino Acid Metabolism	Folate malabsorption, hereditary
S-(2-Methylpropanoyl)-dihydrolipoamide	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
S-(3-Methylbutanoyl)-dihydrolipoamide	HMDB_SMPDB	Samples:	57	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Succinate	HMDB_SMPDB	Samples:	62	Pathways:	56	Hyperprolinemia Type I	Congenital lactic acidosis	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Carnitine Synthesis	Arginine and Proline Metabolism	The oncogenic action of Succinate	Ketone Body Metabolism	Citric Acid Cycle	Butyrate Metabolism	Homocarnosinosis	Beta-Ketothiolase Deficiency	Oxidation of Branched Chain Fatty Acids	Phytanic Acid Peroxisomal Oxidation	2-Hydroxyglutric Aciduria (D And L Form)	Refsum Disease	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Mitochondrial Electron Transport Chain	Hyperprolinemia Type II	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	The oncogenic action of 2-hydroxyglutarate	3-Methylglutaconic Aciduria Type I	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	3-hydroxyisobutyric acid dehydrogenase deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	The oncogenic action of Fumarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Fumarase deficiency	Glutaminolysis and Cancer	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Maple Syrup Urine Disease	Pyruvate dehydrogenase deficiency (E2)	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	L-arginine:glycine amidinotransferase deficiency	3-hydroxyisobutyric aciduria	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Succinyl CoA: 3-ketoacid CoA transferase deficiency
Thiamin diphosphate	HMDB_SMPDB	Samples:	62	Pathways:	51	2-aminoadipic 2-oxoadipic aciduria	Congenital lactic acidosis	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Citric Acid Cycle	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Oxidation of Branched Chain Fatty Acids	Beta-Ketothiolase Deficiency	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Refsum Disease	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Malonyl-coa decarboxylase deficiency	The oncogenic action of 2-hydroxyglutarate	3-Methylglutaconic Aciduria Type I	Threonine and 2-Oxobutanoate Degradation	Lysine Degradation	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Saccharopinuria/Hyperlysinemia II	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Pyridoxine dependency with seizures	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Malonic Aciduria	Fumarase deficiency	Glutaminolysis and Cancer	3-Methylglutaconic Aciduria Type III	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Transfer of Acetyl Groups into Mitochondria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Maple Syrup Urine Disease	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome	Hyperlysinemia II or Saccharopinuria
Acetic acid	HMDB_SMPDB	Samples:	60	Pathways:	12	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Ethanol Degradation	Disulfiram Pathway	Aspartate Metabolism	Canavan Disease	Heroin Pathway	Hypoacetylaspartia	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Morphine	HMDB_SMPDB	Samples:	47	Pathways:	8	Codeine Pathway	Morphine Metabolism Pathway	Heroin Action Pathway	Morphine Pathway	Heroin Pathway	Morphine Action Pathway	Codeine Metabolism Pathway	Codeine Action Pathway
6-Acetylmorphine	HMDB_SMPDB	Samples:	28	Pathways:	2	Heroin Action Pathway	Heroin Pathway
D-Glucose	HMDB_SMPDB	Samples:	66	Pathways:	17	Glibenclamide Action Pathway	Lactose Intolerance	Nateglinide Pathway	Repaglinide Action Pathway	Gliclazide Action Pathway	Glucose-Alanine Cycle	Nateglinide Action Pathway	Lactose Degradation	Transfer of Acetyl Groups into Mitochondria	Pancreas Function	Fanconi-bickel syndrome	Glibenclamide Pathway	Glycogenosis, Type VII. Tarui disease	Gliclazide Pathway	Warburg Effect	Glycolysis	Repaglinide Pathway
Alpha-Lactose	HMDB_SMPDB	Samples:	7	Pathways:	2	Lactose Degradation	Lactose Intolerance
Pyrophosphate	HMDB_SMPDB	Samples:	63	Pathways:	107	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Lactic Acidemia	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Trifunctional protein deficiency	Glycine N-methyltransferase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Homocarnosinosis	Oxidation of Branched Chain Fatty Acids	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Nucleotide Sugars Metabolism	Aspartate Metabolism	Disulfiram Pathway	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Carnitine palmitoyl transferase deficiency (I)	Canavan Disease	Methionine Metabolism	Non Ketotic Hyperglycinemia	Citrullinemia Type I	Hyperglycinemia, non-ketotic	Ethylmalonic Encephalopathy	Galactosemia III	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fructose and Mannose Degradation	Sulfate/Sulfite Metabolism	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Malonic Aciduria	Phenylketonuria	Hypoacetylaspartia	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Pantothenate and CoA Biosynthesis	Propanoate Metabolism	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Lamivudine Metabolism Pathway	Cystathionine Beta-Synthase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Pyruvate Carboxylase Deficiency	Sulfite oxidase deficiency	Phenylacetate Metabolism	Glutamate Metabolism	Pyruvate Metabolism	Fructosuria	Leigh Syndrome	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type III	Alanine Metabolism	Familial Hypercholanemia (FHCA)	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Histidinemia	27-Hydroxylase Deficiency	Pyruvate kinase deficiency	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Phytanic Acid Peroxisomal Oxidation	Bile Acid Biosynthesis	Galactosemia II (GALK)	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Zellweger Syndrome	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	sarcosine oncometabolite pathway 	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Fructose intolerance, hereditary	Betaine Metabolism	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Primary Hyperoxaluria Type I	Congenital Bile Acid Synthesis Defect Type II	Ubiquinone Biosynthesis	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Methionine Adenosyltransferase Deficiency	Prolinemia Type II	Histidine Metabolism	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Hypermethioninemia	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Argininosuccinic Aciduria	Tryptophan Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Selenoamino Acid Metabolism
Uridine triphosphate	HMDB_SMPDB	Samples:	6	Pathways:	4	Lamivudine Metabolism Pathway	Galactosemia III	Nucleotide Sugars Metabolism	Galactosemia II (GALK)
Uridine diphosphate glucose	HMDB_SMPDB	Samples:	4	Pathways:	3	Galactosemia III	Nucleotide Sugars Metabolism	Galactosemia II (GALK)
Uridine 5'-diphosphate	HMDB_SMPDB	Samples:	69	Pathways:	21	Phenytoin (Antiarrhythmic) Pathway	Morphine Metabolism Pathway	Codeine Metabolism Pathway	Valproic Acid Metabolism Pathway	Artemether Metabolism Pathway	Tramadol Metabolism Pathway	Acetaminophen Metabolism Pathway	Tamoxifen Metabolism Pathway	Ibuprofen Metabolism Pathway	Etoposide Metabolism Pathway	Nicotine Metabolism Pathway	Nicotine Pathway	Codeine Pathway	Sorafenib Metabolism Pathway	Tamoxifen Pathway	Lamivudine Metabolism Pathway	Morphine Pathway	Celecoxib Metabolism Pathway	Irinotecan Metabolism Pathway	Celecoxib Pathway	Ibuprofen Pathway
Uridine diphosphategalactose	HMDB_SMPDB	Samples:	4	Pathways:	3	Galactosemia III	Nucleotide Sugars Metabolism	Galactosemia II (GALK)
Magnesium	HMDB_SMPDB	Samples:	77	Pathways:	153	Lidocaine (Antiarrhythmic) Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Butyrate Metabolism	Homocarnosinosis	Oxidation of Branched Chain Fatty Acids	Nisoldipine Pathway	Phenylalanine and Tyrosine Metabolism	Carnitine-acylcarnitine translocase deficiency	Nucleotide Sugars Metabolism	Aspartate Metabolism	Glutaric Aciduria Type I	Teniposide Pathway	Pindolol Pathway	Carnitine palmitoyl transferase deficiency (I)	Canavan Disease	Methionine Metabolism	Ibuprofen Pathway	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Arbutamine Action Pathway	Esmolol Pathway	Fructose and Mannose Degradation	Hypophosphatasia	Adrenoleukodystrophy, X-linked	Sarcosinemia	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Succinic semialdehyde dehydrogenase deficiency	Alprenolol Pathway	Sulfite oxidase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Pyruvate Metabolism	Fructosuria	Atenolol Pathway	Carvedilol Pathway	Teniposide Metabolism Pathway	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Felodipine Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Methotrexate Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Etoposide Metabolism Pathway	Galactosemia II (GALK)	Dopamine beta-hydroxylase deficiency	Quinidine Pathway	sarcosine oncometabolite pathway 	Practolol Action Pathway	Propranolol Pathway	Betaine Metabolism	Epinephrine Action Pathway	Carnitine palmitoyl transferase deficiency (II)	Celecoxib Pathway	Timolol Action Pathway	Nadolol Pathway	Penbutolol Pathway	Phenytoin (Antiarrhythmic) Pathway	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Isoprenaline Action Pathway	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Hypermethioninemia	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Procainamide (Antiarrhythmic) Pathway	Hyperinsulinism-Hyperammonemia Syndrome	Flecainide Pathway	Tyrosinemia Type 3 (TYRO3)	Labetalol Pathway	Tyrosinemia Type I	Congenital lactic acidosis	Verapamil Pathway	Disopyramide Pathway	Trifunctional protein deficiency	Folate Metabolism	Ibutilide Pathway	Glycine N-methyltransferase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Nitrendipine Pathway	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Nebivolol Pathway	Levobunolol Action Pathway	Muscle/Heart Contraction	Disulfiram Pathway	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Beta Oxidation of Very Long Chain Fatty Acids	The oncogenic action of 2-hydroxyglutarate	Gemcitabine Pathway	Betaxolol Pathway	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Bupranolol Action Pathway	Galactosemia III	Amlodipine Pathway	Gemcitabine Metabolism Pathway	Carteolol Action Pathway	Nifedipine Pathway	Sulfate/Sulfite Metabolism	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Fumarase deficiency	Phenylketonuria	Hypoacetylaspartia	Isradipine Pathway	Metoprolol Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Lamivudine Metabolism Pathway	Nimodipine Pathway	Cystathionine Beta-Synthase Deficiency	Phenylacetate Metabolism	Glutamate Metabolism	Warburg Effect	Diltiazem Pathway	Tyrosine Metabolism	Glycolysis	Leigh Syndrome	Monoamine oxidase-a deficiency (MAO-A)	Citric Acid Cycle	Oxprenolol Pathway	Vitamin B6 Metabolism	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Amiodarone Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Fructose intolerance, hereditary	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Mexiletine Pathway	Acebutolol Pathway	Methionine Adenosyltransferase Deficiency	Tyrosinemia, transient, of the newborn	Bevantolol Action Pathway	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Ammonia Recycling	Tocainide Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Bisoprolol Pathway	Glycine and Serine Metabolism	Dobutamine Action Pathway	Folate malabsorption, hereditary	Metipranolol Action Pathway
Galactose 1-phosphate	HMDB_SMPDB	Samples:	4	Pathways:	3	Galactosemia III	Nucleotide Sugars Metabolism	Galactosemia II (GALK)
Zinc (II) ion	HMDB_SMPDB	Samples:	77	Pathways:	96	Ureidopropionase deficiency	Olmesartan Action Pathway	Rabeprazole Pathway	Lactic Acidemia	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Beta-Alanine Metabolism	Degradation of Superoxides	Glycine N-methyltransferase Deficiency	Perindopril Pathway	Homocarnosinosis	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Gamma-Glutamyltransferase Deficiency	Irbesartan Action Pathway	Glutathione Synthetase Deficiency	Aspartate Metabolism	Nucleotide Sugars Metabolism	Fosinopril Pathway	Disulfiram Pathway	Dimethylglycine Dehydrogenase Deficiency	Ramipril Pathway	Gastric Acid Production	Canavan Disease	Methionine Metabolism	Non Ketotic Hyperglycinemia	Angiotensin Metabolism	Hyperglycinemia, non-ketotic	Ibuprofen Pathway	Moexipril Pathway	Galactosemia III	Gamma-glutamyl-transpeptidase deficiency	Carnosinuria, carnosinemia	Lansoprazole Pathway	Fructose and Mannose Degradation	Eprosartan Action Pathway	Trandolapril Pathway	3-Phosphoglycerate dehydrogenase deficiency	Metiamide Action Pathway	Candesartan Action Pathway	Hypoacetylaspartia	Losartan Action Pathway	Omeprazole Pathway	Sarcosinemia	Betazole Action Pathway	Roxatidine acetate Action Pathway	5-Oxoprolinuria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	5-oxoprolinase deficiency	Cilazapril Pathway	Cystathionine Beta-Synthase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Captopril Pathway	Pyruvate Carboxylase Deficiency	Pirenzepine Pathway	Glutamate Metabolism	Valsartan Action Pathway	Pyruvate Metabolism	Fructosuria	Leigh Syndrome	Enalapril Pathway	Alanine Metabolism	Primary hyperoxaluria II, PH2	Forasartan Action Pathway	Pantoprazole Pathway	Histidinemia	Telmisartan Action Pathway	Rescinnamine Pathway	Pyruvate kinase deficiency	Cimetidine Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Galactosemia II (GALK)	Spirapril Pathway	Temocapril Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	sarcosine oncometabolite pathway 	Fructose intolerance, hereditary	Betaine Metabolism	Primary Hyperoxaluria Type I	Celecoxib Pathway	Glutathione Metabolism	Methionine Adenosyltransferase Deficiency	Histidine Metabolism	Hypermethioninemia	Lisinopril Pathway	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Nizatidine Pathway	Benazepril Pathway	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Famotidine Pathway	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	GABA-Transaminase Deficiency	Esomeprazole Pathway	Glycine and Serine Metabolism	Ranitidine Pathway	Quinapril Pathway
Manganese	HMDB_SMPDB	Samples:	62	Pathways:	50	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Alanine Metabolism	Congenital lactic acidosis	Lactic Acidemia	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	The oncogenic action of Succinate	Degradation of Superoxides	Citric Acid Cycle	Histidinemia	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Pyruvate kinase deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Hyperprolinemia Type II	Pyruvate Dehydrogenase Complex Deficiency	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Malonyl-coa decarboxylase deficiency	The oncogenic action of 2-hydroxyglutarate	Citrullinemia Type I	Primary Hyperoxaluria Type I	2-ketoglutarate dehydrogenase complex deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Histidine Metabolism	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	The oncogenic action of Fumarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Urea Cycle	Argininosuccinic Aciduria	Malonic Aciduria	Fumarase deficiency	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Transfer of Acetyl Groups into Mitochondria	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	L-arginine:glycine amidinotransferase deficiency	Pyruvate Carboxylase Deficiency	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome
Glucose 1-phosphate	HMDB_SMPDB	Samples:	8	Pathways:	6	Fanconi-bickel syndrome	Galactosemia III	Nucleotide Sugars Metabolism	Glycogenosis, Type VII. Tarui disease	Glycolysis	Galactosemia II (GALK)
Phosphoric acid	HMDB_SMPDB	Samples:	61	Pathways:	51	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Homocarnosinosis	Vitamin B6 Metabolism	Pyruvate kinase deficiency	2-Hydroxyglutric Aciduria (D And L Form)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Gamma-Glutamyltransferase Deficiency	Hyperprolinemia Type II	Pyruvate Dehydrogenase Complex Deficiency	Glutathione Synthetase Deficiency	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Malonyl-coa decarboxylase deficiency	Fructose intolerance, hereditary	Citrullinemia Type I	Glutathione Metabolism	Gamma-glutamyl-transpeptidase deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fructose and Mannose Degradation	Hypophosphatasia	Urea Cycle	Argininosuccinic Aciduria	Malonic Aciduria	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Hyperinsulinism-Hyperammonemia Syndrome	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Ammonia Recycling	5-Oxoprolinuria	5-oxoprolinase deficiency	Propanoate Metabolism	L-arginine:glycine amidinotransferase deficiency	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism	Warburg Effect	Selenoamino Acid Metabolism	Pyruvate Metabolism	Fructosuria	Leigh Syndrome	Glycolysis
Iron	HMDB_SMPDB	Samples:	56	Pathways:	26	Cerebrotendinous Xanthomatosis (CTX)	Tyrosinemia Type I	Congenital Bile Acid Synthesis Defect Type III	Monoamine oxidase-a deficiency (MAO-A)	Familial Hypercholanemia (FHCA)	Congenital Bile Acid Synthesis Defect Type II	Tyrosinemia, transient, of the newborn	27-Hydroxylase Deficiency	Disulfiram Action Pathway	Oxidation of Branched Chain Fatty Acids	Phenylketonuria	Refsum Disease	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Bile Acid Biosynthesis	Phenylalanine and Tyrosine Metabolism	Galactosemia II (GALK)	Zellweger Syndrome	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Nucleotide Sugars Metabolism	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia Type 3 (TYRO3)	Hawkinsinuria	Tyrosine Metabolism	Galactosemia III
alpha-D-Galactose 1-phosphate	HMDB_SMPDB	Samples:	4	Pathways:	3	Galactosemia III	Nucleotide Sugars Metabolism	Galactosemia II (GALK)
Calcium cation	HMDB_SMPDB	Samples:	94	Pathways:	166	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Levomethadyl Acetate Action Action Pathway	Ureidopropionase deficiency	Alprenolol Action Pathway	Phenindione Action Pathway	Ardeparin Action Pathway	Bisoprolol Action Pathway	Gliclazide Action Pathway	Levorphanol Action Pathway	Aprotinin Action Pathway	Lepirudin Action Pathway	Phenylalanine and Tyrosine Metabolism	Felodipine Action Pathway	Bupivacaine Action Pathway	Isradipine Action Pathway	Ropivacaine Action Pathway	Buprenorphine Action Pathway	Citrullinemia Type I	Enoxaparin Action Pathway	Celecoxib Action Pathway	Arbutamine Action Pathway	Heroin Action Pathway	Nisoldipine Action Pathway	Verapamil Action Pathway	Dihydromorphine Action Pathway	Mexiletine Action Pathway	Alvimopan Action Pathway	Fentanyl Action Pathway	Methadone Action Pathway	Phenytoin (Antiarrhythmic) Action Pathway	Alteplase Action Pathway	Ximelagatran Action Pathway	Labetalol Action Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Pantothenate and CoA Biosynthesis	Hawkinsinuria	Disopyramide Action Pathway	Nalbuphine Action Pathway	Fluoxetine Action Pathway	Glibenclamide Action Pathway	Repaglinide Action Pathway	Teniposide Metabolism Pathway	Hydrocodone Action Pathway	Tocainide Action Pathway	Procainamide (Antiarrhythmic) Action Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Proparacaine Action Pathway	Sufentanil Action Pathway	Escitalopram Action Pathway	Dopamine beta-hydroxylase deficiency	Practolol Action Pathway	Dicoumarol Action Pathway	Chloroprocaine Action Pathway	Pentazocine Action Pathway	Epinephrine Action Pathway	Urokinase Action Pathway	Tenecteplase Action Pathway	Dimethylthiambutene Action Pathway	Streptokinase Action Pathway	Timolol Action Pathway	Desipramine Action Pathway	Oxprenolol Action Pathway	Fondaparinux Action Pathway	Isoprenaline Action Pathway	Remifentanil Action Pathway	Ketobemidone  Action Pathway	Argininosuccinic Aciduria	Ibuprofen Action Pathway	Esmolol Action Pathway	Penbutolol Action Pathway	Morphine Action Pathway	Nateglinide Action Pathway	Nitrendipine Action Pathway	Acebutolol Action Pathway	Levobupivacaine Action Pathway	GABA-Transaminase Deficiency	Tyrosinemia Type 3 (TYRO3)	Bivalirudin Action Pathway	Diphenoxylate Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Cocaine Action Pathway	Ibutilide Action Pathway	Tyrosinemia Type I	Beta-Alanine Metabolism	Ethylmorphine Action Pathway	Dicumarol Action Pathway	Folate Metabolism	3-Methylthiofentanyl Action Pathway	Warfarin Action Pathway	Dibucaine Action Pathway	Levobunolol Action Pathway	Muscle/Heart Contraction	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Teniposide Action Pathway	Procaine Action Pathway	Benzocaine Action Pathway	Acenocoumarol Action Pathway	Nicotine Action Pathway	Bupranolol Action Pathway	Etoposide Action Pathway	Carteolol Action Pathway	Carnosinuria, carnosinemia	Propranolol Action Pathway	Mepivacaine Action Pathway	Nifedipine Action Pathway	Urea Cycle	Phenylketonuria	Metoprolol Action Pathway	Alfentanil Action Pathway	Dezocine Action Pathway	Naloxone Action Pathway	Levallorphan Action Pathway	Pancreas Function	Fosphenytoin (Antiarrhythmic) Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Prilocaine Action Pathway	Tyrosine Metabolism	Reteplase Action Pathway	Atenolol Action Pathway	Thyroid hormone synthesis	Monoamine oxidase-a deficiency (MAO-A)	Diltiazem Action Pathway	Aminocaproic Acid Action Pathway	Carbamoyl Phosphate Synthetase Deficiency	Hydromorphone Action Pathway	Histidinemia	Propoxyphene Action Pathway	Imipramine Action Pathway	Citalopram Action Pathway	Disulfiram Action Pathway	Betaxolol Action Pathway	Alkaptonuria	Oxycodone Action Pathway	Amiodarone Action Pathway	Argininemia	Carvedilol Action Pathway	Methotrexate Action Pathway	Nebivolol Action Pathway	Phenprocoumon Action Pathway	Oxybuprocaine Action Pathway	Clopidogrel Action Pathway	Codeine Action Pathway	Tranexamic Acid Action Pathway	Malate-Aspartate Shuttle	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Bevantolol Action Pathway	Flecainide Action Pathway	Naltrexone Action Pathway	Nimodipine Action Pathway	Tramadol Action Action Pathway	Nadolol Action Pathway	Amlodipine Action Pathway	Quinidine Action Pathway	Anistreplase Action Pathway	Heparin Action Pathway	Argatroban Action Pathway	Oxymorphone Action Pathway	Pindolol Action Pathway	Carfentanil Action Pathway	Dobutamine Action Pathway	Folate malabsorption, hereditary	Metipranolol Action Pathway
D-Glucose 1-phosphate	HMDB_SMPDB	Samples:	8	Pathways:	6	Fanconi-bickel syndrome	Galactosemia III	Nucleotide Sugars Metabolism	Glycogenosis, Type VII. Tarui disease	Glycolysis	Galactosemia II (GALK)
Diphosphate	HMDB_SMPDB	Samples:	63	Pathways:	105	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Lactic Acidemia	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Trifunctional protein deficiency	Glycine N-methyltransferase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Homocarnosinosis	Oxidation of Branched Chain Fatty Acids	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Nucleotide Sugars Metabolism	Aspartate Metabolism	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Carnitine palmitoyl transferase deficiency (I)	Canavan Disease	Methionine Metabolism	Non Ketotic Hyperglycinemia	Citrullinemia Type I	Hyperglycinemia, non-ketotic	Ethylmalonic Encephalopathy	Galactosemia III	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fructose and Mannose Degradation	Sulfate/Sulfite Metabolism	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Malonic Aciduria	Phenylketonuria	Hypoacetylaspartia	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Pantothenate and CoA Biosynthesis	Propanoate Metabolism	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Lamivudine Metabolism Pathway	Cystathionine Beta-Synthase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Pyruvate Carboxylase Deficiency	Sulfite oxidase deficiency	Phenylacetate Metabolism	Glutamate Metabolism	Pyruvate Metabolism	Fructosuria	Leigh Syndrome	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type III	Alanine Metabolism	Familial Hypercholanemia (FHCA)	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Histidinemia	27-Hydroxylase Deficiency	Disulfiram Action Pathway	Pyruvate kinase deficiency	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Phytanic Acid Peroxisomal Oxidation	Bile Acid Biosynthesis	Galactosemia II (GALK)	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Zellweger Syndrome	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Fructose intolerance, hereditary	Betaine Metabolism	Carnitine palmitoyl transferase deficiency (II)	Primary Hyperoxaluria Type I	Congenital Bile Acid Synthesis Defect Type II	Ubiquinone Biosynthesis	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Methionine Adenosyltransferase Deficiency	Prolinemia Type II	Histidine Metabolism	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Hypermethioninemia	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Argininosuccinic Aciduria	Tryptophan Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Selenoamino Acid Metabolism
Lactose	HMDB_SMPDB	Samples:	7	Pathways:	2	Lactose Degradation	Lactose Intolerance
Magnesium cation	HMDB_SMPDB	Samples:	78	Pathways:	149	Alprenolol Action Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Butyrate Metabolism	Bisoprolol Action Pathway	Homocarnosinosis	Oxidation of Branched Chain Fatty Acids	Phenylalanine and Tyrosine Metabolism	Felodipine Action Pathway	Carnitine-acylcarnitine translocase deficiency	Nucleotide Sugars Metabolism	Aspartate Metabolism	Glutaric Aciduria Type I	Isradipine Action Pathway	Carnitine palmitoyl transferase deficiency (I)	Canavan Disease	Methionine Metabolism	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Celecoxib Action Pathway	Arbutamine Action Pathway	Fructose and Mannose Degradation	Hypophosphatasia	Nisoldipine Action Pathway	Verapamil Action Pathway	Mexiletine Action Pathway	Adrenoleukodystrophy, X-linked	Sarcosinemia	Phenytoin (Antiarrhythmic) Action Pathway	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Labetalol Action Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Succinic semialdehyde dehydrogenase deficiency	Sulfite oxidase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Pyruvate Metabolism	Fructosuria	Disopyramide Action Pathway	Teniposide Metabolism Pathway	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Tocainide Action Pathway	Procainamide (Antiarrhythmic) Action Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Gemcitabine Action Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Galactosemia II (GALK)	Dopamine beta-hydroxylase deficiency	Practolol Action Pathway	Betaine Metabolism	Epinephrine Action Pathway	Carnitine palmitoyl transferase deficiency (II)	Timolol Action Pathway	Oxprenolol Action Pathway	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Isoprenaline Action Pathway	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Hypermethioninemia	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Esmolol Action Pathway	Ibuprofen Action Pathway	Penbutolol Action Pathway	Hyperinsulinism-Hyperammonemia Syndrome	Nitrendipine Action Pathway	Acebutolol Action Pathway	Tyrosinemia Type 3 (TYRO3)	Ibutilide Action Pathway	Tyrosinemia Type I	Congenital lactic acidosis	Trifunctional protein deficiency	Folate Metabolism	Glycine N-methyltransferase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Levobunolol Action Pathway	Muscle/Heart Contraction	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Beta Oxidation of Very Long Chain Fatty Acids	The oncogenic action of 2-hydroxyglutarate	Teniposide Action Pathway	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Bupranolol Action Pathway	Galactosemia III	Etoposide Action Pathway	Carteolol Action Pathway	Propranolol Action Pathway	Nifedipine Action Pathway	Sulfate/Sulfite Metabolism	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Fumarase deficiency	Phenylketonuria	Metoprolol Action Pathway	Hypoacetylaspartia	Fosphenytoin (Antiarrhythmic) Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Lamivudine Metabolism Pathway	Cystathionine Beta-Synthase Deficiency	Phenylacetate Metabolism	Glutamate Metabolism	Warburg Effect	Tyrosine Metabolism	Glycolysis	Leigh Syndrome	Atenolol Action Pathway	Monoamine oxidase-a deficiency (MAO-A)	Diltiazem Action Pathway	Citric Acid Cycle	Disulfiram Action Pathway	Betaxolol Action Pathway	Vitamin B6 Metabolism	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Amiodarone Action Pathway	Carvedilol Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Methotrexate Action Pathway	Nebivolol Action Pathway	Fructose intolerance, hereditary	Methionine Adenosyltransferase Deficiency	Tyrosinemia, transient, of the newborn	Bevantolol Action Pathway	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Flecainide Action Pathway	Nimodipine Action Pathway	Glutaminolysis and Cancer	Nadolol Action Pathway	Amlodipine Action Pathway	Quinidine Action Pathway	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Ammonia Recycling	Pindolol Action Pathway	Glycine and Serine Metabolism	Dobutamine Action Pathway	Folate malabsorption, hereditary	Metipranolol Action Pathway
Manganese(2+)	HMDB_SMPDB	Samples:	62	Pathways:	49	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Alanine Metabolism	Congenital lactic acidosis	Lactic Acidemia	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	The oncogenic action of Succinate	Degradation of Superoxides	Citric Acid Cycle	Histidinemia	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Pyruvate kinase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Hyperprolinemia Type II	Pyruvate Dehydrogenase Complex Deficiency	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Malonyl-coa decarboxylase deficiency	The oncogenic action of 2-hydroxyglutarate	Citrullinemia Type I	Primary Hyperoxaluria Type I	2-ketoglutarate dehydrogenase complex deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Histidine Metabolism	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	The oncogenic action of Fumarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Urea Cycle	Argininosuccinic Aciduria	Malonic Aciduria	Fumarase deficiency	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Transfer of Acetyl Groups into Mitochondria	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	L-arginine:glycine amidinotransferase deficiency	Pyruvate Carboxylase Deficiency	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome
UDP	HMDB_SMPDB	Samples:	61	Pathways:	16	Etoposide Action Pathway	Valproic Acid Metabolism Pathway	Artemether Metabolism Pathway	Tramadol Metabolism Pathway	Ibuprofen Action Pathway	Acetaminophen Metabolism Pathway	Tamoxifen Metabolism Pathway	Morphine Action Pathway	Nicotine Action Pathway	Irinotecan Action Pathway	Phenytoin (Antiarrhythmic) Action Pathway	Sorafenib Metabolism Pathway	Tamoxifen Action Pathway	Lamivudine Metabolism Pathway	Codeine Action Pathway	Celecoxib Action Pathway
UDP-alpha-D-galactose	HMDB_SMPDB	Samples:	4	Pathways:	3	Galactosemia III	Nucleotide Sugars Metabolism	Galactosemia II (GALK)
UDP-glucose	HMDB_SMPDB	Samples:	4	Pathways:	3	Galactosemia III	Nucleotide Sugars Metabolism	Galactosemia II (GALK)
UTP	HMDB_SMPDB	Samples:	6	Pathways:	4	Lamivudine Metabolism Pathway	Galactosemia III	Nucleotide Sugars Metabolism	Galactosemia II (GALK)
Zinc cation	HMDB_SMPDB	Samples:	78	Pathways:	95	Ureidopropionase deficiency	Olmesartan Action Pathway	Lactic Acidemia	Beta-Alanine Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Degradation of Superoxides	Glycine N-methyltransferase Deficiency	Homocarnosinosis	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Gamma-Glutamyltransferase Deficiency	Irbesartan Action Pathway	Moexipril Action Pathway	Glutathione Synthetase Deficiency	Aspartate Metabolism	Nucleotide Sugars Metabolism	Dimethylglycine Dehydrogenase Deficiency	Nizatidine Action Pathway	Gastric Acid Production	Canavan Disease	Non Ketotic Hyperglycinemia	Methionine Metabolism	Angiotensin Metabolism	Hyperglycinemia, non-ketotic	Ranitidine Action Pathway	Celecoxib Action Pathway	Galactosemia III	Trandolapril Action Pathway	Gamma-glutamyl-transpeptidase deficiency	Carnosinuria, carnosinemia	Fructose and Mannose Degradation	Cilazapril Action Pathway	Eprosartan Action Pathway	Captopril Action Pathway	3-Phosphoglycerate dehydrogenase deficiency	Metiamide Action Pathway	Candesartan Action Pathway	Hypoacetylaspartia	Perindopril Action Pathway	Losartan Action Pathway	Sarcosinemia	Betazole Action Pathway	Roxatidine acetate Action Pathway	Rescinnamine Action Pathway	5-Oxoprolinuria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	5-oxoprolinase deficiency	Cystathionine Beta-Synthase Deficiency	Famotidine Action Pathway	Succinic semialdehyde dehydrogenase deficiency	Pyruvate Carboxylase Deficiency	Glutamate Metabolism	Valsartan Action Pathway	Pyruvate Metabolism	Fructosuria	Leigh Syndrome	Fosinopril Action Pathway	Alanine Metabolism	Primary hyperoxaluria II, PH2	Lansoprazole Action Pathway	Forasartan Action Pathway	Histidinemia	Telmisartan Action Pathway	Disulfiram Action Pathway	Pyruvate kinase deficiency	2-Hydroxyglutric Aciduria (D And L Form)	Galactosemia II (GALK)	Ramipril Action Pathway	Temocapril Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Fructose intolerance, hereditary	Betaine Metabolism	Benazepril Action Pathway	Primary Hyperoxaluria Type I	Glutathione Metabolism	Pantoprazole Action Pathway	Cimetidine Action Pathway	Methionine Adenosyltransferase Deficiency	Histidine Metabolism	Hypermethioninemia	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Ibuprofen Action Pathway	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pirenzepine Action Pathway	Hyperinsulinism-Hyperammonemia Syndrome	Esomeprazole Action Pathway	Ethanol Degradation	Spirapril Action Pathway	Quinapril Action Pathway	Omeprazole Action Pathway	GABA-Transaminase Deficiency	Enalapril Action Pathway	Lisinopril Action Pathway	Glycine and Serine Metabolism	Rabeprazole Action Pathway
Cortexolone	HMDB_SMPDB	Samples:	16	Pathways:	35	Warfarin Pathway	Aprotinin Pathway	Tenecteplase Pathway	Phenindione Action Pathway	Reteplase Pathway	Ardeparin Pathway	Dicumarol Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Tranexamic Acid Pathway	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Acenocoumarol Pathway	Steroidogenesis	Bivalirudin Pathway	Alteplase Pathway	Dicoumarol Action Pathway	Phenprocoumon Pathway	Lepirudin Pathway	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Streptokinase Pathway	Urokinase Pathway	Aminocaproic Acid Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	Heparin Pathway	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Anistreplase Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Enoxaparin Pathway	Coagulation 	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Ximelagatran Pathway	Fondaparinux Pathway	Argatroban Pathway
Reduced Vitamin K (phylloquinone)	HMDB_SMPDB	Samples:	14	Pathways:	24	Warfarin Pathway	Heparin Pathway	Aprotinin Pathway	Tenecteplase Pathway	Phenindione Action Pathway	Reteplase Pathway	Ardeparin Pathway	Dicumarol Pathway	Anistreplase Pathway	Tranexamic Acid Pathway	Acenocoumarol Pathway	Bivalirudin Pathway	Enoxaparin Pathway	Alteplase Pathway	Coagulation 	Ximelagatran Pathway	Dicoumarol Action Pathway	Phenprocoumon Pathway	Lepirudin Pathway	Fondaparinux Pathway	Argatroban Pathway	Streptokinase Pathway	Urokinase Pathway	Aminocaproic Acid Pathway
Phytonadione	HMDB_SMPDB	Samples:	14	Pathways:	24	Warfarin Pathway	Heparin Pathway	Aprotinin Pathway	Tenecteplase Pathway	Phenindione Action Pathway	Reteplase Pathway	Ardeparin Pathway	Dicumarol Pathway	Anistreplase Pathway	Tranexamic Acid Pathway	Acenocoumarol Pathway	Bivalirudin Pathway	Enoxaparin Pathway	Alteplase Pathway	Coagulation 	Ximelagatran Pathway	Dicoumarol Action Pathway	Phenprocoumon Pathway	Lepirudin Pathway	Fondaparinux Pathway	Argatroban Pathway	Streptokinase Pathway	Urokinase Pathway	Aminocaproic Acid Pathway
Cholesterol	HMDB_SMPDB	Samples:	34	Pathways:	18	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	11-beta-hydroxylase deficiency (CYP11B1)	Familial Hypercholanemia (FHCA)	Corticosterone methyl oxidase I deficiency (CMO I)	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	27-Hydroxylase Deficiency	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Steroidogenesis	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Bile Acid Biosynthesis	Zellweger Syndrome	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)
Formic acid	HMDB_SMPDB	Samples:	47	Pathways:	12	Sepiapterin reductase deficiency	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Dopa-responsive dystonia	Folate Metabolism	Hyperphenylalaninemia due to dhpr-deficiency	Pterine Biosynthesis	Segawa syndrome	Methotrexate Pathway	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Folate malabsorption, hereditary
NADP	HMDB_SMPDB	Samples:	71	Pathways:	119	Ureidopropionase deficiency	Lidocaine (Antiarrhythmic) Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Beta-Alanine Metabolism	Valproic Acid Metabolism Pathway	Degradation of Superoxides	Folate Metabolism	Homocarnosinosis	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Nicotine Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Gamma-Glutamyltransferase Deficiency	Sepiapterin reductase deficiency	Hyperprolinemia Type II	Glutathione Synthetase Deficiency	Disulfiram Pathway	Dopa-responsive dystonia	The oncogenic action of 2-hydroxyglutarate	Glutaric Aciduria Type I	Celecoxib Metabolism Pathway	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Corticosterone methyl oxidase II deficiency - CMO II	Glycerol Kinase Deficiency	Ibuprofen Pathway	Pyridoxine dependency with seizures	Corticosterone methyl oxidase I deficiency (CMO I)	Gamma-glutamyl-transpeptidase deficiency	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fructose and Mannose Degradation	21-hydroxylase deficiency (CYP21)	Hyperphenylalaninemia due to dhpr-deficiency	Glucose-Alanine Cycle	Transfer of Acetyl Groups into Mitochondria	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Tamoxifen Pathway	5-Oxoprolinuria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	5-oxoprolinase deficiency	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Segawa syndrome	Glutamate Metabolism	Warburg Effect	Tyrosine Metabolism	Pyruvate Metabolism	Fructosuria	Lysine Degradation	Leigh Syndrome	Hyperlysinemia II or Saccharopinuria	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Monoamine oxidase-a deficiency (MAO-A)	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Familial Hypercholanemia (FHCA)	Histidinemia	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	27-Hydroxylase Deficiency	Methotrexate Pathway	Pyruvate kinase deficiency	Desipramine Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Phytanic Acid Peroxisomal Oxidation	Lidocaine (Local Anaesthetic) Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Alkaptonuria	Bile Acid Biosynthesis	Steroidogenesis	Ibuprofen Metabolism Pathway	Zellweger Syndrome	Nicotine Pathway	Vitamin A Deficiency	Dopamine beta-hydroxylase deficiency	Pyruvate Dehydrogenase Complex Deficiency	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Fructose intolerance, hereditary	Familial lipoprotein lipase deficiency	17-alpha-hydroxylase deficiency (CYP17)	Saccharopinuria/Hyperlysinemia II	Celecoxib Pathway	Glutathione Metabolism	11-beta-hydroxylase deficiency (CYP11B1)	Imipramine Pathway	Phenytoin (Antiarrhythmic) Pathway	Congenital Bile Acid Synthesis Defect Type II	Ubiquinone Biosynthesis	Ornithine Aminotransferase Deficiency (OAT Deficiency)	The oncogenic action of Fumarate	Prolinemia Type II	D-glyceric acidura	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Apparent mineralocorticoid excess syndrome	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Glutaminolysis and Cancer	Tamoxifen Metabolism Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Glycerolipid Metabolism	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Pterine Biosynthesis	Retinol Metabolism	Folate malabsorption, hereditary
NADPH	HMDB_SMPDB	Samples:	71	Pathways:	129	Ureidopropionase deficiency	Lidocaine (Antiarrhythmic) Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Homocarnosinosis	Nicotine Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Gamma-Glutamyltransferase Deficiency	Glutathione Synthetase Deficiency	Glutaric Aciduria Type I	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Glycerol Kinase Deficiency	Ibuprofen Pathway	Pyridoxine dependency with seizures	Celecoxib Action Pathway	Fructose and Mannose Degradation	21-hydroxylase deficiency (CYP21)	Glucose-Alanine Cycle	Transfer of Acetyl Groups into Mitochondria	Phenytoin (Antiarrhythmic) Action Pathway	Tamoxifen Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Segawa syndrome	Pyruvate Metabolism	Fructosuria	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Methotrexate Pathway	Desipramine Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Lidocaine (Local Anaesthetic) Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Zellweger Syndrome	Nicotine Pathway	Dopamine beta-hydroxylase deficiency	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Familial lipoprotein lipase deficiency	17-alpha-hydroxylase deficiency (CYP17)	Saccharopinuria/Hyperlysinemia II	Celecoxib Pathway	Desipramine Action Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Imipramine Pathway	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	The oncogenic action of Fumarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Ibuprofen Action Pathway	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	GABA-Transaminase Deficiency	Retinol Metabolism	Lidocaine (Local Anaesthetic) Action Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Beta-Alanine Metabolism	Folate Metabolism	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Sepiapterin reductase deficiency	Hyperprolinemia Type II	Disulfiram Pathway	Dopa-responsive dystonia	The oncogenic action of 2-hydroxyglutarate	Celecoxib Metabolism Pathway	Corticosterone methyl oxidase II deficiency - CMO II	Nicotine Action Pathway	Corticosterone methyl oxidase I deficiency (CMO I)	Gamma-glutamyl-transpeptidase deficiency	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Hyperphenylalaninemia due to dhpr-deficiency	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	5-Oxoprolinuria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	5-oxoprolinase deficiency	Tamoxifen Action Pathway	Glutamate Metabolism	Warburg Effect	Tyrosine Metabolism	Leigh Syndrome	Cerebrotendinous Xanthomatosis (CTX)	Monoamine oxidase-a deficiency (MAO-A)	Familial Hypercholanemia (FHCA)	Histidinemia	Imipramine Action Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	27-Hydroxylase Deficiency	Disulfiram Action Pathway	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Bile Acid Biosynthesis	Steroidogenesis	Ibuprofen Metabolism Pathway	Vitamin A Deficiency	Pyruvate Dehydrogenase Complex Deficiency	Methotrexate Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Fructose intolerance, hereditary	Glutathione Metabolism	Congenital Bile Acid Synthesis Defect Type II	Ubiquinone Biosynthesis	Prolinemia Type II	D-glyceric acidura	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Apparent mineralocorticoid excess syndrome	Hyperlysinemia I, Familial	Glutaminolysis and Cancer	Tamoxifen Metabolism Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Glycerolipid Metabolism	L-arginine:glycine amidinotransferase deficiency	Pterine Biosynthesis	Folate malabsorption, hereditary
Heme	HMDB_SMPDB	Samples:	85	Pathways:	89	Lidocaine (Antiarrhythmic) Pathway	Hyperprolinemia Type I	Venlafaxine Metabolism Pathway	Degradation of Superoxides	Valproic Acid Metabolism Pathway	Clopidogrel Pathway	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Nicotine Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Mitochondrial Electron Transport Chain	Hyperprolinemia Type II	Disulfiram Pathway	Sorafenib Metabolism Pathway	Teniposide Pathway	Celecoxib Metabolism Pathway	Teniposide Action Pathway	Corticosterone methyl oxidase II deficiency - CMO II	Irinotecan Metabolism Pathway	Ibuprofen Pathway	Nicotine Action Pathway	Celecoxib Action Pathway	Corticosterone methyl oxidase I deficiency (CMO I)	Etoposide Action Pathway	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	21-hydroxylase deficiency (CYP21)	Sulfate/Sulfite Metabolism	Irinotecan Action Pathway	Methadone Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Phenytoin (Antiarrhythmic) Action Pathway	Prolidase Deficiency (PD)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Tamoxifen Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Tamoxifen Action Pathway	Citalopram Pathway	Sulfite oxidase deficiency	Citalopram Metabolism Pathway	Cerebrotendinous Xanthomatosis (CTX)	Fluoxetine Action Pathway	Congenital Bile Acid Synthesis Defect Type III	Thyroid hormone synthesis	Familial Hypercholanemia (FHCA)	Teniposide Metabolism Pathway	Arginine and Proline Metabolism	Imipramine Action Pathway	Tramadol Metabolism Pathway	Artemether Metabolism Pathway	Citalopram Action Pathway	27-Hydroxylase Deficiency	Disulfiram Action Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Desipramine Pathway	Steroidogenesis	Bile Acid Biosynthesis	Lidocaine (Local Anaesthetic) Pathway	Etoposide Metabolism Pathway	Ibuprofen Metabolism Pathway	Zellweger Syndrome	Nicotine Pathway	Codeine Pathway	Vitamin A Deficiency	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	17-alpha-hydroxylase deficiency (CYP17)	Celecoxib Pathway	Clopidogrel Action Pathway	Desipramine Action Pathway	Codeine Metabolism Pathway	Codeine Action Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Imipramine Pathway	Phenytoin (Antiarrhythmic) Pathway	Congenital Bile Acid Synthesis Defect Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Apparent mineralocorticoid excess syndrome	Ibuprofen Action Pathway	Acetaminophen Metabolism Pathway	Tamoxifen Metabolism Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Tryptophan Metabolism	Clopidogrel Metabolism Pathway	Ethanol Degradation	Fluoxetine Pathway	L-arginine:glycine amidinotransferase deficiency	Methadone Pathway	Retinol Metabolism	Lidocaine (Local Anaesthetic) Action Pathway
Ammonia	HMDB_SMPDB	Samples:	64	Pathways:	82	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Tyrosinemia Type I	Beta-Alanine Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Ureidopropionase deficiency	Folate Metabolism	Glycine N-methyltransferase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocarnosinosis	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Hyperprolinemia Type II	Disulfiram Pathway	Aspartate Metabolism	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Gemcitabine Pathway	Canavan Disease	Non Ketotic Hyperglycinemia	Methionine Metabolism	Citrullinemia Type I	Hyperglycinemia, non-ketotic	Gemcitabine Metabolism Pathway	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Hypophosphatasia	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Glucose-Alanine Cycle	Phenylketonuria	Hypoacetylaspartia	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Citalopram Pathway	Cystathionine Beta-Synthase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism	Hawkinsinuria	Warburg Effect	Tyrosine Metabolism	Citalopram Metabolism Pathway	Monoamine oxidase-a deficiency (MAO-A)	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Histidinemia	Citalopram Action Pathway	Disulfiram Action Pathway	Vitamin B6 Metabolism	Methotrexate Pathway	Gemcitabine Action Pathway	Alkaptonuria	2-Hydroxyglutric Aciduria (D And L Form)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Argininemia	Dopamine beta-hydroxylase deficiency	Methotrexate Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Threonine and 2-Oxobutanoate Degradation	Methionine Adenosyltransferase Deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Histidine Metabolism	Prolinemia Type II	Tyrosinemia, transient, of the newborn	Hypermethioninemia	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Glutaminolysis and Cancer	Hyperinsulinism-Hyperammonemia Syndrome	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Selenoamino Acid Metabolism	Folate malabsorption, hereditary
Cytidine triphosphate	HMDB_SMPDB	Samples:	1	Pathways:	1	Pantothenate and CoA Biosynthesis
Fructose 6-phosphate	HMDB_SMPDB	Samples:	60	Pathways:	13	Hyperinsulinism-Hyperammonemia Syndrome	Fanconi-bickel syndrome	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Glycogenosis, Type VII. Tarui disease	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Succinic semialdehyde dehydrogenase deficiency	Homocarnosinosis	Glutamate Metabolism	Warburg Effect	2-Hydroxyglutric Aciduria (D And L Form)	Fructosuria	Glycolysis
Pyruvic acid	HMDB_SMPDB	Samples:	66	Pathways:	49	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Alanine Metabolism	Congenital lactic acidosis	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Lactic Acidemia	Carbamoyl Phosphate Synthetase Deficiency	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Citric Acid Cycle	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocarnosinosis	Pyruvate kinase deficiency	2-Hydroxyglutric Aciduria (D And L Form)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Non Ketotic Hyperglycinemia	Citrullinemia Type I	Hyperglycinemia, non-ketotic	Primary Hyperoxaluria Type I	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Argininosuccinic Aciduria	Glucose-Alanine Cycle	Fumarase deficiency	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Transfer of Acetyl Groups into Mitochondria	Sarcosinemia	Hyperinsulinism-Hyperammonemia Syndrome	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Ammonia Recycling	Pyruvate Carboxylase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism	Pyruvate dehydrogenase deficiency (E3)	Glycine and Serine Metabolism	Warburg Effect	Pyruvate Metabolism	Glycolysis	Leigh Syndrome
Phosphoenolpyruvic acid	HMDB_SMPDB	Samples:	61	Pathways:	10	Pyruvate Dehydrogenase Complex Deficiency	Fanconi-bickel syndrome	Primary hyperoxaluria II, PH2	Glycogenosis, Type VII. Tarui disease	Warburg Effect	Pyruvate kinase deficiency	Pyruvate Metabolism	Glycolysis	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
L-Glutamine	HMDB_SMPDB	Samples:	61	Pathways:	22	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Carbamoyl Phosphate Synthetase Deficiency	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Urea Cycle	Homocarnosinosis	Argininosuccinic Aciduria	Hypoacetylaspartia	Glutaminolysis and Cancer	2-Hydroxyglutric Aciduria (D And L Form)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Argininemia	Hyperinsulinism-Hyperammonemia Syndrome	Aspartate Metabolism	Ammonia Recycling	The oncogenic action of 2-hydroxyglutarate	Succinic semialdehyde dehydrogenase deficiency	Canavan Disease	Phenylacetate Metabolism	Glutamate Metabolism	Warburg Effect	Citrullinemia Type I
D-Fructose	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
N-Acetyl-D-Glucosamine 6-Phosphate	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Glucosamine 6-phosphate	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Chitin	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Acetate	HMDB_SMPDB	Samples:	60	Pathways:	12	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Ethanol Degradation	Aspartate Metabolism	Heroin Action Pathway	Disulfiram Action Pathway	Canavan Disease	Hypoacetylaspartia	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
beta-D-Fructose	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
CTP	HMDB_SMPDB	Samples:	1	Pathways:	1	Pantothenate and CoA Biosynthesis
D-Fructose 6-phosphate	HMDB_SMPDB	Samples:	60	Pathways:	13	Hyperinsulinism-Hyperammonemia Syndrome	Fanconi-bickel syndrome	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Glycogenosis, Type VII. Tarui disease	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Succinic semialdehyde dehydrogenase deficiency	Homocarnosinosis	Glutamate Metabolism	Warburg Effect	2-Hydroxyglutric Aciduria (D And L Form)	Fructosuria	Glycolysis
D-Glucosamine 6-phosphate	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
N-Acetyl-D-glucosamine 6-phosphate	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Phosphoenolpyruvate	HMDB_SMPDB	Samples:	61	Pathways:	10	Pyruvate Dehydrogenase Complex Deficiency	Fanconi-bickel syndrome	Primary hyperoxaluria II, PH2	Glycogenosis, Type VII. Tarui disease	Warburg Effect	Pyruvate kinase deficiency	Pyruvate Metabolism	Glycolysis	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Pyruvate	HMDB_SMPDB	Samples:	66	Pathways:	48	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Alanine Metabolism	Congenital lactic acidosis	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Lactic Acidemia	Carbamoyl Phosphate Synthetase Deficiency	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Citric Acid Cycle	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocarnosinosis	Pyruvate kinase deficiency	2-Hydroxyglutric Aciduria (D And L Form)	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Non Ketotic Hyperglycinemia	Citrullinemia Type I	Hyperglycinemia, non-ketotic	Primary Hyperoxaluria Type I	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Argininosuccinic Aciduria	Glucose-Alanine Cycle	Fumarase deficiency	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Transfer of Acetyl Groups into Mitochondria	Sarcosinemia	Hyperinsulinism-Hyperammonemia Syndrome	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Ammonia Recycling	Pyruvate Carboxylase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism	Pyruvate dehydrogenase deficiency (E3)	Glycine and Serine Metabolism	Warburg Effect	Pyruvate Metabolism	Glycolysis	Leigh Syndrome
Formaldehyde	HMDB_SMPDB	Samples:	69	Pathways:	37	Fluoxetine Action Pathway	Venlafaxine Metabolism Pathway	Lidocaine (Antiarrhythmic) Pathway	Teniposide Metabolism Pathway	Imipramine Action Pathway	Citalopram Action Pathway	Artemether Metabolism Pathway	Tramadol Metabolism Pathway	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Lidocaine (Local Anaesthetic) Pathway	Etoposide Metabolism Pathway	Nicotine Metabolism Pathway	Nicotine Pathway	Codeine Pathway	Dimethylglycine Dehydrogenase Deficiency	Teniposide Pathway	Teniposide Action Pathway	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Codeine Metabolism Pathway	Nicotine Action Pathway	Codeine Action Pathway	Imipramine Pathway	Etoposide Action Pathway	3-Phosphoglycerate dehydrogenase deficiency	Tamoxifen Metabolism Pathway	Methadone Action Pathway	Sarcosinemia	Tamoxifen Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Tamoxifen Action Pathway	Citalopram Pathway	Fluoxetine Pathway	Glycine and Serine Metabolism	Methadone Pathway	Citalopram Metabolism Pathway	Lidocaine (Local Anaesthetic) Action Pathway
Lidocaine	HMDB_SMPDB	Samples:	33	Pathways:	4	Lidocaine (Antiarrhythmic) Action Pathway	Lidocaine (Local Anaesthetic) Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Lidocaine (Antiarrhythmic) Pathway
3-Hydroxylidocaine	HMDB_SMPDB	Samples:	33	Pathways:	4	Lidocaine (Antiarrhythmic) Action Pathway	Lidocaine (Local Anaesthetic) Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Lidocaine (Antiarrhythmic) Pathway
Monoethylglycinexylidide	HMDB_SMPDB	Samples:	33	Pathways:	4	Lidocaine (Antiarrhythmic) Action Pathway	Lidocaine (Local Anaesthetic) Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Lidocaine (Antiarrhythmic) Pathway
2,6-Dimethylaniline	HMDB_SMPDB	Samples:	33	Pathways:	4	Lidocaine (Antiarrhythmic) Action Pathway	Lidocaine (Local Anaesthetic) Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Lidocaine (Antiarrhythmic) Pathway
3-Hydroxymonoethylglycinexylidide	HMDB_SMPDB	Samples:	33	Pathways:	4	Lidocaine (Antiarrhythmic) Action Pathway	Lidocaine (Local Anaesthetic) Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Lidocaine (Antiarrhythmic) Pathway
Glycinexylidide	HMDB_SMPDB	Samples:	33	Pathways:	4	Lidocaine (Antiarrhythmic) Action Pathway	Lidocaine (Local Anaesthetic) Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Lidocaine (Antiarrhythmic) Pathway
2-Amino-3-methylbenzoate	HMDB_SMPDB	Samples:	33	Pathways:	4	Lidocaine (Antiarrhythmic) Action Pathway	Lidocaine (Local Anaesthetic) Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Lidocaine (Antiarrhythmic) Pathway
4-Hydroxy-2,6-dimethylaniline	HMDB_SMPDB	Samples:	33	Pathways:	4	Lidocaine (Antiarrhythmic) Action Pathway	Lidocaine (Local Anaesthetic) Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Lidocaine (Antiarrhythmic) Pathway
L-Carnitine	HMDB_SMPDB	Samples:	57	Pathways:	17	Carnitine Synthesis	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Trifunctional protein deficiency	Fatty acid Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Oxidation of Branched Chain Fatty Acids	Adrenoleukodystrophy, X-linked	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Carnitine-acylcarnitine translocase deficiency	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Beta Oxidation of Very Long Chain Fatty Acids	Glutaric Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
L-Acetylcarnitine	HMDB_SMPDB	Samples:	50	Pathways:	4	Adrenoleukodystrophy, X-linked	Oxidation of Branched Chain Fatty Acids	Beta Oxidation of Very Long Chain Fatty Acids	Carnitine-acylcarnitine translocase deficiency
Dodecanoic acid	HMDB_SMPDB	Samples:	51	Pathways:	4	Adrenoleukodystrophy, X-linked	Beta Oxidation of Very Long Chain Fatty Acids	Carnitine-acylcarnitine translocase deficiency	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids
Tetradecanoyl-CoA 	HMDB_SMPDB	Samples:	57	Pathways:	16	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Trifunctional protein deficiency	Fatty acid Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Adrenoleukodystrophy, X-linked	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine-acylcarnitine translocase deficiency	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Beta Oxidation of Very Long Chain Fatty Acids	Glutaric Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Tetracosanoic acid	HMDB_SMPDB	Samples:	26	Pathways:	3	Adrenoleukodystrophy, X-linked	Beta Oxidation of Very Long Chain Fatty Acids	Carnitine-acylcarnitine translocase deficiency
Hexacosanoic acid	HMDB_SMPDB	Samples:	26	Pathways:	3	Adrenoleukodystrophy, X-linked	Beta Oxidation of Very Long Chain Fatty Acids	Carnitine-acylcarnitine translocase deficiency
Lauroyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	17	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Trifunctional protein deficiency	Fatty acid Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Adrenoleukodystrophy, X-linked	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine-acylcarnitine translocase deficiency	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Beta Oxidation of Very Long Chain Fatty Acids	Glutaric Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Hexacosanoyl-CoA 	HMDB_SMPDB	Samples:	26	Pathways:	3	Adrenoleukodystrophy, X-linked	Beta Oxidation of Very Long Chain Fatty Acids	Carnitine-acylcarnitine translocase deficiency
Tetracosanoyl-CoA  	HMDB_SMPDB	Samples:	26	Pathways:	3	Adrenoleukodystrophy, X-linked	Beta Oxidation of Very Long Chain Fatty Acids	Carnitine-acylcarnitine translocase deficiency
O-Acetylcarnitine	HMDB_SMPDB	Samples:	50	Pathways:	4	Adrenoleukodystrophy, X-linked	Oxidation of Branched Chain Fatty Acids	Beta Oxidation of Very Long Chain Fatty Acids	Carnitine-acylcarnitine translocase deficiency
Tetracosanoyl-CoA	HMDB_SMPDB	Samples:	26	Pathways:	3	Adrenoleukodystrophy, X-linked	Beta Oxidation of Very Long Chain Fatty Acids	Carnitine-acylcarnitine translocase deficiency
Tetradecanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	16	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Trifunctional protein deficiency	Fatty acid Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Adrenoleukodystrophy, X-linked	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine-acylcarnitine translocase deficiency	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Beta Oxidation of Very Long Chain Fatty Acids	Glutaric Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Bupivacaine	HMDB_SMPDB	Samples:	28	Pathways:	2	Bupivacaine Action Pathway	Bupivacaine Pathway
NADP+	HMDB_SMPDB	Samples:	69	Pathways:	112	Ureidopropionase deficiency	Tyrosinemia Type I	Hyperprolinemia Type I	Beta-Alanine Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Degradation of Superoxides	Valproic Acid Metabolism Pathway	Folate Metabolism	Homocarnosinosis	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Gamma-Glutamyltransferase Deficiency	Sepiapterin reductase deficiency	Hyperprolinemia Type II	Glutathione Synthetase Deficiency	Dopa-responsive dystonia	The oncogenic action of 2-hydroxyglutarate	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Corticosterone methyl oxidase II deficiency - CMO II	Glycerol Kinase Deficiency	Nicotine Action Pathway	Pyridoxine dependency with seizures	Celecoxib Action Pathway	Corticosterone methyl oxidase I deficiency (CMO I)	Gamma-glutamyl-transpeptidase deficiency	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fructose and Mannose Degradation	21-hydroxylase deficiency (CYP21)	Hyperphenylalaninemia due to dhpr-deficiency	Transfer of Acetyl Groups into Mitochondria	Hyperornithinemia with gyrate atrophy (HOGA)	Phenytoin (Antiarrhythmic) Action Pathway	Prolidase Deficiency (PD)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Lidocaine (Antiarrhythmic) Action Pathway	5-Oxoprolinuria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	5-oxoprolinase deficiency	Tamoxifen Action Pathway	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Segawa syndrome	Glutamate Metabolism	Warburg Effect	Tyrosine Metabolism	Pyruvate Metabolism	Fructosuria	Lysine Degradation	Leigh Syndrome	Hyperlysinemia II or Saccharopinuria	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Monoamine oxidase-a deficiency (MAO-A)	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Familial Hypercholanemia (FHCA)	Histidinemia	Imipramine Action Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	27-Hydroxylase Deficiency	Disulfiram Action Pathway	Pyruvate kinase deficiency	2-Hydroxyglutric Aciduria (D And L Form)	Alkaptonuria	Bile Acid Biosynthesis	Steroidogenesis	Zellweger Syndrome	Vitamin A Deficiency	Dopamine beta-hydroxylase deficiency	Pyruvate Dehydrogenase Complex Deficiency	Methotrexate Action Pathway	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Fructose intolerance, hereditary	Familial lipoprotein lipase deficiency	17-alpha-hydroxylase deficiency (CYP17)	Saccharopinuria/Hyperlysinemia II	Glutathione Metabolism	Desipramine Action Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Congenital Bile Acid Synthesis Defect Type II	Ubiquinone Biosynthesis	Ornithine Aminotransferase Deficiency (OAT Deficiency)	The oncogenic action of Fumarate	Prolinemia Type II	D-glyceric acidura	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Apparent mineralocorticoid excess syndrome	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Ibuprofen Action Pathway	Glutaminolysis and Cancer	Tamoxifen Metabolism Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Glycerolipid Metabolism	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Pterine Biosynthesis	Retinol Metabolism	Lidocaine (Local Anaesthetic) Action Pathway	Folate malabsorption, hereditary
Sufentanil	HMDB_SMPDB	Samples:	28	Pathways:	2	Sufentanil Pathway	Sufentanil Action Pathway
Inositol 1,4,5-trisphosphate	HMDB_SMPDB	Samples:	11	Pathways:	49	Atenolol Pathway	Lidocaine (Antiarrhythmic) Pathway	Carvedilol Pathway	Felodipine Pathway	Verapamil Pathway	Disopyramide Pathway	Ibutilide Pathway	Oxprenolol Pathway	Bopindolol Action Pathway	Nitrendipine Pathway	Sotalol Action Pathway	Nisoldipine Pathway	Nebivolol Pathway	Amiodarone Action Pathway	Levobunolol Action Pathway	Muscle/Heart Contraction	Quinidine Pathway	Practolol Action Pathway	Propranolol Pathway	Betaxolol Pathway	Epinephrine Action Pathway	Pindolol Pathway	Timolol Action Pathway	Bupranolol Action Pathway	Nadolol Pathway	Amlodipine Pathway	Mexiletine Pathway	Penbutolol Pathway	Acebutolol Pathway	Arbutamine Action Pathway	Carteolol Action Pathway	Isoprenaline Action Pathway	Phenytoin (Antiarrhythmic) Pathway	Esmolol Pathway	Nifedipine Pathway	Bevantolol Action Pathway	Procainamide (Antiarrhythmic) Pathway	Isradipine Pathway	Flecainide Pathway	Metoprolol Pathway	Nimodipine Pathway	Tocainide Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Alprenolol Pathway	Diltiazem Pathway	Bisoprolol Pathway	Labetalol Pathway	Dobutamine Action Pathway	Metipranolol Action Pathway
DG(14:0/14:1(9Z)/0:0)	HMDB_SMPDB	Samples:	11	Pathways:	49	Atenolol Pathway	Lidocaine (Antiarrhythmic) Pathway	Carvedilol Pathway	Felodipine Pathway	Verapamil Pathway	Disopyramide Pathway	Ibutilide Pathway	Oxprenolol Pathway	Bopindolol Action Pathway	Nitrendipine Pathway	Sotalol Action Pathway	Nisoldipine Pathway	Nebivolol Pathway	Amiodarone Action Pathway	Levobunolol Action Pathway	Muscle/Heart Contraction	Quinidine Pathway	Practolol Action Pathway	Propranolol Pathway	Betaxolol Pathway	Epinephrine Action Pathway	Pindolol Pathway	Timolol Action Pathway	Bupranolol Action Pathway	Nadolol Pathway	Amlodipine Pathway	Mexiletine Pathway	Penbutolol Pathway	Acebutolol Pathway	Arbutamine Action Pathway	Carteolol Action Pathway	Isoprenaline Action Pathway	Phenytoin (Antiarrhythmic) Pathway	Esmolol Pathway	Nifedipine Pathway	Bevantolol Action Pathway	Procainamide (Antiarrhythmic) Pathway	Isradipine Pathway	Flecainide Pathway	Metoprolol Pathway	Nimodipine Pathway	Tocainide Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Alprenolol Pathway	Diltiazem Pathway	Bisoprolol Pathway	Labetalol Pathway	Dobutamine Action Pathway	Metipranolol Action Pathway
PIP2(16:0/20:3(8Z,11Z,14Z))	HMDB_SMPDB	Samples:	11	Pathways:	49	Atenolol Pathway	Lidocaine (Antiarrhythmic) Pathway	Carvedilol Pathway	Felodipine Pathway	Verapamil Pathway	Disopyramide Pathway	Ibutilide Pathway	Oxprenolol Pathway	Bopindolol Action Pathway	Nitrendipine Pathway	Sotalol Action Pathway	Nisoldipine Pathway	Nebivolol Pathway	Amiodarone Action Pathway	Levobunolol Action Pathway	Muscle/Heart Contraction	Quinidine Pathway	Practolol Action Pathway	Propranolol Pathway	Betaxolol Pathway	Epinephrine Action Pathway	Pindolol Pathway	Timolol Action Pathway	Bupranolol Action Pathway	Nadolol Pathway	Amlodipine Pathway	Mexiletine Pathway	Penbutolol Pathway	Acebutolol Pathway	Arbutamine Action Pathway	Carteolol Action Pathway	Isoprenaline Action Pathway	Phenytoin (Antiarrhythmic) Pathway	Esmolol Pathway	Nifedipine Pathway	Bevantolol Action Pathway	Procainamide (Antiarrhythmic) Pathway	Isradipine Pathway	Flecainide Pathway	Metoprolol Pathway	Nimodipine Pathway	Tocainide Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Alprenolol Pathway	Diltiazem Pathway	Bisoprolol Pathway	Labetalol Pathway	Dobutamine Action Pathway	Metipranolol Action Pathway
Labetalol	HMDB_SMPDB	Samples:	8	Pathways:	2	Labetalol Action Pathway	Labetalol Pathway
Levorphanol	HMDB_SMPDB	Samples:	28	Pathways:	1	Levorphanol Action Pathway
L-Noradrenaline	HMDB_SMPDB	Samples:	61	Pathways:	63	Nalbuphine Action Pathway	Fluoxetine Action Pathway	Levomethadyl Acetate Action Action Pathway	Monoamine oxidase-a deficiency (MAO-A)	Ethylmorphine Action Pathway	Tyrosinemia Type I	Hydrocodone Action Pathway	Aromatic L-Aminoacid Decarboxylase Deficiency	Hydromorphone Action Pathway	Propoxyphene Action Pathway	3-Methylthiofentanyl Action Pathway	Citalopram Action Pathway	Imipramine Action Pathway	Disulfiram Action Pathway	Levorphanol Action Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Dibucaine Action Pathway	Proparacaine Action Pathway	Alkaptonuria	Sufentanil Action Pathway	Oxycodone Action Pathway	Escitalopram Action Pathway	Dopamine beta-hydroxylase deficiency	Bupivacaine Action Pathway	Chloroprocaine Action Pathway	Pentazocine Action Pathway	Catecholamine Biosynthesis	Procaine Action Pathway	Ropivacaine Action Pathway	Benzocaine Action Pathway	Buprenorphine Action Pathway	Dimethylthiambutene Action Pathway	Oxybuprocaine Action Pathway	Desipramine Action Pathway	Codeine Action Pathway	Nicotine Action Pathway	Tyrosine hydroxylase deficiency	Remifentanil Action Pathway	Tyrosinemia, transient, of the newborn	Heroin Action Pathway	Mepivacaine Action Pathway	Ketobemidone  Action Pathway	Naltrexone Action Pathway	Dihydromorphine Action Pathway	Tramadol Action Action Pathway	Morphine Action Pathway	Alfentanil Action Pathway	Dezocine Action Pathway	Alvimopan Action Pathway	Fentanyl Action Pathway	Naloxone Action Pathway	Levallorphan Action Pathway	Methadone Action Pathway	Prilocaine Action Pathway	Levobupivacaine Action Pathway	Oxymorphone Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Carfentanil Action Pathway	Diphenoxylate Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Cocaine Action Pathway
Potassium cation	HMDB_SMPDB	Samples:	78	Pathways:	170	Alprenolol Action Pathway	Levomethadyl Acetate Action Action Pathway	Bisoprolol Action Pathway	Gliclazide Action Pathway	Levorphanol Action Pathway	Lysinuric Protein Intolerance	Felodipine Action Pathway	Triamterene Action Pathway	Furosemide Action Pathway	Bupivacaine Action Pathway	Isradipine Action Pathway	Nizatidine Action Pathway	Ropivacaine Action Pathway	Gastric Acid Production	Methionine Metabolism	Buprenorphine Action Pathway	Eplerenone Action Pathway	Arbutamine Action Pathway	Heroin Action Pathway	Nisoldipine Action Pathway	Polythiazide Action Pathway	Verapamil Action Pathway	Dihydromorphine Action Pathway	Metiamide Action Pathway	Mexiletine Action Pathway	Alvimopan Action Pathway	Fentanyl Action Pathway	Methadone Action Pathway	Phenytoin (Antiarrhythmic) Action Pathway	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Methyclothiazide Action Pathway	Labetalol Action Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Iminoglycinuria	Blue diaper syndrome	Ethacrynic Acid Action Pathway	Pyruvate Metabolism	Disopyramide Action Pathway	Nalbuphine Action Pathway	Fluoxetine Action Pathway	Lactose Intolerance	Glibenclamide Action Pathway	Repaglinide Action Pathway	Hydrocodone Action Pathway	Bendroflumethiazide Action Pathway	Primary hyperoxaluria II, PH2	Procainamide (Antiarrhythmic) Action Pathway	Tocainide Action Pathway	Lansoprazole Action Pathway	Spironolactone Action Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Proparacaine Action Pathway	Sufentanil Action Pathway	Escitalopram Action Pathway	Hydrochlorothiazide Action Pathway	Practolol Action Pathway	Chloroprocaine Action Pathway	Betaine Metabolism	Pentazocine Action Pathway	Epinephrine Action Pathway	Trichlormethiazide Action Pathway	Dimethylthiambutene Action Pathway	Timolol Action Pathway	Desipramine Action Pathway	Oxprenolol Action Pathway	Pantoprazole Action Pathway	Cimetidine Action Pathway	Isoprenaline Action Pathway	Remifentanil Action Pathway	Chlorthalidone Action Pathway	Hypermethioninemia	Ketobemidone  Action Pathway	Esmolol Action Pathway	Nateglinide Action Pathway	Penbutolol Action Pathway	Morphine Action Pathway	Nitrendipine Action Pathway	Acebutolol Action Pathway	Amiloride Action Pathway	Levobupivacaine Action Pathway	Omeprazole Action Pathway	Diphenoxylate Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Cocaine Action Pathway	Ibutilide Action Pathway	Rabeprazole Action Pathway	Kidney Function	Ethylmorphine Action Pathway	3-Methylthiofentanyl Action Pathway	Glycine N-methyltransferase Deficiency	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Bumetanide Action Pathway	Dibucaine Action Pathway	Levobunolol Action Pathway	Trehalose Degradation	Muscle/Heart Contraction	Procaine Action Pathway	Benzocaine Action Pathway	Quinethazone Action Pathway	Ranitidine Action Pathway	Nicotine Action Pathway	Bupranolol Action Pathway	Glucose Transporter Defect (SGLT2)	Torsemide Action Pathway	Carteolol Action Pathway	Propranolol Action Pathway	Mepivacaine Action Pathway	Nifedipine Action Pathway	Cystinuria	Metoprolol Action Pathway	Alfentanil Action Pathway	Dezocine Action Pathway	Naloxone Action Pathway	Lactose Degradation	Levallorphan Action Pathway	Pancreas Function	Betazole Action Pathway	Roxatidine acetate Action Pathway	Fosphenytoin (Antiarrhythmic) Action Pathway	Hydroflumethiazide Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Prilocaine Action Pathway	Cystathionine Beta-Synthase Deficiency	Famotidine Action Pathway	Warburg Effect	Glycolysis	Leigh Syndrome	Atenolol Action Pathway	Lysinuric protein intolerance (LPI)	Cyclothiazide Action Pathway	Diltiazem Action Pathway	Hydromorphone Action Pathway	Propoxyphene Action Pathway	Imipramine Action Pathway	Citalopram Action Pathway	Betaxolol Action Pathway	Pyruvate kinase deficiency	Metolazone Action Pathway	Oxycodone Action Pathway	Amiodarone Action Pathway	Carvedilol Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Nebivolol Action Pathway	Chlorothiazide Action Pathway	Oxybuprocaine Action Pathway	Codeine Action Pathway	Indapamide Action Pathway	Methionine Adenosyltransferase Deficiency	Bevantolol Action Pathway	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Flecainide Action Pathway	Hartnup Disorder	Naltrexone Action Pathway	Nimodipine Action Pathway	Tramadol Action Action Pathway	Nadolol Action Pathway	Amlodipine Action Pathway	Quinidine Action Pathway	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pirenzepine Action Pathway	Esomeprazole Action Pathway	Oxymorphone Action Pathway	Pindolol Action Pathway	Carfentanil Action Pathway	Dobutamine Action Pathway	Metipranolol Action Pathway
Sodium cation	HMDB_SMPDB	Samples:	76	Pathways:	135	Alprenolol Action Pathway	Levomethadyl Acetate Action Action Pathway	Capecitabine Action Pathway	Bisoprolol Action Pathway	Levorphanol Action Pathway	Lysinuric Protein Intolerance	Felodipine Action Pathway	Triamterene Action Pathway	Furosemide Action Pathway	Bupivacaine Action Pathway	Isradipine Action Pathway	Ropivacaine Action Pathway	Buprenorphine Action Pathway	Eplerenone Action Pathway	Arbutamine Action Pathway	Heroin Action Pathway	Nisoldipine Action Pathway	Polythiazide Action Pathway	Verapamil Action Pathway	Dihydromorphine Action Pathway	Mexiletine Action Pathway	Alvimopan Action Pathway	Fentanyl Action Pathway	Methadone Action Pathway	Phenytoin (Antiarrhythmic) Action Pathway	Methyclothiazide Action Pathway	Labetalol Action Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Iminoglycinuria	Blue diaper syndrome	Ethacrynic Acid Action Pathway	Disopyramide Action Pathway	Nalbuphine Action Pathway	Fluoxetine Action Pathway	Lactose Intolerance	Hydrocodone Action Pathway	Bendroflumethiazide Action Pathway	Tocainide Action Pathway	Procainamide (Antiarrhythmic) Action Pathway	Spironolactone Action Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Proparacaine Action Pathway	Sufentanil Action Pathway	Escitalopram Action Pathway	Hydrochlorothiazide Action Pathway	Practolol Action Pathway	Chloroprocaine Action Pathway	Pentazocine Action Pathway	Epinephrine Action Pathway	Trichlormethiazide Action Pathway	Dimethylthiambutene Action Pathway	Timolol Action Pathway	Desipramine Action Pathway	Oxprenolol Action Pathway	Isoprenaline Action Pathway	Remifentanil Action Pathway	Chlorthalidone Action Pathway	Ketobemidone  Action Pathway	Esmolol Action Pathway	Penbutolol Action Pathway	Morphine Action Pathway	Nitrendipine Action Pathway	Acebutolol Action Pathway	Amiloride Action Pathway	Levobupivacaine Action Pathway	Capecitabine Metabolism Pathway	Diphenoxylate Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Cocaine Action Pathway	Ibutilide Action Pathway	Kidney Function	Ethylmorphine Action Pathway	3-Methylthiofentanyl Action Pathway	Bumetanide Action Pathway	Dibucaine Action Pathway	Levobunolol Action Pathway	Trehalose Degradation	Muscle/Heart Contraction	Procaine Action Pathway	Benzocaine Action Pathway	Quinethazone Action Pathway	Nicotine Action Pathway	Bupranolol Action Pathway	Glucose Transporter Defect (SGLT2)	Torsemide Action Pathway	Carteolol Action Pathway	Propranolol Action Pathway	Mepivacaine Action Pathway	Nifedipine Action Pathway	Cystinuria	Metoprolol Action Pathway	Alfentanil Action Pathway	Dezocine Action Pathway	Naloxone Action Pathway	Lactose Degradation	Levallorphan Action Pathway	Fosphenytoin (Antiarrhythmic) Action Pathway	Hydroflumethiazide Action Pathway	Prilocaine Action Pathway	Atenolol Action Pathway	Lysinuric protein intolerance (LPI)	Cyclothiazide Action Pathway	Thyroid hormone synthesis	Diltiazem Action Pathway	Hydromorphone Action Pathway	Propoxyphene Action Pathway	Imipramine Action Pathway	Citalopram Action Pathway	Betaxolol Action Pathway	Metolazone Action Pathway	Oxycodone Action Pathway	Amiodarone Action Pathway	Carvedilol Action Pathway	Nebivolol Action Pathway	Chlorothiazide Action Pathway	Oxybuprocaine Action Pathway	Codeine Action Pathway	Indapamide Action Pathway	Bevantolol Action Pathway	Flecainide Action Pathway	Hartnup Disorder	Naltrexone Action Pathway	Nimodipine Action Pathway	Tramadol Action Action Pathway	Nadolol Action Pathway	Amlodipine Action Pathway	Quinidine Action Pathway	Oxymorphone Action Pathway	Pindolol Action Pathway	Carfentanil Action Pathway	Dobutamine Action Pathway	Metipranolol Action Pathway
Glutathione	HMDB_SMPDB	Samples:	61	Pathways:	23	Gamma-glutamyl-transpeptidase deficiency	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Primary hyperoxaluria II, PH2	Homocarnosinosis	Ibuprofen Action Pathway	Acetaminophen Metabolism Pathway	Pyruvate kinase deficiency	2-Hydroxyglutric Aciduria (D And L Form)	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Gamma-Glutamyltransferase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Pyruvate Dehydrogenase Complex Deficiency	Glutathione Synthetase Deficiency	5-Oxoprolinuria	5-oxoprolinase deficiency	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism	Celecoxib Pathway	Pyruvate Metabolism	Glutathione Metabolism	Ibuprofen Pathway	Leigh Syndrome	Celecoxib Action Pathway
Uridine diphosphate glucuronic acid	HMDB_SMPDB	Samples:	68	Pathways:	23	Phenytoin (Antiarrhythmic) Pathway	Morphine Metabolism Pathway	Codeine Metabolism Pathway	Valproic Acid Metabolism Pathway	Artemether Metabolism Pathway	Tramadol Metabolism Pathway	Acetaminophen Metabolism Pathway	Tamoxifen Metabolism Pathway	Ibuprofen Metabolism Pathway	Etoposide Metabolism Pathway	Nicotine Metabolism Pathway	Galactosemia II (GALK)	Nicotine Pathway	Codeine Pathway	Sorafenib Metabolism Pathway	Nucleotide Sugars Metabolism	Tamoxifen Pathway	Morphine Pathway	Celecoxib Metabolism Pathway	Irinotecan Metabolism Pathway	Celecoxib Pathway	Ibuprofen Pathway	Galactosemia III
Arachidonic acid	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
Leukotriene B4	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
Prostaglandin F2a	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
Leukotriene C4	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
Prostaglandin E2	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
Prostaglandin I2	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
Leukotriene A4	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
Prostaglandin H2	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
Prostaglandin D2	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
Thromboxane A2	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
20-Hydroxy-leukotriene B4	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
Ibuprofen	HMDB_SMPDB	Samples:	16	Pathways:	3	Ibuprofen Pathway	Ibuprofen Action Pathway	Ibuprofen Metabolism Pathway
5,6-Epoxy-8,11,14-eicosatrienoic acid	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
8,9-Epoxyeicosatrienoic acid	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
14,15-DiHETrE	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
8,9-DiHETrE	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
11,12-DiHETrE	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
5,6-DHET	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
Prostaglandin J2	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
Prostaglandin A2	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
Prostaglandin G2	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
Thromboxane B2	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
Oxidized glutathione	HMDB_SMPDB	Samples:	30	Pathways:	14	Gamma-Glutamyltransferase Deficiency	Gamma-glutamyl-transpeptidase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Glutathione Synthetase Deficiency	5-Oxoprolinuria	5-oxoprolinase deficiency	Succinic semialdehyde dehydrogenase deficiency	Homocarnosinosis	Glutamate Metabolism	Celecoxib Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Glutathione Metabolism	Ibuprofen Pathway
15(S)-HETE	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
12-Keto-leukotriene B4	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
Prostaglandin B2	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
Delta-12-Prostaglandin J2	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
6-Ketoprostaglandin E1	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
11-Dehydro-thromboxane B2	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
12(S)-HPETE	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
15(S)-HPETE	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
14,15-Epoxy-5,8,11-eicosatrienoic acid	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
8-Isoprostane	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
11,12-Epoxyeicosatrienoic acid	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
8-HETE	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
16(R)-HETE	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
11,12,15-THETA	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
12(R)-HPETE	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
11H-14,15-EETA	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
11,14,15-THETA	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
8(S)-HPETE	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
15H-11,12-EETA	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
15-Deoxy-d-12,14-PGJ2	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
20-Hydroxyeicosatetraenoic acid	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
20-Carboxy-leukotriene B4	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
PC(14:0/20:4(5Z,8Z,11Z,14Z))	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
5-KETE	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
LysoPC(14:0)	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
5-HETE	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
5-HPETE	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
19(S)-HETE	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
11-Epi-PGF2a	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
Fe3+	HMDB_SMPDB	Samples:	60	Pathways:	21	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Ubiquinone Biosynthesis	Gemcitabine Metabolism Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Ibuprofen Action Pathway	Phenylketonuria	Gemcitabine Action Pathway	Alkaptonuria	Phenylalanine and Tyrosine Metabolism	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Gemcitabine Pathway	Tyrosinemia Type 3 (TYRO3)	Hawkinsinuria	Tyrosine Metabolism	Celecoxib Pathway	Ibuprofen Pathway	Celecoxib Action Pathway
12-KETE	HMDB_SMPDB	Samples:	8	Pathways:	2	Celecoxib Pathway	Ibuprofen Pathway
Arachidonate	HMDB_SMPDB	Samples:	14	Pathways:	4	Celecoxib Pathway	Ibuprofen Pathway	Ibuprofen Action Pathway	Celecoxib Action Pathway
Tramadol	HMDB_SMPDB	Samples:	35	Pathways:	2	Tramadol Metabolism Pathway	Tramadol Action Action Pathway
Tetrahydrobiopterin	HMDB_SMPDB	Samples:	57	Pathways:	36	Tyrosinemia Type I	Hyperprolinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Arginine and Proline Metabolism	Aromatic L-Aminoacid Decarboxylase Deficiency	Disulfiram Action Pathway	Alkaptonuria	Phenylalanine and Tyrosine Metabolism	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Sepiapterin reductase deficiency	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dopa-responsive dystonia	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Catecholamine Biosynthesis	Tyrosine hydroxylase deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Tyrosinemia, transient, of the newborn	Hyperphenylalaninemia due to dhpr-deficiency	Phenylketonuria	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Tyrosinemia Type 3 (TYRO3)	L-arginine:glycine amidinotransferase deficiency	Pterine Biosynthesis	Hawkinsinuria	Segawa syndrome	Tyrosine Metabolism
Adenosine monophosphate	HMDB_SMPDB	Samples:	59	Pathways:	84	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Lactic Acidemia	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Trifunctional protein deficiency	Glycine N-methyltransferase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocarnosinosis	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Disulfiram Pathway	Aspartate Metabolism	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Malonyl-coa decarboxylase deficiency	Carnitine palmitoyl transferase deficiency (I)	Non Ketotic Hyperglycinemia	Methionine Metabolism	Canavan Disease	Citrullinemia Type I	Hyperglycinemia, non-ketotic	Ethylmalonic Encephalopathy	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Malonic Aciduria	Phenylketonuria	Hypoacetylaspartia	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Pantothenate and CoA Biosynthesis	Propanoate Metabolism	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	Pyruvate Carboxylase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Phenylacetate Metabolism	Glutamate Metabolism	Pyruvate Metabolism	Leigh Syndrome	Alanine Metabolism	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Histidinemia	Pyruvate kinase deficiency	2-Hydroxyglutric Aciduria (D And L Form)	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Primary Hyperoxaluria Type I	Methionine Adenosyltransferase Deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Histidine Metabolism	Prolinemia Type II	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Hypermethioninemia	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Argininosuccinic Aciduria	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Selenoamino Acid Metabolism
Argininosuccinic acid	HMDB_SMPDB	Samples:	51	Pathways:	21	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Carbamoyl Phosphate Synthetase Deficiency	Arginine and Proline Metabolism	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Urea Cycle	Argininosuccinic Aciduria	Hypoacetylaspartia	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Aspartate Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	L-arginine:glycine amidinotransferase deficiency	Canavan Disease	Citrullinemia Type I
Creatine	HMDB_SMPDB	Samples:	53	Pathways:	19	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Arginine and Proline Metabolism	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dimethylglycine Dehydrogenase Deficiency	L-arginine:glycine amidinotransferase deficiency	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
Glycine	HMDB_SMPDB	Samples:	54	Pathways:	53	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type III	Alanine Metabolism	Familial Hypercholanemia (FHCA)	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Hyperprolinemia Type I	Arginine and Proline Metabolism	Lactic Acidemia	Carnitine Synthesis	Glycine N-methyltransferase Deficiency	27-Hydroxylase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocarnosinosis	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	2-Hydroxyglutric Aciduria (D And L Form)	Bile Acid Biosynthesis	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Zellweger Syndrome	Gamma-Glutamyltransferase Deficiency	Hyperprolinemia Type II	Glutathione Synthetase Deficiency	sarcosine oncometabolite pathway 	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dimethylglycine Dehydrogenase Deficiency	Non Ketotic Hyperglycinemia	Methionine Metabolism	Hyperglycinemia, non-ketotic	Glutathione Metabolism	Primary Hyperoxaluria Type I	Congenital Bile Acid Synthesis Defect Type II	Gamma-glutamyl-transpeptidase deficiency	Methionine Adenosyltransferase Deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	Hypermethioninemia	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Hyperinsulinism-Hyperammonemia Syndrome	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	5-Oxoprolinuria	Ammonia Recycling	5-oxoprolinase deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	L-arginine:glycine amidinotransferase deficiency	Pyruvate Carboxylase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism	Glycine and Serine Metabolism
Guanidoacetic acid	HMDB_SMPDB	Samples:	53	Pathways:	19	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Arginine and Proline Metabolism	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dimethylglycine Dehydrogenase Deficiency	L-arginine:glycine amidinotransferase deficiency	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
Fumaric acid	HMDB_SMPDB	Samples:	62	Pathways:	48	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Congenital lactic acidosis	Tyrosinemia Type I	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	The oncogenic action of Succinate	Citric Acid Cycle	Alkaptonuria	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Argininemia	Mitochondrial Electron Transport Chain	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Disulfiram Pathway	Aspartate Metabolism	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	The oncogenic action of 2-hydroxyglutarate	Canavan Disease	Citrullinemia Type I	2-ketoglutarate dehydrogenase complex deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	The oncogenic action of Fumarate	Tyrosinemia, transient, of the newborn	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Urea Cycle	Argininosuccinic Aciduria	Fumarase deficiency	Glutaminolysis and Cancer	Phenylketonuria	Hypoacetylaspartia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Pyruvate dehydrogenase deficiency (E2)	Tyrosinemia Type 3 (TYRO3)	L-arginine:glycine amidinotransferase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Tyrosine Metabolism
L-Proline	HMDB_SMPDB	Samples:	59	Pathways:	14	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	The oncogenic action of Fumarate	The oncogenic action of Succinate	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
L-Aspartic acid	HMDB_SMPDB	Samples:	59	Pathways:	42	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Beta-Alanine Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Tyrosinemia Type I	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Ureidopropionase deficiency	Homocarnosinosis	Alkaptonuria	2-Hydroxyglutric Aciduria (D And L Form)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Disulfiram Pathway	Aspartate Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Canavan Disease	Citrullinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Malate-Aspartate Shuttle	Prolinemia Type II	Tyrosinemia, transient, of the newborn	Urea Cycle	Argininosuccinic Aciduria	Hypoacetylaspartia	Glutaminolysis and Cancer	Hyperinsulinism-Hyperammonemia Syndrome	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Ammonia Recycling	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism	Hawkinsinuria	Tyrosine Metabolism
Ornithine	HMDB_SMPDB	Samples:	53	Pathways:	19	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Carbamoyl Phosphate Synthetase Deficiency	Arginine and Proline Metabolism	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Urea Cycle	Argininosuccinic Aciduria	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	L-arginine:glycine amidinotransferase deficiency	Citrullinemia Type I	Glycine and Serine Metabolism
Oxalacetic acid	HMDB_SMPDB	Samples:	62	Pathways:	61	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Alanine Metabolism	Congenital lactic acidosis	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Lactic Acidemia	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Monoamine oxidase-a deficiency (MAO-A)	Primary hyperoxaluria II, PH2	Citric Acid Cycle	The oncogenic action of Succinate	Homocarnosinosis	Pyruvate kinase deficiency	Alkaptonuria	2-Hydroxyglutric Aciduria (D And L Form)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Disulfiram Pathway	Pyruvate Dehydrogenase Complex Deficiency	Aspartate Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	The oncogenic action of 2-hydroxyglutarate	Tyrosinemia Type I	Canavan Disease	Citrullinemia Type I	Primary Hyperoxaluria Type I	2-ketoglutarate dehydrogenase complex deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Malate-Aspartate Shuttle	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Mitochondrial complex II deficiency	Prolinemia Type II	The oncogenic action of Fumarate	Tyrosinemia, transient, of the newborn	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Urea Cycle	Argininosuccinic Aciduria	Fumarase deficiency	Glutaminolysis and Cancer	Hypoacetylaspartia	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Transfer of Acetyl Groups into Mitochondria	Hyperinsulinism-Hyperammonemia Syndrome	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Pyruvate dehydrogenase deficiency (E2)	L-arginine:glycine amidinotransferase deficiency	Pyruvate Carboxylase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Tyrosine Metabolism	Pyruvate Metabolism	Leigh Syndrome
Urea	HMDB_SMPDB	Samples:	57	Pathways:	66	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Kidney Function	Indapamide Pathway	Bumetanide Action Pathway	Lysinuric Protein Intolerance	Cyclothiazide Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Triamterene Action Pathway	Hyperprolinemia Type II	Furosemide Action Pathway	Citrullinemia Type I	Quinethazone Action Pathway	Eplerenone Action Pathway	Glucose Transporter Defect (SGLT2)	Torsemide Action Pathway	Ethacrynic Acid pathway	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Chlorthalidone Pathway	Polythiazide Action Pathway	Urea Cycle	Cystinuria	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hydrochlorothiazide Pathway	Methyclothiazide Action Pathway	Hydroflumethiazide Action Pathway	Methyclothiazide Pathway	Iminoglycinuria	Blue diaper syndrome	Ethacrynic Acid Action Pathway	Amiloride Pathway	Bendroflumethiazide Pathway	Lysinuric protein intolerance (LPI)	Cyclothiazide Action Pathway	Arginine and Proline Metabolism	Bendroflumethiazide Action Pathway	Carbamoyl Phosphate Synthetase Deficiency	Spironolactone Action Pathway	Spironolactone Pathway	Trichlormethiazide Pathway	Hydroflumethiazide Pathway	Metolazone Action Pathway	Hydrochlorothiazide Action Pathway	Argininemia	Polythiazide Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Bumetanide Pathway	Trichlormethiazide Action Pathway	Chlorothiazide Action Pathway	Chlorothiazide Pathway	Furosemide Pathway	Eplerenone Pathway	Torsemide Pathway	Indapamide Action Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Chlorthalidone Action Pathway	Triamterene Pathway	Hartnup Disorder	Argininosuccinic Aciduria	Amiloride Action Pathway	L-arginine:glycine amidinotransferase deficiency	Quinethazone Pathway	Metolazone Pathway
L-Arginine	HMDB_SMPDB	Samples:	53	Pathways:	28	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Argininosuccinic Aciduria	Hypoacetylaspartia	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type II	Prolidase Deficiency (PD)	Aspartate Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dimethylglycine Dehydrogenase Deficiency	L-arginine:glycine amidinotransferase deficiency	Canavan Disease	Non Ketotic Hyperglycinemia	Citrullinemia Type I	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
Citrulline	HMDB_SMPDB	Samples:	51	Pathways:	21	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Carbamoyl Phosphate Synthetase Deficiency	Arginine and Proline Metabolism	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Urea Cycle	Argininosuccinic Aciduria	Hypoacetylaspartia	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Aspartate Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	L-arginine:glycine amidinotransferase deficiency	Canavan Disease	Citrullinemia Type I
S-Adenosylhomocysteine	HMDB_SMPDB	Samples:	60	Pathways:	46	Tyrosinemia Type I	Hyperprolinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Carnitine Synthesis	Arginine and Proline Metabolism	Aromatic L-Aminoacid Decarboxylase Deficiency	Histidinemia	Glycine N-methyltransferase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Alkaptonuria	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Disulfiram Pathway	sarcosine oncometabolite pathway 	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dimethylglycine Dehydrogenase Deficiency	Betaine Metabolism	Catecholamine Biosynthesis	Non Ketotic Hyperglycinemia	Methionine Metabolism	Hyperglycinemia, non-ketotic	Tyrosine hydroxylase deficiency	Ubiquinone Biosynthesis	Phenytoin (Antiarrhythmic) Pathway	Methionine Adenosyltransferase Deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Histidine Metabolism	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	Tyrosinemia, transient, of the newborn	Hypermethioninemia	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Tryptophan Metabolism	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	L-arginine:glycine amidinotransferase deficiency	Hawkinsinuria	Glycine and Serine Metabolism	Tyrosine Metabolism
Carbamoyl phosphate	HMDB_SMPDB	Samples:	51	Pathways:	28	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Urea Cycle	Homocarnosinosis	Argininosuccinic Aciduria	Hypoacetylaspartia	2-Hydroxyglutric Aciduria (D And L Form)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Hyperinsulinism-Hyperammonemia Syndrome	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type II	Prolidase Deficiency (PD)	Aspartate Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Ammonia Recycling	L-arginine:glycine amidinotransferase deficiency	Succinic semialdehyde dehydrogenase deficiency	Canavan Disease	Glutamate Metabolism	Citrullinemia Type I
S-Adenosylmethionine	HMDB_SMPDB	Samples:	60	Pathways:	46	Tyrosinemia Type I	Hyperprolinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Carnitine Synthesis	Arginine and Proline Metabolism	Aromatic L-Aminoacid Decarboxylase Deficiency	Histidinemia	Glycine N-methyltransferase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Alkaptonuria	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Disulfiram Pathway	sarcosine oncometabolite pathway 	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dimethylglycine Dehydrogenase Deficiency	Betaine Metabolism	Catecholamine Biosynthesis	Non Ketotic Hyperglycinemia	Methionine Metabolism	Hyperglycinemia, non-ketotic	Tyrosine hydroxylase deficiency	Ubiquinone Biosynthesis	Phenytoin (Antiarrhythmic) Pathway	Methionine Adenosyltransferase Deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Histidine Metabolism	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	Tyrosinemia, transient, of the newborn	Hypermethioninemia	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Tryptophan Metabolism	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	L-arginine:glycine amidinotransferase deficiency	Hawkinsinuria	Glycine and Serine Metabolism	Tyrosine Metabolism
1-Pyrroline-5-carboxylic acid	HMDB_SMPDB	Samples:	51	Pathways:	18	Hyperprolinemia Type I	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Arginine and Proline Metabolism	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	Homocarnosinosis	2-Hydroxyglutric Aciduria (D And L Form)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type II	Prolidase Deficiency (PD)	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	L-arginine:glycine amidinotransferase deficiency	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism
Pyrroline hydroxycarboxylic acid	HMDB_SMPDB	Samples:	51	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
Phosphocreatine	HMDB_SMPDB	Samples:	51	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
Flavin Mononucleotide	HMDB_SMPDB	Samples:	51	Pathways:	19	Ureidopropionase deficiency	Hyperprolinemia Type I	Beta-Alanine Metabolism	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Carnosinuria, carnosinemia	Arginine and Proline Metabolism	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	Hypophosphatasia	Vitamin B6 Metabolism	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Pantothenate and CoA Biosynthesis	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency
4-Hydroxy-2-oxoglutaric acid	HMDB_SMPDB	Samples:	51	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
L-Glutamic gamma-semialdehyde	HMDB_SMPDB	Samples:	51	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
1-Pyrroline-4-hydroxy-2-carboxylate	HMDB_SMPDB	Samples:	51	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
4-Hydroxy-L-glutamic acid	HMDB_SMPDB	Samples:	51	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
Nitric oxide	HMDB_SMPDB	Samples:	51	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
D-Proline	HMDB_SMPDB	Samples:	51	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
N-(o)-Hydroxyarginine	HMDB_SMPDB	Samples:	51	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
4-Hydroxy-L-proline	HMDB_SMPDB	Samples:	51	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
L-4-Hydroxyglutamate semialdehyde	HMDB_SMPDB	Samples:	51	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
1-Pyrroline-2-carboxylic acid	HMDB_SMPDB	Samples:	51	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
1-Pyrroline-2-carboxylate	HMDB_SMPDB	Samples:	51	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
4-Hydroxy-2-oxoglutarate	HMDB_SMPDB	Samples:	51	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
4-Hydroxy-L-glutamate	HMDB_SMPDB	Samples:	51	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
AMP	HMDB_SMPDB	Samples:	59	Pathways:	83	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Lactic Acidemia	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Trifunctional protein deficiency	Glycine N-methyltransferase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocarnosinosis	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Aspartate Metabolism	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Malonyl-coa decarboxylase deficiency	Carnitine palmitoyl transferase deficiency (I)	Non Ketotic Hyperglycinemia	Methionine Metabolism	Canavan Disease	Citrullinemia Type I	Hyperglycinemia, non-ketotic	Ethylmalonic Encephalopathy	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Malonic Aciduria	Phenylketonuria	Hypoacetylaspartia	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Pantothenate and CoA Biosynthesis	Propanoate Metabolism	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	Pyruvate Carboxylase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Phenylacetate Metabolism	Glutamate Metabolism	Pyruvate Metabolism	Leigh Syndrome	Alanine Metabolism	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Histidinemia	Disulfiram Action Pathway	Pyruvate kinase deficiency	2-Hydroxyglutric Aciduria (D And L Form)	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Carnitine palmitoyl transferase deficiency (II)	Primary Hyperoxaluria Type I	Methionine Adenosyltransferase Deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Histidine Metabolism	Prolinemia Type II	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Hypermethioninemia	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Argininosuccinic Aciduria	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Selenoamino Acid Metabolism
cis-4-Hydroxy-L-proline	HMDB_SMPDB	Samples:	51	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
Delta1-Pyrroline-5-carboxylate	HMDB_SMPDB	Samples:	51	Pathways:	18	Hyperprolinemia Type I	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Arginine and Proline Metabolism	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	Homocarnosinosis	2-Hydroxyglutric Aciduria (D And L Form)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type II	Prolidase Deficiency (PD)	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	L-arginine:glycine amidinotransferase deficiency	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism
FMN	HMDB_SMPDB	Samples:	51	Pathways:	19	Ureidopropionase deficiency	Hyperprolinemia Type I	Beta-Alanine Metabolism	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Carnosinuria, carnosinemia	Arginine and Proline Metabolism	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	Hypophosphatasia	Vitamin B6 Metabolism	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Pantothenate and CoA Biosynthesis	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency
Fumarate	HMDB_SMPDB	Samples:	62	Pathways:	47	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Congenital lactic acidosis	Tyrosinemia Type I	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	The oncogenic action of Succinate	Citric Acid Cycle	Disulfiram Action Pathway	Alkaptonuria	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Argininemia	Mitochondrial Electron Transport Chain	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Aspartate Metabolism	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	The oncogenic action of 2-hydroxyglutarate	Canavan Disease	Citrullinemia Type I	2-ketoglutarate dehydrogenase complex deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	The oncogenic action of Fumarate	Tyrosinemia, transient, of the newborn	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Urea Cycle	Argininosuccinic Aciduria	Fumarase deficiency	Glutaminolysis and Cancer	Phenylketonuria	Hypoacetylaspartia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Pyruvate dehydrogenase deficiency (E2)	Tyrosinemia Type 3 (TYRO3)	L-arginine:glycine amidinotransferase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Tyrosine Metabolism
Guanidinoacetate	HMDB_SMPDB	Samples:	53	Pathways:	19	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Arginine and Proline Metabolism	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dimethylglycine Dehydrogenase Deficiency	L-arginine:glycine amidinotransferase deficiency	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
L-1-Pyrroline-3-hydroxy-5-carboxylate	HMDB_SMPDB	Samples:	51	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
L-Aspartate	HMDB_SMPDB	Samples:	59	Pathways:	42	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Beta-Alanine Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Tyrosinemia Type I	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Ureidopropionase deficiency	Disulfiram Action Pathway	Homocarnosinosis	Alkaptonuria	2-Hydroxyglutric Aciduria (D And L Form)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Aspartate Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Canavan Disease	Citrullinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Malate-Aspartate Shuttle	Prolinemia Type II	Tyrosinemia, transient, of the newborn	Urea Cycle	Argininosuccinic Aciduria	Hypoacetylaspartia	Glutaminolysis and Cancer	Hyperinsulinism-Hyperammonemia Syndrome	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Ammonia Recycling	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism	Hawkinsinuria	Tyrosine Metabolism
L-Citrulline	HMDB_SMPDB	Samples:	51	Pathways:	21	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Carbamoyl Phosphate Synthetase Deficiency	Arginine and Proline Metabolism	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Urea Cycle	Argininosuccinic Aciduria	Hypoacetylaspartia	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Aspartate Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	L-arginine:glycine amidinotransferase deficiency	Canavan Disease	Citrullinemia Type I
L-Glutamate 5-semialdehyde	HMDB_SMPDB	Samples:	51	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
L-Ornithine	HMDB_SMPDB	Samples:	51	Pathways:	18	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Carbamoyl Phosphate Synthetase Deficiency	Arginine and Proline Metabolism	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Urea Cycle	Argininosuccinic Aciduria	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	L-arginine:glycine amidinotransferase deficiency	Citrullinemia Type I
N(omega)-Hydroxyarginine	HMDB_SMPDB	Samples:	51	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
N-(L-Arginino)succinate	HMDB_SMPDB	Samples:	51	Pathways:	21	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Carbamoyl Phosphate Synthetase Deficiency	Arginine and Proline Metabolism	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Urea Cycle	Argininosuccinic Aciduria	Hypoacetylaspartia	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Aspartate Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	L-arginine:glycine amidinotransferase deficiency	Canavan Disease	Citrullinemia Type I
Oxaloacetate	HMDB_SMPDB	Samples:	62	Pathways:	60	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Alanine Metabolism	Congenital lactic acidosis	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Lactic Acidemia	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Monoamine oxidase-a deficiency (MAO-A)	Primary hyperoxaluria II, PH2	Citric Acid Cycle	The oncogenic action of Succinate	Disulfiram Action Pathway	Homocarnosinosis	Pyruvate kinase deficiency	Alkaptonuria	2-Hydroxyglutric Aciduria (D And L Form)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Pyruvate Dehydrogenase Complex Deficiency	Aspartate Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	The oncogenic action of 2-hydroxyglutarate	Tyrosinemia Type I	Canavan Disease	Citrullinemia Type I	Primary Hyperoxaluria Type I	2-ketoglutarate dehydrogenase complex deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Malate-Aspartate Shuttle	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Mitochondrial complex II deficiency	Prolinemia Type II	The oncogenic action of Fumarate	Tyrosinemia, transient, of the newborn	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Urea Cycle	Argininosuccinic Aciduria	Fumarase deficiency	Glutaminolysis and Cancer	Hypoacetylaspartia	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Transfer of Acetyl Groups into Mitochondria	Hyperinsulinism-Hyperammonemia Syndrome	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Pyruvate dehydrogenase deficiency (E2)	L-arginine:glycine amidinotransferase deficiency	Pyruvate Carboxylase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Tyrosine Metabolism	Pyruvate Metabolism	Leigh Syndrome
S-Adenosyl-L-homocysteine	HMDB_SMPDB	Samples:	58	Pathways:	45	Tyrosinemia Type I	Hyperprolinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Carnitine Synthesis	Arginine and Proline Metabolism	Aromatic L-Aminoacid Decarboxylase Deficiency	Histidinemia	Glycine N-methyltransferase Deficiency	Disulfiram Action Pathway	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Alkaptonuria	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dimethylglycine Dehydrogenase Deficiency	Betaine Metabolism	Catecholamine Biosynthesis	Non Ketotic Hyperglycinemia	Methionine Metabolism	Hyperglycinemia, non-ketotic	Tyrosine hydroxylase deficiency	Ubiquinone Biosynthesis	Methionine Adenosyltransferase Deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Histidine Metabolism	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	Tyrosinemia, transient, of the newborn	Hypermethioninemia	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Tryptophan Metabolism	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Phenytoin (Antiarrhythmic) Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	L-arginine:glycine amidinotransferase deficiency	Hawkinsinuria	Glycine and Serine Metabolism	Tyrosine Metabolism
S-Adenosyl-L-methionine	HMDB_SMPDB	Samples:	58	Pathways:	45	Tyrosinemia Type I	Hyperprolinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Carnitine Synthesis	Arginine and Proline Metabolism	Aromatic L-Aminoacid Decarboxylase Deficiency	Histidinemia	Glycine N-methyltransferase Deficiency	Disulfiram Action Pathway	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Alkaptonuria	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dimethylglycine Dehydrogenase Deficiency	Betaine Metabolism	Catecholamine Biosynthesis	Non Ketotic Hyperglycinemia	Methionine Metabolism	Hyperglycinemia, non-ketotic	Tyrosine hydroxylase deficiency	Ubiquinone Biosynthesis	Methionine Adenosyltransferase Deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Histidine Metabolism	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	Tyrosinemia, transient, of the newborn	Hypermethioninemia	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Tryptophan Metabolism	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Phenytoin (Antiarrhythmic) Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	L-arginine:glycine amidinotransferase deficiency	Hawkinsinuria	Glycine and Serine Metabolism	Tyrosine Metabolism
UDP-glucuronate	HMDB_SMPDB	Samples:	60	Pathways:	18	Etoposide Action Pathway	Valproic Acid Metabolism Pathway	Artemether Metabolism Pathway	Tramadol Metabolism Pathway	Ibuprofen Action Pathway	Acetaminophen Metabolism Pathway	Tamoxifen Metabolism Pathway	Morphine Action Pathway	Nicotine Action Pathway	Galactosemia II (GALK)	Irinotecan Action Pathway	Phenytoin (Antiarrhythmic) Action Pathway	Sorafenib Metabolism Pathway	Nucleotide Sugars Metabolism	Tamoxifen Action Pathway	Codeine Action Pathway	Celecoxib Action Pathway	Galactosemia III
L-Alanine	HMDB_SMPDB	Samples:	58	Pathways:	27	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Alanine Metabolism	Lactic Acidemia	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Carbamoyl Phosphate Synthetase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocarnosinosis	Argininosuccinic Aciduria	Glucose-Alanine Cycle	Glutaminolysis and Cancer	2-Hydroxyglutric Aciduria (D And L Form)	Tryptophan Metabolism	Selenoamino Acid Metabolism	Argininemia	Sarcosinemia	Hyperinsulinism-Hyperammonemia Syndrome	Dimethylglycine Dehydrogenase Deficiency	Pyruvate Carboxylase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Non Ketotic Hyperglycinemia	Glutamate Metabolism	Citrullinemia Type I	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Primary Hyperoxaluria Type I
Palmitic acid	HMDB_SMPDB	Samples:	57	Pathways:	23	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Familial Hypercholanemia (FHCA)	Fatty Acid Elongation In Mitochondria	D-glyceric acidura	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Trifunctional protein deficiency	Fatty acid Metabolism	27-Hydroxylase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Bile Acid Biosynthesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Zellweger Syndrome	Glycerolipid Metabolism	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Familial lipoprotein lipase deficiency	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Glycerol Kinase Deficiency	Ethylmalonic Encephalopathy
L-Palmitoylcarnitine	HMDB_SMPDB	Samples:	57	Pathways:	10	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Octanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	14	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Butyryl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	15	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Butyrate Metabolism	Glutaric Aciduria Type I	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Fatty acid Metabolism	Trifunctional protein deficiency	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
3-Hydroxybutyryl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	19	2-aminoadipic 2-oxoadipic aciduria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Butyrate Metabolism	Trifunctional protein deficiency	Hyperlysinemia I, Familial	Fatty acid Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Ethylmalonic Encephalopathy	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Lysine Degradation	Pyridoxine dependency with seizures	Hyperlysinemia II or Saccharopinuria
Palmityl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	17	Fatty Acid Elongation In Mitochondria	D-glyceric acidura	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Trifunctional protein deficiency	Fatty acid Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Glycerolipid Metabolism	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Familial lipoprotein lipase deficiency	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Glycerol Kinase Deficiency	Ethylmalonic Encephalopathy
Glutaryl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	16	2-aminoadipic 2-oxoadipic aciduria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Trifunctional protein deficiency	Hyperlysinemia I, Familial	Fatty acid Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Ethylmalonic Encephalopathy	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Lysine Degradation	Pyridoxine dependency with seizures	Hyperlysinemia II or Saccharopinuria
Crotonoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	19	2-aminoadipic 2-oxoadipic aciduria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Butyrate Metabolism	Trifunctional protein deficiency	Hyperlysinemia I, Familial	Fatty acid Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Ethylmalonic Encephalopathy	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Lysine Degradation	Pyridoxine dependency with seizures	Hyperlysinemia II or Saccharopinuria
(S)-3-Hydroxyhexadecanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(S)-3-Hydroxytetradecanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
3-Oxotetradecanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(S)-3-Hydroxydodecanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
3-Oxododecanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(S)-Hydroxydecanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
3-Oxodecanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(S)-Hydroxyoctanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	14	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
3-Oxooctanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	14	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(S)-Hydroxyhexanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	14	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
3-Oxohexanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	14	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
trans-2-Hexenoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	15	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(2E)-Hexadecenoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(2E)-Tetradecenoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(2E)-Decenoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(2E)-Octenoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	14	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
3-Oxohexadecanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Decanoyl-CoA (n-C10:0CoA)	HMDB_SMPDB	Samples:	57	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(R)-3-Hydroxybutanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	19	2-aminoadipic 2-oxoadipic aciduria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Butyrate Metabolism	Trifunctional protein deficiency	Hyperlysinemia I, Familial	Fatty acid Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Ethylmalonic Encephalopathy	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Lysine Degradation	Pyridoxine dependency with seizures	Hyperlysinemia II or Saccharopinuria
(S)-3-Hydroxyoctanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	12	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
3-Oxopalmitoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Butanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	15	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Butyrate Metabolism	Glutaric Aciduria Type I	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Fatty acid Metabolism	Trifunctional protein deficiency	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Decanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	12	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Hexadecanoic acid	HMDB_SMPDB	Samples:	57	Pathways:	23	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Familial Hypercholanemia (FHCA)	Fatty Acid Elongation In Mitochondria	D-glyceric acidura	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Trifunctional protein deficiency	Fatty acid Metabolism	27-Hydroxylase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Bile Acid Biosynthesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Zellweger Syndrome	Glycerolipid Metabolism	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Familial lipoprotein lipase deficiency	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Glycerol Kinase Deficiency	Ethylmalonic Encephalopathy
Hexanoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	15	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Palmitoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	17	Fatty Acid Elongation In Mitochondria	D-glyceric acidura	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Trifunctional protein deficiency	Fatty acid Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Glycerolipid Metabolism	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Familial lipoprotein lipase deficiency	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Glycerol Kinase Deficiency	Ethylmalonic Encephalopathy
trans-Dec-2-enoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	12	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
trans-Hex-2-enoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	14	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
trans-Hexadec-2-enoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
trans-Oct-2-enoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	12	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
trans-Tetradec-2-enoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Etoposide	HMDB_SMPDB	Samples:	1	Pathways:	2	Etoposide Action Pathway	Etoposide Metabolism Pathway
Alfentanil	HMDB_SMPDB	Samples:	28	Pathways:	2	Alfentanil Action Pathway	Alfentanil Pathway
Guanosine diphosphate	HMDB_SMPDB	Samples:	62	Pathways:	23	Congenital lactic acidosis	The oncogenic action of Fumarate	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Mitochondrial complex II deficiency	Citric Acid Cycle	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Fumarase deficiency	Glutaminolysis and Cancer	Pyruvate kinase deficiency	Hypoacetylaspartia	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Pyruvate Dehydrogenase Complex Deficiency	Aspartate Metabolism	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of 2-hydroxyglutarate	Canavan Disease	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome	2-ketoglutarate dehydrogenase complex deficiency
Guanosine triphosphate	HMDB_SMPDB	Samples:	62	Pathways:	33	Congenital lactic acidosis	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Citric Acid Cycle	Pyruvate kinase deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Sepiapterin reductase deficiency	Pyruvate Dehydrogenase Complex Deficiency	Aspartate Metabolism	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	The oncogenic action of 2-hydroxyglutarate	Fructose intolerance, hereditary	Canavan Disease	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Fructose and Mannose Degradation	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Hyperphenylalaninemia due to dhpr-deficiency	Fumarase deficiency	Glutaminolysis and Cancer	Hypoacetylaspartia	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Pyruvate dehydrogenase deficiency (E2)	Pterine Biosynthesis	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Segawa syndrome	Pyruvate Metabolism	Fructosuria	Leigh Syndrome
GDP	HMDB_SMPDB	Samples:	62	Pathways:	22	Congenital lactic acidosis	The oncogenic action of Fumarate	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Mitochondrial complex II deficiency	Citric Acid Cycle	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Fumarase deficiency	Glutaminolysis and Cancer	Pyruvate kinase deficiency	Hypoacetylaspartia	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pyruvate Dehydrogenase Complex Deficiency	Aspartate Metabolism	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of 2-hydroxyglutarate	Canavan Disease	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome	2-ketoglutarate dehydrogenase complex deficiency
GTP	HMDB_SMPDB	Samples:	62	Pathways:	32	Congenital lactic acidosis	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Citric Acid Cycle	Pyruvate kinase deficiency	Sepiapterin reductase deficiency	Pyruvate Dehydrogenase Complex Deficiency	Aspartate Metabolism	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	The oncogenic action of 2-hydroxyglutarate	Fructose intolerance, hereditary	Canavan Disease	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Fructose and Mannose Degradation	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Hyperphenylalaninemia due to dhpr-deficiency	Fumarase deficiency	Glutaminolysis and Cancer	Hypoacetylaspartia	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Pyruvate dehydrogenase deficiency (E2)	Pterine Biosynthesis	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Segawa syndrome	Pyruvate Metabolism	Fructosuria	Leigh Syndrome
Beta-D-Glucose	HMDB_SMPDB	Samples:	11	Pathways:	4	Glycolysis	Trehalose Degradation	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease
Trehalose	HMDB_SMPDB	Samples:	7	Pathways:	1	Trehalose Degradation
Hydrogen	HMDB_SMPDB	Samples:	64	Pathways:	28	Rabeprazole Pathway	Degradation of Superoxides	Carnitine Synthesis	Primary hyperoxaluria II, PH2	Pantoprazole Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Rabeprazole Action Pathway	Malonic Aciduria	Pyruvate kinase deficiency	Omeprazole Pathway	Transfer of Acetyl Groups into Mitochondria	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Mitochondrial Electron Transport Chain	Trehalose Degradation	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Pyruvate Dehydrogenase Complex Deficiency	Ethanol Degradation	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Propanoate Metabolism	Malonyl-coa decarboxylase deficiency	Threonine and 2-Oxobutanoate Degradation	Omeprazole Action Pathway	Catecholamine Biosynthesis	Warburg Effect	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Pyruvate Metabolism	Leigh Syndrome	Pantoprazole Action Pathway
Alpha-D-Glucose	HMDB_SMPDB	Samples:	20	Pathways:	11	Trehalose Degradation	Fanconi-bickel syndrome	Nucleotide Sugars Metabolism	Glycogenosis, Type VII. Tarui disease	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Galactosemia III	Fructosuria	Retinol Metabolism	Glycolysis	Galactosemia II (GALK)
Beta-D-Glucose 6-phosphate	HMDB_SMPDB	Samples:	62	Pathways:	5	Trehalose Degradation	Fanconi-bickel syndrome	Warburg Effect	Glycogenosis, Type VII. Tarui disease	Glycolysis
alpha,alpha-Trehalose	HMDB_SMPDB	Samples:	7	Pathways:	1	Trehalose Degradation
alpha-D-Glucose	HMDB_SMPDB	Samples:	18	Pathways:	10	Trehalose Degradation	Fanconi-bickel syndrome	Nucleotide Sugars Metabolism	Glycogenosis, Type VII. Tarui disease	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Galactosemia III	Fructosuria	Glycolysis	Galactosemia II (GALK)
beta-D-Glucose	HMDB_SMPDB	Samples:	11	Pathways:	4	Glycolysis	Trehalose Degradation	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease
beta-D-Glucose 6-phosphate	HMDB_SMPDB	Samples:	62	Pathways:	5	Trehalose Degradation	Fanconi-bickel syndrome	Warburg Effect	Glycogenosis, Type VII. Tarui disease	Glycolysis
Aldosterone	HMDB_SMPDB	Samples:	59	Pathways:	95	Olmesartan Action Pathway	Kidney Function	Indapamide Pathway	Perindopril Pathway	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Bumetanide Action Pathway	Lysinuric Protein Intolerance	Cyclothiazide Pathway	Triamterene Action Pathway	Furosemide Action Pathway	Moexipril Action Pathway	Irbesartan Action Pathway	Fosinopril Pathway	Ramipril Pathway	Corticosterone methyl oxidase II deficiency - CMO II	Quinethazone Action Pathway	Angiotensin Metabolism	Eplerenone Action Pathway	Moexipril Pathway	Corticosterone methyl oxidase I deficiency (CMO I)	Trandolapril Action Pathway	Glucose Transporter Defect (SGLT2)	Torsemide Action Pathway	Ethacrynic Acid pathway	Cilazapril Action Pathway	21-hydroxylase deficiency (CYP21)	Chlorthalidone Pathway	Eprosartan Action Pathway	Trandolapril Pathway	Captopril Action Pathway	Polythiazide Action Pathway	Cystinuria	Candesartan Action Pathway	Perindopril Action Pathway	Losartan Action Pathway	Rescinnamine Action Pathway	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Methyclothiazide Pathway	Methyclothiazide Action Pathway	Hydrochlorothiazide Pathway	Hydroflumethiazide Action Pathway	Cilazapril Pathway	Blue diaper syndrome	Iminoglycinuria	Ethacrynic Acid Action Pathway	Captopril Pathway	Amiloride Pathway	Valsartan Action Pathway	Bendroflumethiazide Pathway	Enalapril Pathway	Lysinuric protein intolerance (LPI)	Fosinopril Action Pathway	Cyclothiazide Action Pathway	Forasartan Action Pathway	Bendroflumethiazide Action Pathway	Telmisartan Action Pathway	Spironolactone Action Pathway	Spironolactone Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Trichlormethiazide Pathway	Rescinnamine Pathway	Hydroflumethiazide Pathway	Metolazone Action Pathway	Steroidogenesis	Spirapril Pathway	Ramipril Action Pathway	Hydrochlorothiazide Action Pathway	Polythiazide Pathway	Temocapril Action Pathway	Bumetanide Pathway	Trichlormethiazide Action Pathway	Chlorothiazide Action Pathway	17-alpha-hydroxylase deficiency (CYP17)	Chlorothiazide Pathway	Benazepril Action Pathway	Furosemide Pathway	Eplerenone Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Torsemide Pathway	Indapamide Action Pathway	Apparent mineralocorticoid excess syndrome	Chlorthalidone Action Pathway	Lisinopril Pathway	Triamterene Pathway	Hartnup Disorder	Benazepril Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Amiloride Action Pathway	Spirapril Action Pathway	Quinapril Action Pathway	Enalapril Action Pathway	Lisinopril Action Pathway	Quinethazone Pathway	Metolazone Pathway	Quinapril Pathway
Chloride ion	HMDB_SMPDB	Samples:	63	Pathways:	65	Rabeprazole Pathway	Olmesartan Action Pathway	Kidney Function	Indapamide Pathway	Perindopril Pathway	Lysinuric Protein Intolerance	Cyclothiazide Pathway	Irbesartan Action Pathway	Fosinopril Pathway	Ramipril Pathway	Gastric Acid Production	Angiotensin Metabolism	Moexipril Pathway	Glucose Transporter Defect (SGLT2)	Ethacrynic Acid pathway	Lansoprazole Pathway	Eprosartan Action Pathway	Chlorthalidone Pathway	Trandolapril Pathway	Cystinuria	Metiamide Action Pathway	Candesartan Action Pathway	Losartan Action Pathway	Omeprazole Pathway	Betazole Action Pathway	Roxatidine acetate Action Pathway	Hydrochlorothiazide Pathway	Methyclothiazide Pathway	Cilazapril Pathway	Blue diaper syndrome	Iminoglycinuria	Captopril Pathway	Pirenzepine Pathway	Amiloride Pathway	Valsartan Action Pathway	Bendroflumethiazide Pathway	Enalapril Pathway	Lysinuric protein intolerance (LPI)	Forasartan Action Pathway	Pantoprazole Pathway	Telmisartan Action Pathway	Spironolactone Pathway	Trichlormethiazide Pathway	Rescinnamine Pathway	Hydroflumethiazide Pathway	Cimetidine Pathway	Spirapril Pathway	Temocapril Action Pathway	Polythiazide Pathway	Bumetanide Pathway	Chlorothiazide Pathway	Furosemide Pathway	Eplerenone Pathway	Torsemide Pathway	Triamterene Pathway	Lisinopril Pathway	Hartnup Disorder	Nizatidine Pathway	Benazepril Pathway	Famotidine Pathway	Esomeprazole Pathway	Quinethazone Pathway	Metolazone Pathway	Ranitidine Pathway	Quinapril Pathway
Angiotensin II	HMDB_SMPDB	Samples:	16	Pathways:	36	Olmesartan Action Pathway	Forasartan Action Pathway	Telmisartan Action Pathway	Rescinnamine Pathway	Perindopril Pathway	Quinapril Pathway	Spirapril Pathway	Ramipril Action Pathway	Temocapril Action Pathway	Irbesartan Action Pathway	Moexipril Action Pathway	Fosinopril Pathway	Ramipril Pathway	Angiotensin Metabolism	Benazepril Action Pathway	Moexipril Pathway	Trandolapril Action Pathway	Cilazapril Action Pathway	Eprosartan Action Pathway	Lisinopril Pathway	Trandolapril Pathway	Captopril Action Pathway	Benazepril Pathway	Candesartan Action Pathway	Perindopril Action Pathway	Losartan Action Pathway	Rescinnamine Action Pathway	Spirapril Action Pathway	Quinapril Action Pathway	Cilazapril Pathway	Enalapril Action Pathway	Lisinopril Action Pathway	Captopril Pathway	Valsartan Action Pathway	Enalapril Pathway	Fosinopril Action Pathway
Vasopressin	HMDB_SMPDB	Samples:	16	Pathways:	36	Olmesartan Action Pathway	Forasartan Action Pathway	Telmisartan Action Pathway	Rescinnamine Pathway	Perindopril Pathway	Quinapril Pathway	Spirapril Pathway	Ramipril Action Pathway	Temocapril Action Pathway	Irbesartan Action Pathway	Moexipril Action Pathway	Fosinopril Pathway	Ramipril Pathway	Angiotensin Metabolism	Benazepril Action Pathway	Moexipril Pathway	Trandolapril Action Pathway	Cilazapril Action Pathway	Eprosartan Action Pathway	Lisinopril Pathway	Trandolapril Pathway	Captopril Action Pathway	Benazepril Pathway	Candesartan Action Pathway	Perindopril Action Pathway	Losartan Action Pathway	Rescinnamine Action Pathway	Spirapril Action Pathway	Quinapril Action Pathway	Cilazapril Pathway	Enalapril Action Pathway	Lisinopril Action Pathway	Captopril Pathway	Valsartan Action Pathway	Enalapril Pathway	Fosinopril Action Pathway
Losartan	HMDB_SMPDB	Samples:	16	Pathways:	1	Losartan Action Pathway
Angiotensin I	HMDB_SMPDB	Samples:	16	Pathways:	23	Olmesartan Action Pathway	Forasartan Action Pathway	Eprosartan Action Pathway	Telmisartan Action Pathway	Lisinopril Pathway	Trandolapril Pathway	Rescinnamine Pathway	Perindopril Pathway	Enalapril Pathway	Benazepril Pathway	Candesartan Action Pathway	Losartan Action Pathway	Quinapril Pathway	Spirapril Pathway	Temocapril Action Pathway	Irbesartan Action Pathway	Fosinopril Pathway	Cilazapril Pathway	Captopril Pathway	Ramipril Pathway	Valsartan Action Pathway	Angiotensin Metabolism	Moexipril Pathway
D-Galactose	HMDB_SMPDB	Samples:	11	Pathways:	5	Lactose Intolerance	Galactosemia III	Nucleotide Sugars Metabolism	Lactose Degradation	Galactosemia II (GALK)
UDP-D-Xylose	HMDB_SMPDB	Samples:	4	Pathways:	3	Galactosemia III	Nucleotide Sugars Metabolism	Galactosemia II (GALK)
Glucose 6-phosphate	HMDB_SMPDB	Samples:	60	Pathways:	7	Fanconi-bickel syndrome	Warburg Effect	Nucleotide Sugars Metabolism	Glycogenosis, Type VII. Tarui disease	Galactosemia III	Glycolysis	Galactosemia II (GALK)
alpha-D-Galactose	HMDB_SMPDB	Samples:	11	Pathways:	5	Lactose Intolerance	Galactosemia III	Nucleotide Sugars Metabolism	Lactose Degradation	Galactosemia II (GALK)
D-Glucose 6-phosphate	HMDB_SMPDB	Samples:	60	Pathways:	7	Fanconi-bickel syndrome	Warburg Effect	Nucleotide Sugars Metabolism	Glycogenosis, Type VII. Tarui disease	Galactosemia III	Glycolysis	Galactosemia II (GALK)
UDP-D-xylose	HMDB_SMPDB	Samples:	4	Pathways:	3	Galactosemia III	Nucleotide Sugars Metabolism	Galactosemia II (GALK)
2-Ketobutyric acid	HMDB_SMPDB	Samples:	55	Pathways:	17	Methionine Adenosyltransferase Deficiency	Hypermethioninemia	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Sarcosinemia	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Threonine and 2-Oxobutanoate Degradation	Cystathionine Beta-Synthase Deficiency	Non Ketotic Hyperglycinemia	Methionine Metabolism	Glycine and Serine Metabolism	Selenoamino Acid Metabolism	Hyperglycinemia, non-ketotic
L-Cystathionine	HMDB_SMPDB	Samples:	53	Pathways:	15	Sarcosinemia	Methionine Adenosyltransferase Deficiency	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Hypermethioninemia	Cystathionine Beta-Synthase Deficiency	Glycine N-methyltransferase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Methionine Metabolism	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Glycine and Serine Metabolism	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic
L-Serine	HMDB_SMPDB	Samples:	54	Pathways:	18	Methionine Adenosyltransferase Deficiency	Hypermethioninemia	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Sarcosinemia	sarcosine oncometabolite pathway 	Ammonia Recycling	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	Non Ketotic Hyperglycinemia	Methionine Metabolism	Glycine and Serine Metabolism	Selenoamino Acid Metabolism	Hyperglycinemia, non-ketotic
L-Cysteine	HMDB_SMPDB	Samples:	57	Pathways:	76	Kidney Function	Indapamide Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Glycine N-methyltransferase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocarnosinosis	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Bumetanide Action Pathway	Lysinuric Protein Intolerance	Cyclothiazide Pathway	Gamma-Glutamyltransferase Deficiency	Triamterene Action Pathway	Furosemide Action Pathway	Glutathione Synthetase Deficiency	Dimethylglycine Dehydrogenase Deficiency	Non Ketotic Hyperglycinemia	Methionine Metabolism	Quinethazone Action Pathway	Hyperglycinemia, non-ketotic	Eplerenone Action Pathway	Glucose Transporter Defect (SGLT2)	Gamma-glutamyl-transpeptidase deficiency	Torsemide Action Pathway	Ethacrynic Acid pathway	Chlorthalidone Pathway	3-Phosphoglycerate dehydrogenase deficiency	Polythiazide Action Pathway	Cystinuria	Sarcosinemia	Methyclothiazide Pathway	Pantothenate and CoA Biosynthesis	Hydrochlorothiazide Pathway	5-Oxoprolinuria	Hydroflumethiazide Action Pathway	5-oxoprolinase deficiency	Iminoglycinuria	Blue diaper syndrome	Cystathionine Beta-Synthase Deficiency	Methyclothiazide Action Pathway	Ethacrynic Acid Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Amiloride Pathway	Glutamate Metabolism	Succinic semialdehyde dehydrogenase deficiency	Bendroflumethiazide Pathway	Lysinuric protein intolerance (LPI)	Cyclothiazide Action Pathway	Bendroflumethiazide Action Pathway	Spironolactone Action Pathway	Spironolactone Pathway	Trichlormethiazide Pathway	Hydroflumethiazide Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Metolazone Action Pathway	Hydrochlorothiazide Action Pathway	Polythiazide Pathway	Bumetanide Pathway	Trichlormethiazide Action Pathway	Chlorothiazide Action Pathway	Chlorothiazide Pathway	Glutathione Metabolism	Furosemide Pathway	Eplerenone Pathway	Torsemide Pathway	Indapamide Action Pathway	Methionine Adenosyltransferase Deficiency	Chlorthalidone Action Pathway	Hypermethioninemia	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Triamterene Pathway	Hartnup Disorder	Hyperinsulinism-Hyperammonemia Syndrome	Amiloride Action Pathway	Quinethazone Pathway	Glycine and Serine Metabolism	Metolazone Pathway
Homocysteine	HMDB_SMPDB	Samples:	55	Pathways:	18	Methionine Adenosyltransferase Deficiency	Hypermethioninemia	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Glycine N-methyltransferase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Sarcosinemia	sarcosine oncometabolite pathway 	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	Betaine Metabolism	Catecholamine Biosynthesis	Non Ketotic Hyperglycinemia	Methionine Metabolism	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
2-Oxobutanoate	HMDB_SMPDB	Samples:	56	Pathways:	21	Methionine Adenosyltransferase Deficiency	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Hypermethioninemia	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Malonic Aciduria	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Sarcosinemia	Propanoate Metabolism	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	Threonine and 2-Oxobutanoate Degradation	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	Non Ketotic Hyperglycinemia	Methionine Metabolism	Glycine and Serine Metabolism	Selenoamino Acid Metabolism	Hyperglycinemia, non-ketotic
L-Homocysteine	HMDB_SMPDB	Samples:	53	Pathways:	16	Methionine Adenosyltransferase Deficiency	Hypermethioninemia	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Sarcosinemia	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	Betaine Metabolism	Non Ketotic Hyperglycinemia	Methionine Metabolism	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
Alprenolol	HMDB_SMPDB	Samples:	8	Pathways:	1	Alprenolol Pathway
Formate	HMDB_SMPDB	Samples:	47	Pathways:	12	Sepiapterin reductase deficiency	Methotrexate Action Pathway	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Dopa-responsive dystonia	Folate Metabolism	Hyperphenylalaninemia due to dhpr-deficiency	Pterine Biosynthesis	Segawa syndrome	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Folate malabsorption, hereditary
Gemcitabine	HMDB_SMPDB	Samples:	2	Pathways:	3	Gemcitabine Pathway	Gemcitabine Metabolism Pathway	Gemcitabine Action Pathway
Zinc	HMDB_SMPDB	Samples:	65	Pathways:	37	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Glycine N-methyltransferase Deficiency	Vitamin B6 Metabolism	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Alkaptonuria	Gamma-Glutamyltransferase Deficiency	Sepiapterin reductase deficiency	Dopamine beta-hydroxylase deficiency	Vitamin A Deficiency	Disulfiram Pathway	Glutathione Synthetase Deficiency	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Gemcitabine Pathway	Dopa-responsive dystonia	Celecoxib Metabolism Pathway	Methionine Metabolism	Glutathione Metabolism	Celecoxib Pathway	Gamma-glutamyl-transpeptidase deficiency	Gemcitabine Metabolism Pathway	Methionine Adenosyltransferase Deficiency	Tyrosinemia, transient, of the newborn	Hypermethioninemia	Hypophosphatasia	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Hyperphenylalaninemia due to dhpr-deficiency	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	5-Oxoprolinuria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	5-oxoprolinase deficiency	Cystathionine Beta-Synthase Deficiency	Pterine Biosynthesis	Hawkinsinuria	Segawa syndrome	Tyrosine Metabolism	Retinol Metabolism
Gemcitabine triphosphate	HMDB_SMPDB	Samples:	2	Pathways:	2	Gemcitabine Pathway	Gemcitabine Metabolism Pathway
Gemcitabine diphosphate	HMDB_SMPDB	Samples:	2	Pathways:	2	Gemcitabine Pathway	Gemcitabine Metabolism Pathway
Lansoprazole	HMDB_SMPDB	Samples:	6	Pathways:	1	Lansoprazole Pathway
Bupranolol	HMDB_SMPDB	Samples:	8	Pathways:	1	Bupranolol Action Pathway
D-myo-Inositol 1,4,5-trisphosphate	HMDB_SMPDB	Samples:	8	Pathways:	49	Alprenolol Action Pathway	Diltiazem Action Pathway	Tocainide Action Pathway	Procainamide (Antiarrhythmic) Action Pathway	Bisoprolol Action Pathway	Betaxolol Action Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Felodipine Action Pathway	Amiodarone Action Pathway	Levobunolol Action Pathway	Carvedilol Action Pathway	Muscle/Heart Contraction	Nebivolol Action Pathway	Practolol Action Pathway	Isradipine Action Pathway	Epinephrine Action Pathway	Timolol Action Pathway	Bupranolol Action Pathway	Oxprenolol Action Pathway	Arbutamine Action Pathway	Carteolol Action Pathway	Isoprenaline Action Pathway	Propranolol Action Pathway	Bevantolol Action Pathway	Flecainide Action Pathway	Nifedipine Action Pathway	Nisoldipine Action Pathway	Verapamil Action Pathway	Esmolol Action Pathway	Metoprolol Action Pathway	Nadolol Action Pathway	Mexiletine Action Pathway	Amlodipine Action Pathway	Nimodipine Action Pathway	Penbutolol Action Pathway	Quinidine Action Pathway	Ibutilide Action Pathway	Atenolol Action Pathway	Fosphenytoin (Antiarrhythmic) Action Pathway	Nitrendipine Action Pathway	Acebutolol Action Pathway	Phenytoin (Antiarrhythmic) Action Pathway	Labetalol Action Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Pindolol Action Pathway	Dobutamine Action Pathway	Disopyramide Action Pathway	Metipranolol Action Pathway
Betaine	HMDB_SMPDB	Samples:	53	Pathways:	17	Methionine Adenosyltransferase Deficiency	Hypermethioninemia	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Sarcosinemia	sarcosine oncometabolite pathway 	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	Betaine Metabolism	Non Ketotic Hyperglycinemia	Methionine Metabolism	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
Dimethylglycine	HMDB_SMPDB	Samples:	53	Pathways:	17	Methionine Adenosyltransferase Deficiency	Hypermethioninemia	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Sarcosinemia	sarcosine oncometabolite pathway 	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	Betaine Metabolism	Non Ketotic Hyperglycinemia	Methionine Metabolism	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
Glyoxylic acid	HMDB_SMPDB	Samples:	52	Pathways:	11	Sarcosinemia	Alanine Metabolism	Lactic Acidemia	Dimethylglycine Dehydrogenase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Pyruvate Carboxylase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Primary Hyperoxaluria Type I
Glyceric acid	HMDB_SMPDB	Samples:	52	Pathways:	11	Sarcosinemia	Glycerolipid Metabolism	D-glyceric acidura	Dimethylglycine Dehydrogenase Deficiency	Glycerol Kinase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Familial lipoprotein lipase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
Orotidylic acid	HMDB_SMPDB	Samples:	52	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
Sarcosine	HMDB_SMPDB	Samples:	53	Pathways:	16	Methionine Adenosyltransferase Deficiency	Hypermethioninemia	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Sarcosinemia	sarcosine oncometabolite pathway 	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	Non Ketotic Hyperglycinemia	Methionine Metabolism	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
Phosphoserine	HMDB_SMPDB	Samples:	52	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
L-Methionine	HMDB_SMPDB	Samples:	53	Pathways:	17	Methionine Adenosyltransferase Deficiency	Hypermethioninemia	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Sarcosinemia	sarcosine oncometabolite pathway 	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	Betaine Metabolism	Non Ketotic Hyperglycinemia	Methionine Metabolism	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
3-Phosphoglyceric acid	HMDB_SMPDB	Samples:	60	Pathways:	15	Sarcosinemia	Glycerolipid Metabolism	Fanconi-bickel syndrome	D-glyceric acidura	Glycogenosis, Type VII. Tarui disease	Dimethylglycine Dehydrogenase Deficiency	Glycerol Kinase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Familial lipoprotein lipase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Warburg Effect	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Glycolysis
Phosphohydroxypyruvic acid	HMDB_SMPDB	Samples:	52	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
5-Aminolevulinic acid	HMDB_SMPDB	Samples:	52	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
Pyruvaldehyde	HMDB_SMPDB	Samples:	57	Pathways:	13	Sarcosinemia	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Dimethylglycine Dehydrogenase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Pyruvate Metabolism	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Pyruvate kinase deficiency	Hyperglycinemia, non-ketotic	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Hydroxypyruvic acid	HMDB_SMPDB	Samples:	52	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
5,10-Methylene-THF	HMDB_SMPDB	Samples:	53	Pathways:	20	Methionine Adenosyltransferase Deficiency	Folate Metabolism	Hypermethioninemia	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Methotrexate Pathway	Sarcosinemia	sarcosine oncometabolite pathway 	Ammonia Recycling	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	Non Ketotic Hyperglycinemia	Methionine Metabolism	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Folate malabsorption, hereditary
Tetrahydrofolic acid	HMDB_SMPDB	Samples:	54	Pathways:	24	Methionine Adenosyltransferase Deficiency	Histidine Metabolism	Histidinemia	Folate Metabolism	Hypermethioninemia	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Methotrexate Pathway	Sarcosinemia	sarcosine oncometabolite pathway 	Ammonia Recycling	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	Betaine Metabolism	Non Ketotic Hyperglycinemia	Methionine Metabolism	Pterine Biosynthesis	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Folate malabsorption, hereditary
Aminoacetone	HMDB_SMPDB	Samples:	52	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
D-Serine	HMDB_SMPDB	Samples:	52	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
L-2-Amino-3-oxobutanoic acid	HMDB_SMPDB	Samples:	52	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
Dihydrolipoate	HMDB_SMPDB	Samples:	52	Pathways:	8	Sarcosinemia	Ammonia Recycling	Dimethylglycine Dehydrogenase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
8-[(Aminomethyl)sulfanyl]-6-sulfanyloctanoic acid	HMDB_SMPDB	Samples:	52	Pathways:	8	Sarcosinemia	Ammonia Recycling	Dimethylglycine Dehydrogenase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
3-Phosphonooxypyruvate	HMDB_SMPDB	Samples:	52	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
5,10-Methylenetetrahydrofolate	HMDB_SMPDB	Samples:	53	Pathways:	19	Methionine Adenosyltransferase Deficiency	Folate Metabolism	Hypermethioninemia	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Sarcosinemia	Methotrexate Action Pathway	Ammonia Recycling	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	Non Ketotic Hyperglycinemia	Methionine Metabolism	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Folate malabsorption, hereditary
5-Aminolevulinate	HMDB_SMPDB	Samples:	52	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
D-Glycerate	HMDB_SMPDB	Samples:	52	Pathways:	11	Sarcosinemia	Glycerolipid Metabolism	D-glyceric acidura	Dimethylglycine Dehydrogenase Deficiency	Glycerol Kinase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Familial lipoprotein lipase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
Glycerate 3-phosphate	HMDB_SMPDB	Samples:	60	Pathways:	15	Sarcosinemia	Glycerolipid Metabolism	Fanconi-bickel syndrome	D-glyceric acidura	Glycogenosis, Type VII. Tarui disease	Dimethylglycine Dehydrogenase Deficiency	Glycerol Kinase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Familial lipoprotein lipase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Warburg Effect	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Glycolysis
Glyoxylate	HMDB_SMPDB	Samples:	52	Pathways:	11	Sarcosinemia	Alanine Metabolism	Lactic Acidemia	Dimethylglycine Dehydrogenase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Pyruvate Carboxylase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Primary Hyperoxaluria Type I
Hydroxypyruvate	HMDB_SMPDB	Samples:	52	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
Lipoate	HMDB_SMPDB	Samples:	52	Pathways:	8	Sarcosinemia	Ammonia Recycling	Dimethylglycine Dehydrogenase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
Methylglyoxal	HMDB_SMPDB	Samples:	57	Pathways:	13	Sarcosinemia	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Dimethylglycine Dehydrogenase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Pyruvate Metabolism	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Pyruvate kinase deficiency	Hyperglycinemia, non-ketotic	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
N,N-Dimethylglycine	HMDB_SMPDB	Samples:	53	Pathways:	16	Methionine Adenosyltransferase Deficiency	Hypermethioninemia	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Sarcosinemia	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	Betaine Metabolism	Non Ketotic Hyperglycinemia	Methionine Metabolism	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
O-Phospho-L-serine	HMDB_SMPDB	Samples:	52	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
Orotidine 5'-phosphate	HMDB_SMPDB	Samples:	52	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
Tetrahydrofolate	HMDB_SMPDB	Samples:	53	Pathways:	22	Methionine Adenosyltransferase Deficiency	Histidine Metabolism	Histidinemia	Folate Metabolism	Hypermethioninemia	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Sarcosinemia	Methotrexate Action Pathway	Ammonia Recycling	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cystathionine Beta-Synthase Deficiency	Betaine Metabolism	Non Ketotic Hyperglycinemia	Methionine Metabolism	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Folate malabsorption, hereditary
Homogentisic acid	HMDB_SMPDB	Samples:	55	Pathways:	12	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia, transient, of the newborn	Tyrosinemia Type 3 (TYRO3)	Hawkinsinuria	Phenylketonuria	Tyrosine Metabolism	Alkaptonuria	Phenylalanine and Tyrosine Metabolism
L-Tyrosine	HMDB_SMPDB	Samples:	65	Pathways:	17	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Thyroid hormone synthesis	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Disulfiram Action Pathway	Phenylketonuria	Alkaptonuria	Phenylalanine and Tyrosine Metabolism	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia Type 3 (TYRO3)	Catecholamine Biosynthesis	Hawkinsinuria	Tyrosine Metabolism
L-Phenylalanine	HMDB_SMPDB	Samples:	40	Pathways:	4	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia Type 3 (TYRO3)	Phenylketonuria	Phenylalanine and Tyrosine Metabolism
Phenylpyruvic acid	HMDB_SMPDB	Samples:	40	Pathways:	4	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia Type 3 (TYRO3)	Phenylketonuria	Phenylalanine and Tyrosine Metabolism
Fe2+	HMDB_SMPDB	Samples:	62	Pathways:	13	Tyrosine hydroxylase deficiency	Vitamin A Deficiency	The oncogenic action of Fumarate	Carnitine Synthesis	The oncogenic action of Succinate	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Aromatic L-Aminoacid Decarboxylase Deficiency	Tyrosinemia Type 3 (TYRO3)	Catecholamine Biosynthesis	Phenylketonuria	Tryptophan Metabolism	Retinol Metabolism	Phenylalanine and Tyrosine Metabolism
4-Hydroxyphenylpyruvic acid	HMDB_SMPDB	Samples:	55	Pathways:	12	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia, transient, of the newborn	Tyrosinemia Type 3 (TYRO3)	Hawkinsinuria	Phenylketonuria	Tyrosine Metabolism	Alkaptonuria	Phenylalanine and Tyrosine Metabolism
4-Fumarylacetoacetic acid	HMDB_SMPDB	Samples:	55	Pathways:	12	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia, transient, of the newborn	Tyrosinemia Type 3 (TYRO3)	Hawkinsinuria	Phenylketonuria	Tyrosine Metabolism	Alkaptonuria	Phenylalanine and Tyrosine Metabolism
Maleylacetoacetic acid	HMDB_SMPDB	Samples:	55	Pathways:	12	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia, transient, of the newborn	Tyrosinemia Type 3 (TYRO3)	Hawkinsinuria	Phenylketonuria	Tyrosine Metabolism	Alkaptonuria	Phenylalanine and Tyrosine Metabolism
4a-Hydroxytetrahydrobiopterin	HMDB_SMPDB	Samples:	55	Pathways:	14	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia, transient, of the newborn	Tyrosinemia Type 3 (TYRO3)	Disulfiram Action Pathway	Hawkinsinuria	Phenylketonuria	Tyrosine Metabolism	Alkaptonuria	Tryptophan Metabolism	Phenylalanine and Tyrosine Metabolism
L-erythro-tetrahydrobiopterin	HMDB_SMPDB	Samples:	40	Pathways:	4	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia Type 3 (TYRO3)	Phenylketonuria	Phenylalanine and Tyrosine Metabolism
3-(4-Hydroxyphenyl)pyruvate	HMDB_SMPDB	Samples:	55	Pathways:	12	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia, transient, of the newborn	Tyrosinemia Type 3 (TYRO3)	Disulfiram Action Pathway	Hawkinsinuria	Phenylketonuria	Tyrosine Metabolism	Alkaptonuria	Phenylalanine and Tyrosine Metabolism
4-Fumarylacetoacetate	HMDB_SMPDB	Samples:	55	Pathways:	12	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia, transient, of the newborn	Tyrosinemia Type 3 (TYRO3)	Disulfiram Action Pathway	Hawkinsinuria	Phenylketonuria	Tyrosine Metabolism	Alkaptonuria	Phenylalanine and Tyrosine Metabolism
4-Maleylacetoacetate	HMDB_SMPDB	Samples:	55	Pathways:	12	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia, transient, of the newborn	Tyrosinemia Type 3 (TYRO3)	Disulfiram Action Pathway	Hawkinsinuria	Phenylketonuria	Tyrosine Metabolism	Alkaptonuria	Phenylalanine and Tyrosine Metabolism
Homogentisate	HMDB_SMPDB	Samples:	55	Pathways:	12	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia, transient, of the newborn	Tyrosinemia Type 3 (TYRO3)	Disulfiram Action Pathway	Hawkinsinuria	Phenylketonuria	Tyrosine Metabolism	Alkaptonuria	Phenylalanine and Tyrosine Metabolism
Phenylpyruvate	HMDB_SMPDB	Samples:	40	Pathways:	4	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia Type 3 (TYRO3)	Phenylketonuria	Phenylalanine and Tyrosine Metabolism
D-Mannose	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
L-Fucose	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
Sorbitol	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
D-Fructose 2,6-bisphosphate	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
Glyceraldehyde	HMDB_SMPDB	Samples:	7	Pathways:	7	Familial lipoprotein lipase deficiency	Glycerolipid Metabolism	D-glyceric acidura	Fructosuria	Glycerol Kinase Deficiency	Fructose and Mannose Degradation	Fructose intolerance, hereditary
Fructose 1,6-bisphosphate	HMDB_SMPDB	Samples:	60	Pathways:	7	Fanconi-bickel syndrome	Warburg Effect	Glycogenosis, Type VII. Tarui disease	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Glycolysis
Fructose 1-phosphate	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
Mannose 6-phosphate	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
GDP-L-fucose	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
D-Glyceraldehyde 3-phosphate	HMDB_SMPDB	Samples:	60	Pathways:	8	Mitochondrial Electron Transport Chain	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Warburg Effect	Fructosuria	Glycolysis
Guanosine diphosphate mannose	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
Fucose 1-phosphate	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
GDP-4-Dehydro-6-deoxy-D-mannose	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
Dihydroxyacetone phosphate	HMDB_SMPDB	Samples:	60	Pathways:	12	Glycerolipid Metabolism	Mitochondrial Electron Transport Chain	Fanconi-bickel syndrome	D-glyceric acidura	Glycogenosis, Type VII. Tarui disease	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Familial lipoprotein lipase deficiency	Warburg Effect	Glycerol Kinase Deficiency	Fructosuria	Glycolysis
D-Mannose 1-phosphate	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
Beta-D-Fructose 2-phosphate	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
6-Deoxy-L-galactose	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
beta-D-Fructose 2,6-bisphosphate	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
beta-D-Fructose 2-phosphate	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
D-Fructose 1,6-bisphosphate	HMDB_SMPDB	Samples:	60	Pathways:	7	Fanconi-bickel syndrome	Warburg Effect	Glycogenosis, Type VII. Tarui disease	Fructosuria	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Glycolysis
D-Fructose 1-phosphate	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
D-Mannose 6-phosphate	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
D-Sorbitol	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
GDP-4-dehydro-6-deoxy-D-mannose	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
GDP-mannose	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
Glyceraldehyde 3-phosphate	HMDB_SMPDB	Samples:	60	Pathways:	8	Mitochondrial Electron Transport Chain	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Warburg Effect	Fructosuria	Glycolysis
Glycerone phosphate	HMDB_SMPDB	Samples:	60	Pathways:	12	Glycerolipid Metabolism	Mitochondrial Electron Transport Chain	Fanconi-bickel syndrome	D-glyceric acidura	Glycogenosis, Type VII. Tarui disease	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Familial lipoprotein lipase deficiency	Warburg Effect	Glycerol Kinase Deficiency	Fructosuria	Glycolysis
L-Fucose 1-phosphate	HMDB_SMPDB	Samples:	4	Pathways:	3	Fructose and Mannose Degradation	Fructose intolerance, hereditary	Fructosuria
Metoprolol	HMDB_SMPDB	Samples:	8	Pathways:	2	Metoprolol Pathway	Metoprolol Action Pathway
Histamine	HMDB_SMPDB	Samples:	30	Pathways:	26	Cimetidine Action Pathway	Rabeprazole Pathway	Ranitidine Pathway	Lansoprazole Action Pathway	Histidine Metabolism	Lansoprazole Pathway	Pantoprazole Pathway	Histidinemia	Rabeprazole Action Pathway	Nizatidine Pathway	Metiamide Action Pathway	Cimetidine Pathway	Omeprazole Pathway	Pirenzepine Action Pathway	Famotidine Pathway	Betazole Action Pathway	Esomeprazole Action Pathway	Roxatidine acetate Action Pathway	Omeprazole Action Pathway	Esomeprazole Pathway	Nizatidine Action Pathway	Famotidine Action Pathway	Gastric Acid Production	Pirenzepine Pathway	Ranitidine Action Pathway	Pantoprazole Action Pathway
Acetylcholine 	HMDB_SMPDB	Samples:	6	Pathways:	14	Betazole Action Pathway	Rabeprazole Pathway	Roxatidine acetate Action Pathway	Lansoprazole Pathway	Pantoprazole Pathway	Esomeprazole Pathway	Gastric Acid Production	Pirenzepine Pathway	Nizatidine Pathway	Metiamide Action Pathway	Cimetidine Pathway	Ranitidine Pathway	Omeprazole Pathway	Famotidine Pathway
Cimetidine	HMDB_SMPDB	Samples:	6	Pathways:	2	Cimetidine Action Pathway	Cimetidine Pathway
Histamium	HMDB_SMPDB	Samples:	30	Pathways:	16	Rabeprazole Pathway	Histidine Metabolism	Lansoprazole Pathway	Pantoprazole Pathway	Histidinemia	Nizatidine Pathway	Metiamide Action Pathway	Cimetidine Pathway	Omeprazole Pathway	Famotidine Pathway	Betazole Action Pathway	Roxatidine acetate Action Pathway	Esomeprazole Pathway	Gastric Acid Production	Pirenzepine Pathway	Ranitidine Pathway
Disopyramide	HMDB_SMPDB	Samples:	8	Pathways:	2	Disopyramide Pathway	Disopyramide Action Pathway
Carteolol	HMDB_SMPDB	Samples:	8	Pathways:	1	Carteolol Action Pathway
Beta-Alanine	HMDB_SMPDB	Samples:	52	Pathways:	13	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Histidine Metabolism	Aspartate Metabolism	Propanoate Metabolism	Histidinemia	Malonyl-coa decarboxylase deficiency	GABA-Transaminase Deficiency	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Canavan Disease	Malonic Aciduria	Hypoacetylaspartia
L-Asparagine	HMDB_SMPDB	Samples:	34	Pathways:	4	Ammonia Recycling	Canavan Disease	Hypoacetylaspartia	Aspartate Metabolism
Inosinic acid	HMDB_SMPDB	Samples:	1	Pathways:	3	Canavan Disease	Hypoacetylaspartia	Aspartate Metabolism
Adenylsuccinic acid	HMDB_SMPDB	Samples:	1	Pathways:	3	Canavan Disease	Hypoacetylaspartia	Aspartate Metabolism
N-Acetyl-L-aspartic acid	HMDB_SMPDB	Samples:	1	Pathways:	3	Canavan Disease	Hypoacetylaspartia	Aspartate Metabolism
Ureidosuccinic acid	HMDB_SMPDB	Samples:	1	Pathways:	3	Canavan Disease	Hypoacetylaspartia	Aspartate Metabolism
D-Aspartic acid	HMDB_SMPDB	Samples:	1	Pathways:	3	Canavan Disease	Hypoacetylaspartia	Aspartate Metabolism
Malonic semialdehyde	HMDB_SMPDB	Samples:	52	Pathways:	11	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Aspartate Metabolism	Propanoate Metabolism	Malonyl-coa decarboxylase deficiency	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	GABA-Transaminase Deficiency	Canavan Disease	Malonic Aciduria	Hypoacetylaspartia
3-Oxopropanoate	HMDB_SMPDB	Samples:	52	Pathways:	11	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Aspartate Metabolism	Propanoate Metabolism	Malonyl-coa decarboxylase deficiency	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	GABA-Transaminase Deficiency	Canavan Disease	Malonic Aciduria	Hypoacetylaspartia
beta-Alanine	HMDB_SMPDB	Samples:	52	Pathways:	13	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Histidine Metabolism	Aspartate Metabolism	Propanoate Metabolism	Histidinemia	Malonyl-coa decarboxylase deficiency	GABA-Transaminase Deficiency	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Canavan Disease	Malonic Aciduria	Hypoacetylaspartia
D-Aspartate	HMDB_SMPDB	Samples:	1	Pathways:	3	Canavan Disease	Hypoacetylaspartia	Aspartate Metabolism
IMP	HMDB_SMPDB	Samples:	1	Pathways:	3	Canavan Disease	Hypoacetylaspartia	Aspartate Metabolism
N-Acetyl-L-aspartate	HMDB_SMPDB	Samples:	1	Pathways:	3	Canavan Disease	Hypoacetylaspartia	Aspartate Metabolism
N-Carbamoyl-L-aspartate	HMDB_SMPDB	Samples:	1	Pathways:	3	Canavan Disease	Hypoacetylaspartia	Aspartate Metabolism
N6-(1,2-Dicarboxyethyl)-AMP	HMDB_SMPDB	Samples:	1	Pathways:	3	Canavan Disease	Hypoacetylaspartia	Aspartate Metabolism
cis-Aconitic acid	HMDB_SMPDB	Samples:	62	Pathways:	13	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	2-ketoglutarate dehydrogenase complex deficiency
Citric acid	HMDB_SMPDB	Samples:	62	Pathways:	15	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	Warburg Effect	Transfer of Acetyl Groups into Mitochondria	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	2-ketoglutarate dehydrogenase complex deficiency
L-Malic acid	HMDB_SMPDB	Samples:	62	Pathways:	21	Congenital lactic acidosis	The oncogenic action of Fumarate	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Mitochondrial complex II deficiency	Citric Acid Cycle	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Fumarase deficiency	Glutaminolysis and Cancer	Pyruvate kinase deficiency	Transfer of Acetyl Groups into Mitochondria	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pyruvate Dehydrogenase Complex Deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of 2-hydroxyglutarate	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome	2-ketoglutarate dehydrogenase complex deficiency
Isocitric acid	HMDB_SMPDB	Samples:	62	Pathways:	14	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	Warburg Effect	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	2-ketoglutarate dehydrogenase complex deficiency
D-2-Hydroxyglutaric acid	HMDB_SMPDB	Samples:	60	Pathways:	1	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 
Coenzyme Q10	HMDB_SMPDB	Samples:	62	Pathways:	15	Mitochondrial Electron Transport Chain	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	Warburg Effect	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	2-ketoglutarate dehydrogenase complex deficiency
FADH	HMDB_SMPDB	Samples:	62	Pathways:	14	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	Warburg Effect	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	2-ketoglutarate dehydrogenase complex deficiency
2-Hydroxyglutarate	HMDB_SMPDB	Samples:	61	Pathways:	5	The oncogenic action of Fumarate	The oncogenic action of Succinate	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria
QH(2)	HMDB_SMPDB	Samples:	62	Pathways:	11	Congenital lactic acidosis	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Warburg Effect	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	2-ketoglutarate dehydrogenase complex deficiency
L-Lysine	HMDB_SMPDB	Samples:	57	Pathways:	8	2-aminoadipic 2-oxoadipic aciduria	Carnitine Synthesis	Glutaric Aciduria Type I	Hyperlysinemia I, Familial	Saccharopinuria/Hyperlysinemia II	Lysine Degradation	Pyridoxine dependency with seizures	Hyperlysinemia II or Saccharopinuria
Oxoadipic acid	HMDB_SMPDB	Samples:	57	Pathways:	7	Lysine Degradation	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Glutaric Aciduria Type I	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
Saccharopine	HMDB_SMPDB	Samples:	57	Pathways:	7	Lysine Degradation	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Glutaric Aciduria Type I	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
Aminoadipic acid	HMDB_SMPDB	Samples:	57	Pathways:	7	Lysine Degradation	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Glutaric Aciduria Type I	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
L-Pipecolic acid	HMDB_SMPDB	Samples:	57	Pathways:	7	Lysine Degradation	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Glutaric Aciduria Type I	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
Allysine	HMDB_SMPDB	Samples:	57	Pathways:	7	Lysine Degradation	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Glutaric Aciduria Type I	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
(S)-2,3,4,5-Tetrahydropiperidine-2-carboxylate	HMDB_SMPDB	Samples:	57	Pathways:	7	Lysine Degradation	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Glutaric Aciduria Type I	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
2-Oxoadipate	HMDB_SMPDB	Samples:	56	Pathways:	6	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Lysine Degradation	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
L-2-Aminoadipate	HMDB_SMPDB	Samples:	56	Pathways:	6	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Lysine Degradation	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
L-Pipecolate	HMDB_SMPDB	Samples:	56	Pathways:	6	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Lysine Degradation	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
N6-(L-1,3-Dicarboxypropyl)-L-lysine	HMDB_SMPDB	Samples:	56	Pathways:	6	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Lysine Degradation	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
Methadyl Acetate	HMDB_SMPDB	Samples:	28	Pathways:	1	Methadyl Acetate Action Pathway
Adenosine	HMDB_SMPDB	Samples:	44	Pathways:	10	Methionine Adenosyltransferase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Hypermethioninemia	Glycine N-methyltransferase Deficiency	Cystathionine Beta-Synthase Deficiency	Betaine Metabolism	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Methionine Metabolism	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Selenoamino Acid Metabolism
Phosphoribosyl pyrophosphate	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
10-Formyltetrahydrofolate	HMDB_SMPDB	Samples:	43	Pathways:	12	Methionine Adenosyltransferase Deficiency	Methotrexate Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Hypermethioninemia	Cystathionine Beta-Synthase Deficiency	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Methionine Metabolism	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Methotrexate Pathway	Folate malabsorption, hereditary
5-Phosphoribosylamine	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Adenosine diphosphate ribose	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Guanosine monophosphate	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
D-Ribose 5-phosphate	HMDB_SMPDB	Samples:	56	Pathways:	1	Warburg Effect
Xanthylic acid	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
5-Phospho-alpha-D-ribose 1-diphosphate	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
ADP-ribose	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
GMP	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Xanthosine 5'-phosphate	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
3',4'-Dihydrodiol	HMDB_SMPDB	Samples:	11	Pathways:	2	Phenytoin (Antiarrhythmic) Pathway	Fosphenytoin (Antiarrhythmic) Pathway
Phenytoin	HMDB_SMPDB	Samples:	11	Pathways:	4	Phenytoin (Antiarrhythmic) Pathway	Fosphenytoin (Antiarrhythmic) Action Pathway	Phenytoin (Antiarrhythmic) Action Pathway	Fosphenytoin (Antiarrhythmic) Pathway
4-Hydroxyphenytoin glucuronide	HMDB_SMPDB	Samples:	11	Pathways:	1	Phenytoin (Antiarrhythmic) Pathway
Adenosine 3',5'-diphosphate	HMDB_SMPDB	Samples:	7	Pathways:	5	Sulfite oxidase deficiency	Acetaminophen Metabolism Pathway	Tamoxifen Metabolism Pathway	Tamoxifen Pathway	Sulfate/Sulfite Metabolism
O-Phosphoethanolamine	HMDB_SMPDB	Samples:	2	Pathways:	1	Lamivudine Metabolism Pathway
Phosphoadenosine phosphosulfate	HMDB_SMPDB	Samples:	7	Pathways:	5	Sulfite oxidase deficiency	Acetaminophen Metabolism Pathway	Tamoxifen Metabolism Pathway	Tamoxifen Pathway	Sulfate/Sulfite Metabolism
Sulfate	HMDB_SMPDB	Samples:	1	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Phosphorylcholine	HMDB_SMPDB	Samples:	2	Pathways:	1	Lamivudine Metabolism Pathway
3'-Phosphoadenylyl sulfate	HMDB_SMPDB	Samples:	7	Pathways:	5	Sulfite oxidase deficiency	Acetaminophen Metabolism Pathway	Tamoxifen Metabolism Pathway	Tamoxifen Action Pathway	Sulfate/Sulfite Metabolism
Adenosine 3',5'-bisphosphate	HMDB_SMPDB	Samples:	7	Pathways:	5	Sulfite oxidase deficiency	Acetaminophen Metabolism Pathway	Tamoxifen Metabolism Pathway	Tamoxifen Action Pathway	Sulfate/Sulfite Metabolism
Choline phosphate	HMDB_SMPDB	Samples:	2	Pathways:	1	Lamivudine Metabolism Pathway
Ethanolamine phosphate	HMDB_SMPDB	Samples:	2	Pathways:	1	Lamivudine Metabolism Pathway
Phosphatidylcholine	HMDB_SMPDB	Samples:	14	Pathways:	4	Vitamin A Deficiency	Retinol Metabolism	Ibuprofen Action Pathway	Celecoxib Action Pathway
D-Ribulose 5-phosphate	HMDB_SMPDB	Samples:	56	Pathways:	1	Warburg Effect
Xylulose 5-phosphate	HMDB_SMPDB	Samples:	56	Pathways:	1	Warburg Effect
Acetaldehyde	HMDB_SMPDB	Samples:	58	Pathways:	9	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Ethanol Degradation	Disulfiram Pathway	Disulfiram Action Pathway	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
D-Sedoheptulose 7-phosphate	HMDB_SMPDB	Samples:	56	Pathways:	1	Warburg Effect
6-Phosphogluconic acid	HMDB_SMPDB	Samples:	56	Pathways:	1	Warburg Effect
D-Erythrose 4-phosphate	HMDB_SMPDB	Samples:	56	Pathways:	1	Warburg Effect
6-Phospho-D-gluconate	HMDB_SMPDB	Samples:	56	Pathways:	1	Warburg Effect
D-Xylulose 5-phosphate	HMDB_SMPDB	Samples:	56	Pathways:	1	Warburg Effect
Glycerol	HMDB_SMPDB	Samples:	3	Pathways:	4	Familial lipoprotein lipase deficiency	Glycerol Kinase Deficiency	D-glyceric acidura	Glycerolipid Metabolism
Normorphine	HMDB_SMPDB	Samples:	29	Pathways:	3	Morphine Metabolism Pathway	Morphine Pathway	Morphine Action Pathway
Perindopril	HMDB_SMPDB	Samples:	16	Pathways:	2	Perindopril Pathway	Perindopril Action Pathway
Perindoprilat glucuronide	HMDB_SMPDB	Samples:	16	Pathways:	1	Perindopril Pathway
Dihydrobiopterin	HMDB_SMPDB	Samples:	37	Pathways:	10	Tyrosine hydroxylase deficiency	Sepiapterin reductase deficiency	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Aromatic L-Aminoacid Decarboxylase Deficiency	Dopa-responsive dystonia	Catecholamine Biosynthesis	Hyperphenylalaninemia due to dhpr-deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
Folic acid	HMDB_SMPDB	Samples:	46	Pathways:	5	Pterine Biosynthesis	Methotrexate Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
Sepiapterin	HMDB_SMPDB	Samples:	4	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
Neopterin	HMDB_SMPDB	Samples:	4	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
Dihydroneopterin triphosphate	HMDB_SMPDB	Samples:	4	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
Dihydrofolic acid	HMDB_SMPDB	Samples:	46	Pathways:	5	Pterine Biosynthesis	Methotrexate Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
Dyspropterin	HMDB_SMPDB	Samples:	4	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
7,8-Dihydropteroic acid	HMDB_SMPDB	Samples:	4	Pathways:	1	Pterine Biosynthesis
6-Lactoyltetrahydropterin	HMDB_SMPDB	Samples:	4	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
7,8-Dihydroneopterin	HMDB_SMPDB	Samples:	4	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
2,5-Diaminopyrimidine nucleoside triphosphate 	HMDB_SMPDB	Samples:	4	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
Formamidopyrimidine nucleoside triphosphate	HMDB_SMPDB	Samples:	4	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
2,5-Diamino-6-(5'-triphosphoryl-3',4'-trihydroxy-2'-oxopentyl)-amino-4-oxopyrimidine	HMDB_SMPDB	Samples:	4	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
Dihydroneopterin phosphate	HMDB_SMPDB	Samples:	4	Pathways:	1	Pterine Biosynthesis
Tetrahydrofolyl-[Glu](2)	HMDB_SMPDB	Samples:	46	Pathways:	5	Pterine Biosynthesis	Methotrexate Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
Tetrahydrofolyl-[Glu](n)	HMDB_SMPDB	Samples:	46	Pathways:	5	Pterine Biosynthesis	Methotrexate Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
PPPi	HMDB_SMPDB	Samples:	4	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
1-hydroxy-2-Oxopropyl tetrahydropterin	HMDB_SMPDB	Samples:	4	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
2,5-Diaminopyrimidine nucleoside triphosphate	HMDB_SMPDB	Samples:	4	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
6-Lactoyl-5,6,7,8-tetrahydropterin	HMDB_SMPDB	Samples:	4	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
6-Pyruvoyltetrahydropterin	HMDB_SMPDB	Samples:	4	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
7,8-Dihydrobiopterin	HMDB_SMPDB	Samples:	37	Pathways:	10	Tyrosine hydroxylase deficiency	Sepiapterin reductase deficiency	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Aromatic L-Aminoacid Decarboxylase Deficiency	Dopa-responsive dystonia	Catecholamine Biosynthesis	Hyperphenylalaninemia due to dhpr-deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
7,8-Dihydroneopterin 3'-triphosphate	HMDB_SMPDB	Samples:	4	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
Polyphosphate	HMDB_SMPDB	Samples:	4	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
Irinotecan	HMDB_SMPDB	Samples:	1	Pathways:	2	Irinotecan Metabolism Pathway	Irinotecan Action Pathway
APC	HMDB_SMPDB	Samples:	1	Pathways:	2	Irinotecan Metabolism Pathway	Irinotecan Action Pathway
Metipranolol	HMDB_SMPDB	Samples:	8	Pathways:	1	Metipranolol Action Pathway
Taurocholic acid	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Glycocholic acid	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Taurine	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3a,7a-Dihydroxycoprostanic acid	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Chenodeoxycholic acid	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Cholic acid	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Deoxycholic acid	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Deoxycholic acid glycine conjugate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Chenodeoxycholic acid glycine conjugate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Lithocholic acid glycine conjugate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Lithocholyltaurine	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Lithocholic acid	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Taurodeoxycholic acid	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Taurochenodesoxycholic acid	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
27-Deoxy-5b-cyprinol	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Choloyl-CoA	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
24-Hydroxycholesterol	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
5-b-Cholestane-3a ,7a ,12a-triol	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7a-Hydroxycholesterol	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7a-Hydroxy-cholestene-3-one	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
27-Hydroxycholesterol	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3a,7a-Dihydroxy-5b-cholestanoyl-CoA	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7a,12a-Dihydroxy-cholestene-3-one	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3a,7a,12a-Trihydroxy-5b-cholestan-26-al	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3'-AMP	HMDB_SMPDB	Samples:	42	Pathways:	8	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Tryptophan Metabolism	Bile Acid Biosynthesis
3a,7a,12a-Trihydroxy-5b-cholestanoic acid	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
25-Hydroxycholesterol	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7-a,25-Dihydroxycholesterol	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7-a,27-Dihydroxycholesterol	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Chenodeoxycholoyl-CoA	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
CE(22:2(13Z,16Z))	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
5b-Cyprinol sulfate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3a,7a,12a-Trihydroxy-5b-cholest-24-enoyl-CoA	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3a,7a,12a,24-Tetrahydroxy-5b-cholestanoyl-CoA	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3a,7a,12a-Trihydroxy-5b-24-oxocholestanoyl-CoA	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7a-Hydroxy-5b-cholestan-3-one	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3a,7a-Dihydroxy-5b-cholestane	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3a,7a-Dihydroxy-5b-cholestan-26-al	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3a,7a-Dihydroxy-5b-cholest-24-enoyl-CoA	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
(24R)-Cholest-5-ene-3-beta,7-alpha,24-triol  	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3 beta-Hydroxy-5-cholestenoate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3 beta,7 alpha-Dihydroxy-5-cholestenoate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3 alpha,7 alpha,26-Trihydroxy-5beta-cholestane	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3 alpha,7 alpha,24-Trihydroxy-5beta-cholestanoyl-CoA	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7 alpha-Hydroxy-3-oxo-4-cholestenoate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7 alpha,26-Dihydroxy-4-cholesten-3-one	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestanoyl-CoA	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestane	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-CoA	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha,12alpha-Trihydroxy-5beta-cholest-24-enoyl-CoA	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-al	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestane	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha,24-Trihydroxy-5beta-cholestanoyl-CoA	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha,26-Trihydroxy-5beta-cholestane	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha-Dihydroxy-5beta-cholest-24-enoyl-CoA	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha-Dihydroxy-5beta-cholestan-26-al	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha-Dihydroxy-5beta-cholestane	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3beta,7alpha-Dihydroxy-5-cholestenoate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3beta-Hydroxy-5-cholestenoate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
5beta-Cyprinolsulfate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7alpha,12alpha-Dihydroxy-5beta-cholestan-3-one	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7alpha,26-Dihydroxy-4-cholesten-3-one	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7alpha,27-Dihydroxycholesterol	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7alpha-Hydroxy-3-oxo-4-cholestenoate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7alpha-Hydroxy-5beta-cholestan-3-one	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7alpha-Hydroxycholest-4-en-3-one	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7alpha-Hydroxycholesterol	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Cerebrosterol	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Chenodeoxycholate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Cholest-5-ene-3beta,7alpha,25-triol	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Cholesterol ester	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Glycochenodeoxycholate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Glycocholate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Glycodeoxycholate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Glycolithocholate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Taurochenodeoxycholate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Taurocholate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Taurodeoxycholate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Taurolithocholate	HMDB_SMPDB	Samples:	33	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Bumetanide	HMDB_SMPDB	Samples:	44	Pathways:	1	Bumetanide Pathway
Forasartan	HMDB_SMPDB	Samples:	16	Pathways:	1	Forasartan Action Pathway
Choline	HMDB_SMPDB	Samples:	44	Pathways:	10	Methionine Adenosyltransferase Deficiency	sarcosine oncometabolite pathway 	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Hypermethioninemia	Glycine N-methyltransferase Deficiency	Cystathionine Beta-Synthase Deficiency	Betaine Metabolism	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Methionine Metabolism	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type
L-Homoserine	HMDB_SMPDB	Samples:	43	Pathways:	8	Methionine Adenosyltransferase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Hypermethioninemia	Cystathionine Beta-Synthase Deficiency	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Methionine Metabolism	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type
5-Methylthioribose 1-phosphate	HMDB_SMPDB	Samples:	43	Pathways:	8	Methionine Adenosyltransferase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Hypermethioninemia	Cystathionine Beta-Synthase Deficiency	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Methionine Metabolism	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type
S-Adenosylmethioninamine	HMDB_SMPDB	Samples:	43	Pathways:	8	Methionine Adenosyltransferase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Hypermethioninemia	Cystathionine Beta-Synthase Deficiency	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Methionine Metabolism	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type
5'-Methylthioadenosine	HMDB_SMPDB	Samples:	43	Pathways:	8	Methionine Adenosyltransferase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Hypermethioninemia	Cystathionine Beta-Synthase Deficiency	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Methionine Metabolism	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type
Spermidine	HMDB_SMPDB	Samples:	43	Pathways:	8	Methionine Adenosyltransferase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Hypermethioninemia	Cystathionine Beta-Synthase Deficiency	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Methionine Metabolism	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type
5-Methyltetrahydrofolic acid	HMDB_SMPDB	Samples:	44	Pathways:	13	Methionine Adenosyltransferase Deficiency	sarcosine oncometabolite pathway 	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Hypermethioninemia	Glycine N-methyltransferase Deficiency	Cystathionine Beta-Synthase Deficiency	Betaine Metabolism	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Methionine Metabolism	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Methotrexate Pathway	Folate malabsorption, hereditary
Putrescine	HMDB_SMPDB	Samples:	43	Pathways:	8	Methionine Adenosyltransferase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Hypermethioninemia	Cystathionine Beta-Synthase Deficiency	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Methionine Metabolism	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type
2-Oxo-4-methylthiobutanoic acid	HMDB_SMPDB	Samples:	43	Pathways:	8	Methionine Adenosyltransferase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Hypermethioninemia	Cystathionine Beta-Synthase Deficiency	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Methionine Metabolism	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type
Methionine sulfoxide	HMDB_SMPDB	Samples:	43	Pathways:	8	Methionine Adenosyltransferase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Hypermethioninemia	Cystathionine Beta-Synthase Deficiency	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Methionine Metabolism	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type
4-Methylthio-2-oxobutanoic acid	HMDB_SMPDB	Samples:	43	Pathways:	8	Methionine Adenosyltransferase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Hypermethioninemia	Cystathionine Beta-Synthase Deficiency	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Methionine Metabolism	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type
5-Methyltetrahydrofolate	HMDB_SMPDB	Samples:	43	Pathways:	12	Methionine Adenosyltransferase Deficiency	Methotrexate Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Hypermethioninemia	Glycine N-methyltransferase Deficiency	Cystathionine Beta-Synthase Deficiency	Betaine Metabolism	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Methionine Metabolism	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type	Folate malabsorption, hereditary
S-Methyl-5-thio-D-ribose 1-phosphate	HMDB_SMPDB	Samples:	43	Pathways:	8	Methionine Adenosyltransferase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Hypermethioninemia	Cystathionine Beta-Synthase Deficiency	Glycine N-methyltransferase Deficiency	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	Methionine Metabolism	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type
Deoxycorticosterone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Cortisol	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Pregnenolone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Tetrahydrocorticosterone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
18-Hydroxycorticosterone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17a-Hydroxypregnenolone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17-Hydroxyprogesterone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Tetrahydrocortisone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Tetrahydrocortisol	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
4-Methylpentanal	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Corticosterone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Progesterone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Cortisone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Dihydrocortisol	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
5a-Pregnane-3,20-dione	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
21-Hydroxypregnenolone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11-Dehydrocorticosterone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
21-Deoxycortisol	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11b-Hydroxyprogesterone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
22b-Hydroxycholesterol	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
20alpha-Hydroxycholesterol	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
3a,11b,21-Trihydroxy-20-oxo-5b-pregnan-18-al	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11b,21-Dihydroxy-3,20-oxo-5b-pregnan-18-al	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
3a,21-Dihydroxy-5b-pregnane-11,20-dione	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
21-Hydroxy-5b-pregnane-3,11,20-trione	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11b,21-Dihydroxy-5b-pregnane-3,20-dione	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17a,21-Dihydroxy-5b-pregnane-3,11,20-trione	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
3a-Hydroxy-5b-pregnane-20-one	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11b,17a,21-Trihydroxypreg-nenolone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17a,21-Dihydroxypreg-nenolone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
20a,22b-Dihydroxycholesterol	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17a,20a-Dihydroxycholesterol	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11-Deoxycorticosterone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11-Deoxycortisol	HMDB_SMPDB	Samples:	16	Pathways:	34	Aminocaproic Acid Action Pathway	Phenindione Action Pathway	Ardeparin Action Pathway	Dicumarol Action Pathway	Warfarin Action Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Aprotinin Action Pathway	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Steroidogenesis	Lepirudin Action Pathway	Dicoumarol Action Pathway	Phenprocoumon Action Pathway	Urokinase Action Pathway	Tenecteplase Action Pathway	17-alpha-hydroxylase deficiency (CYP17)	Corticosterone methyl oxidase II deficiency - CMO II	Streptokinase Action Pathway	Acenocoumarol Action Pathway	Enoxaparin Action Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	Tranexamic Acid Action Pathway	Fondaparinux Action Pathway	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Anistreplase Action Pathway	Heparin Action Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Argatroban Action Pathway	Alteplase Action Pathway	Ximelagatran Action Pathway	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Bivalirudin Action Pathway	Reteplase Action Pathway
11beta,17alpha,21-Trihydroxy-5beta-pregnane-3,20-dione	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11beta,17alpha,21-Trihydroxypregnenolone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11beta,21-Dihydroxy-3,20-oxo-5beta-pregnan-18-al	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11beta,21-Dihydroxy-5beta-pregnane-3,20-dione	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11beta-Hydroxyprogesterone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17alpha,20alpha-Dihydroxycholesterol	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17alpha,21-Dihydroxy-5beta-pregnane-3,11,20-trione	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17alpha,21-Dihydroxypregnenolone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17alpha-Hydroxypregnenolone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17alpha-Hydroxyprogesterone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
20alpha,22beta-Dihydroxycholesterol	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
21-Hydroxy-5beta-pregnane-3,11,20-trione	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
22(R)-Hydroxycholesterol	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
3alpha,11beta,21-Trihydroxy-20-oxo-5beta-pregnan-18-al	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
3alpha,21-Dihydroxy-5beta-pregnane-11,20-dione	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
5alpha-Pregnane-3,20-dione	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Pregnanolone	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Urocortisol	HMDB_SMPDB	Samples:	2	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Levallorphan	HMDB_SMPDB	Samples:	28	Pathways:	1	Levallorphan Action Pathway
Omeprazole	HMDB_SMPDB	Samples:	6	Pathways:	2	Omeprazole Pathway	Omeprazole Action Pathway
5-Hydroxyomeprazole	HMDB_SMPDB	Samples:	6	Pathways:	1	Omeprazole Pathway
Argatroban	HMDB_SMPDB	Samples:	7	Pathways:	2	Argatroban Pathway	Argatroban Action Pathway
Cytidine monophosphate	HMDB_SMPDB	Samples:	1	Pathways:	1	Pantothenate and CoA Biosynthesis
Pantothenic acid	HMDB_SMPDB	Samples:	42	Pathways:	5	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Pantothenate and CoA Biosynthesis	GABA-Transaminase Deficiency
D-4'-Phosphopantothenate	HMDB_SMPDB	Samples:	1	Pathways:	1	Pantothenate and CoA Biosynthesis
4-Phosphopantothenoylcysteine	HMDB_SMPDB	Samples:	1	Pathways:	1	Pantothenate and CoA Biosynthesis
Dephospho-CoA	HMDB_SMPDB	Samples:	1	Pathways:	1	Pantothenate and CoA Biosynthesis
Pantetheine 4'-phosphate	HMDB_SMPDB	Samples:	1	Pathways:	1	Pantothenate and CoA Biosynthesis
Cysteamine	HMDB_SMPDB	Samples:	1	Pathways:	1	Pantothenate and CoA Biosynthesis
Pantetheine	HMDB_SMPDB	Samples:	50	Pathways:	5	Malonic Aciduria	Malonyl-coa decarboxylase deficiency	Pantothenate and CoA Biosynthesis	Propanoate Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders
Pantothenol	HMDB_SMPDB	Samples:	1	Pathways:	1	Pantothenate and CoA Biosynthesis
D-Pantothenoyl-L-cysteine	HMDB_SMPDB	Samples:	1	Pathways:	1	Pantothenate and CoA Biosynthesis
(R)-4'-Phosphopantothenoyl-L-cysteine	HMDB_SMPDB	Samples:	1	Pathways:	1	Pantothenate and CoA Biosynthesis
CMP	HMDB_SMPDB	Samples:	1	Pathways:	1	Pantothenate and CoA Biosynthesis
N-((R)-Pantothenoyl)-L-cysteine	HMDB_SMPDB	Samples:	1	Pathways:	1	Pantothenate and CoA Biosynthesis
Pantothenate	HMDB_SMPDB	Samples:	42	Pathways:	5	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Pantothenate and CoA Biosynthesis	GABA-Transaminase Deficiency
(S)-2-Hydroxyglutarate	HMDB_SMPDB	Samples:	60	Pathways:	1	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria
(S)-Malate	HMDB_SMPDB	Samples:	62	Pathways:	20	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Fumarase deficiency	Glutaminolysis and Cancer	Pyruvate kinase deficiency	Transfer of Acetyl Groups into Mitochondria	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pyruvate Dehydrogenase Complex Deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of 2-hydroxyglutarate	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome	2-ketoglutarate dehydrogenase complex deficiency
cis-Aconitate	HMDB_SMPDB	Samples:	62	Pathways:	12	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	2-ketoglutarate dehydrogenase complex deficiency
Citrate	HMDB_SMPDB	Samples:	62	Pathways:	14	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	Warburg Effect	Transfer of Acetyl Groups into Mitochondria	2-ketoglutarate dehydrogenase complex deficiency
FADH2	HMDB_SMPDB	Samples:	62	Pathways:	13	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	Warburg Effect	2-ketoglutarate dehydrogenase complex deficiency
Isocitrate	HMDB_SMPDB	Samples:	62	Pathways:	13	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	Warburg Effect	2-ketoglutarate dehydrogenase complex deficiency
NH4+	HMDB_SMPDB	Samples:	61	Pathways:	2	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria
Ubiquinone-10	HMDB_SMPDB	Samples:	62	Pathways:	14	Mitochondrial Electron Transport Chain	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	Warburg Effect	2-ketoglutarate dehydrogenase complex deficiency
Glycerol 3-phosphate	HMDB_SMPDB	Samples:	51	Pathways:	5	Familial lipoprotein lipase deficiency	Glycerolipid Metabolism	Mitochondrial Electron Transport Chain	D-glyceric acidura	Glycerol Kinase Deficiency
PA(16:0/16:0)	HMDB_SMPDB	Samples:	3	Pathways:	4	Familial lipoprotein lipase deficiency	Glycerol Kinase Deficiency	D-glyceric acidura	Glycerolipid Metabolism
Hydroquinone	HMDB_SMPDB	Samples:	3	Pathways:	4	Familial lipoprotein lipase deficiency	Glycerol Kinase Deficiency	D-glyceric acidura	Glycerolipid Metabolism
Quinone	HMDB_SMPDB	Samples:	3	Pathways:	4	Familial lipoprotein lipase deficiency	Glycerol Kinase Deficiency	D-glyceric acidura	Glycerolipid Metabolism
TG(16:0/16:0/16:0)	HMDB_SMPDB	Samples:	3	Pathways:	4	Familial lipoprotein lipase deficiency	Glycerol Kinase Deficiency	D-glyceric acidura	Glycerolipid Metabolism
LPA(16:0/0:0)	HMDB_SMPDB	Samples:	3	Pathways:	4	Familial lipoprotein lipase deficiency	Glycerol Kinase Deficiency	D-glyceric acidura	Glycerolipid Metabolism
MG(0:0/16:0/0:0)	HMDB_SMPDB	Samples:	3	Pathways:	4	Familial lipoprotein lipase deficiency	Glycerol Kinase Deficiency	D-glyceric acidura	Glycerolipid Metabolism
Diacylglycerol	HMDB_SMPDB	Samples:	3	Pathways:	4	Familial lipoprotein lipase deficiency	Glycerol Kinase Deficiency	D-glyceric acidura	Glycerolipid Metabolism
p-Benzoquinone	HMDB_SMPDB	Samples:	3	Pathways:	4	Familial lipoprotein lipase deficiency	Glycerol Kinase Deficiency	D-glyceric acidura	Glycerolipid Metabolism
Phosphatidate	HMDB_SMPDB	Samples:	3	Pathways:	4	Familial lipoprotein lipase deficiency	Glycerol Kinase Deficiency	D-glyceric acidura	Glycerolipid Metabolism
sn-Glycerol 3-phosphate	HMDB_SMPDB	Samples:	51	Pathways:	5	Familial lipoprotein lipase deficiency	Glycerolipid Metabolism	Mitochondrial Electron Transport Chain	D-glyceric acidura	Glycerol Kinase Deficiency
Dimethylamine	HMDB_SMPDB	Samples:	44	Pathways:	3	Citalopram Metabolism Pathway	Citalopram Pathway	Citalopram Action Pathway
Citalopram	HMDB_SMPDB	Samples:	44	Pathways:	3	Citalopram Metabolism Pathway	Citalopram Pathway	Citalopram Action Pathway
N-Desmethylcitalopram	HMDB_SMPDB	Samples:	44	Pathways:	2	Citalopram Metabolism Pathway	Citalopram Pathway
Dibucaine	HMDB_SMPDB	Samples:	28	Pathways:	2	Dibucaine Pathway	Dibucaine Action Pathway
p-Hydroxyphenylacetic acid	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3-Methoxytyramine	HMDB_SMPDB	Samples:	54	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Ascorbic acid	HMDB_SMPDB	Samples:	60	Pathways:	17	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	The oncogenic action of Fumarate	Carnitine Synthesis	The oncogenic action of Succinate	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Oxidation of Branched Chain Fatty Acids	Refsum Disease	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Catecholamine Biosynthesis	Hawkinsinuria	Tyrosine Metabolism
Epinephrine	HMDB_SMPDB	Samples:	56	Pathways:	12	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Catecholamine Biosynthesis	Epinephrine Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Homovanillic acid	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Methylamine	HMDB_SMPDB	Samples:	54	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
L-Dopa	HMDB_SMPDB	Samples:	54	Pathways:	11	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Catecholamine Biosynthesis	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Vanillylmandelic acid	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Tyramine	HMDB_SMPDB	Samples:	54	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3,4-Dihydroxyphenylglycol	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Copper	HMDB_SMPDB	Samples:	55	Pathways:	19	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Ureidopropionase deficiency	Beta-Alanine Metabolism	Degradation of Superoxides	Carnosinuria, carnosinemia	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Histidinemia	Disulfiram Action Pathway	Alkaptonuria	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	GABA-Transaminase Deficiency	Catecholamine Biosynthesis	Hawkinsinuria	Tyrosine Metabolism
Normetanephrine	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Pyrocatechol	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Dopaquinone	HMDB_SMPDB	Samples:	54	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
5,6-Dihydroxyindole-2-carboxylic acid	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Dehydroascorbic acid	HMDB_SMPDB	Samples:	54	Pathways:	11	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Catecholamine Biosynthesis	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3,4-Dihydroxybenzeneacetic acid	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Guaiacol	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
L-Dopachrome	HMDB_SMPDB	Samples:	54	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Vanylglycol	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3,4-Dihydroxymandelic acid	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3,4-Dihydroxyphenylacetaldehyde	HMDB_SMPDB	Samples:	54	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
5,6-Dihydroxyindole	HMDB_SMPDB	Samples:	54	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3-Methoxy-4-hydroxyphenylglycolaldehyde	HMDB_SMPDB	Samples:	54	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Metanephrine	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Leucodopachrome	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Melanin	HMDB_SMPDB	Samples:	54	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Homovanillin	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3,4-Dihydroxymandelaldehyde	HMDB_SMPDB	Samples:	54	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Indole-5,6-quinone	HMDB_SMPDB	Samples:	54	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
2-Hydroxy-3-(4-hydroxyphenyl)propenoic acid	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Topaquinone	HMDB_SMPDB	Samples:	55	Pathways:	14	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Ureidopropionase deficiency	Dopamine beta-hydroxylase deficiency	Beta-Alanine Metabolism	Disulfiram Pathway	Carnosinuria, carnosinemia	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Histidinemia	GABA-Transaminase Deficiency	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Pyrroloquinoline quinone	HMDB_SMPDB	Samples:	54	Pathways:	11	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Catecholamine Biosynthesis	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Methylammonium	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
2-Carboxy-2,3-dihydro-5,6-dihydroxyindole	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
2-Hydroxy-3-(4-hydroxyphenyl)propenoate	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3,4-Dihydroxy-L-phenylalanine	HMDB_SMPDB	Samples:	54	Pathways:	11	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Catecholamine Biosynthesis	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3,4-Dihydroxymandelate	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3,4-Dihydroxyphenylacetate	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3,4-Dihydroxyphenylethyleneglycol	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3-Methoxy-4-hydroxymandelate	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3-Methoxy-4-hydroxyphenylacetaldehyde	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3-Methoxy-4-hydroxyphenylethyleneglycol	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
4-Hydroxyphenylacetate	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
5,6-Dihydroxyindole-2-carboxylate	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Ascorbate	HMDB_SMPDB	Samples:	60	Pathways:	17	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	The oncogenic action of Fumarate	Carnitine Synthesis	The oncogenic action of Succinate	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Disulfiram Action Pathway	Oxidation of Branched Chain Fatty Acids	Refsum Disease	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Dopamine beta-hydroxylase deficiency	Catecholamine Biosynthesis	Hawkinsinuria	Tyrosine Metabolism
Catechol	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Homovanillate	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
L-Adrenaline	HMDB_SMPDB	Samples:	56	Pathways:	12	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Catecholamine Biosynthesis	Disulfiram Action Pathway	Epinephrine Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
L-Metanephrine	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
L-Normetanephrine	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
o-Methoxyphenol	HMDB_SMPDB	Samples:	54	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
PQQ	HMDB_SMPDB	Samples:	54	Pathways:	11	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Catecholamine Biosynthesis	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Codeine	HMDB_SMPDB	Samples:	43	Pathways:	3	Codeine Metabolism Pathway	Codeine Action Pathway	Codeine Pathway
Codeine-6-glucuronide	HMDB_SMPDB	Samples:	43	Pathways:	3	Codeine Metabolism Pathway	Codeine Action Pathway	Codeine Pathway
Norcodeine	HMDB_SMPDB	Samples:	43	Pathways:	3	Codeine Metabolism Pathway	Codeine Action Pathway	Codeine Pathway
4-Hydroxyproline	HMDB_SMPDB	Samples:	59	Pathways:	2	The oncogenic action of Fumarate	The oncogenic action of Succinate
Hydroxyproline	HMDB_SMPDB	Samples:	59	Pathways:	2	The oncogenic action of Fumarate	The oncogenic action of Succinate
Ubiquinol	HMDB_SMPDB	Samples:	59	Pathways:	3	The oncogenic action of Fumarate	Glutaminolysis and Cancer	The oncogenic action of Succinate
Moexipril	HMDB_SMPDB	Samples:	16	Pathways:	2	Moexipril Pathway	Moexipril Action Pathway
Oxycodone	HMDB_SMPDB	Samples:	28	Pathways:	2	Oxycodone Pathway	Oxycodone Action Pathway
Stearic acid	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
Stearoyl-CoA	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
Octadecanoic acid	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
Procainamide	HMDB_SMPDB	Samples:	8	Pathways:	2	Procainamide (Antiarrhythmic) Action Pathway	Procainamide (Antiarrhythmic) Pathway
Lisinopril	HMDB_SMPDB	Samples:	16	Pathways:	1	Lisinopril Pathway
Cysteinylglycine	HMDB_SMPDB	Samples:	9	Pathways:	6	Gamma-Glutamyltransferase Deficiency	Gamma-glutamyl-transpeptidase deficiency	Glutathione Synthetase Deficiency	5-Oxoprolinuria	Glutathione Metabolism	5-oxoprolinase deficiency
Pyroglutamic acid	HMDB_SMPDB	Samples:	9	Pathways:	6	Gamma-Glutamyltransferase Deficiency	Gamma-glutamyl-transpeptidase deficiency	Glutathione Synthetase Deficiency	5-Oxoprolinuria	Glutathione Metabolism	5-oxoprolinase deficiency
Gamma-Glutamylcysteine	HMDB_SMPDB	Samples:	29	Pathways:	12	Gamma-Glutamyltransferase Deficiency	Gamma-glutamyl-transpeptidase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Glutathione Synthetase Deficiency	5-Oxoprolinuria	5-oxoprolinase deficiency	Succinic semialdehyde dehydrogenase deficiency	Homocarnosinosis	Glutamate Metabolism	2-Hydroxyglutric Aciduria (D And L Form)	Glutathione Metabolism
Bromomethane	HMDB_SMPDB	Samples:	9	Pathways:	6	Gamma-Glutamyltransferase Deficiency	Gamma-glutamyl-transpeptidase deficiency	Glutathione Synthetase Deficiency	5-Oxoprolinuria	Glutathione Metabolism	5-oxoprolinase deficiency
Cys-Gly	HMDB_SMPDB	Samples:	9	Pathways:	6	Gamma-Glutamyltransferase Deficiency	Gamma-glutamyl-transpeptidase deficiency	Glutathione Synthetase Deficiency	5-Oxoprolinuria	Glutathione Metabolism	5-oxoprolinase deficiency
gamma-L-Glutamyl-L-cysteine	HMDB_SMPDB	Samples:	29	Pathways:	12	Gamma-Glutamyltransferase Deficiency	Gamma-glutamyl-transpeptidase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Glutathione Synthetase Deficiency	5-Oxoprolinuria	5-oxoprolinase deficiency	Succinic semialdehyde dehydrogenase deficiency	Homocarnosinosis	Glutamate Metabolism	2-Hydroxyglutric Aciduria (D And L Form)	Glutathione Metabolism
Glutathione disulfide	HMDB_SMPDB	Samples:	31	Pathways:	14	Gamma-Glutamyltransferase Deficiency	Gamma-glutamyl-transpeptidase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Glutathione Synthetase Deficiency	5-Oxoprolinuria	5-oxoprolinase deficiency	Succinic semialdehyde dehydrogenase deficiency	Homocarnosinosis	Glutamate Metabolism	Ibuprofen Action Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Glutathione Metabolism	Celecoxib Action Pathway
Methyl bromide	HMDB_SMPDB	Samples:	9	Pathways:	6	Gamma-Glutamyltransferase Deficiency	Gamma-glutamyl-transpeptidase deficiency	Glutathione Synthetase Deficiency	5-Oxoprolinuria	Glutathione Metabolism	5-oxoprolinase deficiency
Pidolic acid	HMDB_SMPDB	Samples:	9	Pathways:	6	Gamma-Glutamyltransferase Deficiency	Gamma-glutamyl-transpeptidase deficiency	Glutathione Synthetase Deficiency	5-Oxoprolinuria	Glutathione Metabolism	5-oxoprolinase deficiency
Felodipine	HMDB_SMPDB	Samples:	8	Pathways:	1	Felodipine Pathway
Rabeprazole	HMDB_SMPDB	Samples:	6	Pathways:	2	Rabeprazole Pathway	Rabeprazole Action Pathway
L-Lactic acid	HMDB_SMPDB	Samples:	58	Pathways:	8	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Warburg Effect	Glutaminolysis and Cancer	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Malic acid	HMDB_SMPDB	Samples:	59	Pathways:	2	The oncogenic action of Fumarate	Malate-Aspartate Shuttle
Glyceric acid 1,3-biphosphate	HMDB_SMPDB	Samples:	60	Pathways:	5	Mitochondrial Electron Transport Chain	Fanconi-bickel syndrome	Warburg Effect	Glycogenosis, Type VII. Tarui disease	Glycolysis
2,3-Diphosphoglyceric acid	HMDB_SMPDB	Samples:	4	Pathways:	3	Glycolysis	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease
2-Phospho-D-glyceric acid	HMDB_SMPDB	Samples:	60	Pathways:	4	Fanconi-bickel syndrome	Glycolysis	Warburg Effect	Glycogenosis, Type VII. Tarui disease
(S)-Lactate	HMDB_SMPDB	Samples:	58	Pathways:	8	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Warburg Effect	Glutaminolysis and Cancer	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
2,3-Bisphospho-D-glycerate	HMDB_SMPDB	Samples:	4	Pathways:	3	Glycolysis	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease
2-Phospho-D-glycerate	HMDB_SMPDB	Samples:	60	Pathways:	4	Fanconi-bickel syndrome	Glycolysis	Warburg Effect	Glycogenosis, Type VII. Tarui disease
3-Phospho-D-glyceroyl phosphate	HMDB_SMPDB	Samples:	60	Pathways:	5	Mitochondrial Electron Transport Chain	Fanconi-bickel syndrome	Warburg Effect	Glycogenosis, Type VII. Tarui disease	Glycolysis
Malate	HMDB_SMPDB	Samples:	59	Pathways:	2	The oncogenic action of Fumarate	Malate-Aspartate Shuttle
(15S)-15-Hydroxy-5,8,11-cis-13-trans-eicosatetraenoate	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
1-Acyl-sn-glycero-3-phosphocholine	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
11,12-DHET	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
11,12-EET	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
11-epi-Prostaglandin F2alpha	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
12-OxoETE	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
14,15-DHET	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
14,15-EET	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
15-Deoxy-Delta12,14-PGJ2	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
20-COOH-Leukotriene B4	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
20-HETE	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
20-OH-Leukotriene B4	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
5(S)-HETE	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
5(S)-HPETE	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
5,6-EET	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
5-OxoETE	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
6-Keto-prostaglandin E1	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
6-Keto-prostaglandin F1alpha	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
8(S)-HETE	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
8,9-DHET	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
8,9-EET	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
9,11,15-Trihydroxy-prosta-5,13-dien-1-oic acid	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
Leukotriene D4	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
Prostaglandin C2	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
Prostaglandin F2alpha	HMDB_SMPDB	Samples:	13	Pathways:	2	Ibuprofen Action Pathway	Celecoxib Action Pathway
Furosemide	HMDB_SMPDB	Samples:	44	Pathways:	2	Furosemide Pathway	Furosemide Action Pathway
Quinapril	HMDB_SMPDB	Samples:	16	Pathways:	2	Quinapril Action Pathway	Quinapril Pathway
Quinaprilat	HMDB_SMPDB	Samples:	16	Pathways:	1	Quinapril Pathway
Spironolactone	HMDB_SMPDB	Samples:	44	Pathways:	2	Spironolactone Pathway	Spironolactone Action Pathway
Nicotine imine	HMDB_SMPDB	Samples:	39	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Cotinine glucuronide	HMDB_SMPDB	Samples:	39	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Cotinine	HMDB_SMPDB	Samples:	39	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Nornicotine	HMDB_SMPDB	Samples:	39	Pathways:	3	Nicotine Pathway	Nicotine Action Pathway	Nicotine Metabolism Pathway
trans-3-Hydroxycotinine glucuronide	HMDB_SMPDB	Samples:	39	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Nicotine glucuronide	HMDB_SMPDB	Samples:	39	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Norcotinine	HMDB_SMPDB	Samples:	39	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Hydroxycotinine	HMDB_SMPDB	Samples:	39	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Cotinine N-oxide	HMDB_SMPDB	Samples:	39	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
5'-Hydroxycotinine	HMDB_SMPDB	Samples:	39	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Nicotine-1'-N-oxide	HMDB_SMPDB	Samples:	39	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Nicotine	HMDB_SMPDB	Samples:	39	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Methylmalonyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	1	Valine, Leucine and Isoleucine Degradation
Carnosine	HMDB_SMPDB	Samples:	42	Pathways:	6	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Histidine Metabolism	Histidinemia	GABA-Transaminase Deficiency
L-Histidine	HMDB_SMPDB	Samples:	48	Pathways:	7	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Histidine Metabolism	Ammonia Recycling	Histidinemia	GABA-Transaminase Deficiency
Urocanic acid	HMDB_SMPDB	Samples:	42	Pathways:	3	Ammonia Recycling	Histidinemia	Histidine Metabolism
3-Methylhistidine	HMDB_SMPDB	Samples:	42	Pathways:	6	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Histidine Metabolism	Histidinemia	GABA-Transaminase Deficiency
Formiminoglutamic acid	HMDB_SMPDB	Samples:	24	Pathways:	2	Histidinemia	Histidine Metabolism
1-Methylhistamine	HMDB_SMPDB	Samples:	24	Pathways:	2	Histidinemia	Histidine Metabolism
4-Imidazolone-5-propionic acid	HMDB_SMPDB	Samples:	24	Pathways:	2	Histidinemia	Histidine Metabolism
5-Formiminotetrahydrofolic acid	HMDB_SMPDB	Samples:	43	Pathways:	6	Methotrexate Pathway	Histidine Metabolism	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Histidinemia	Folate Metabolism	Folate malabsorption, hereditary
Imidazoleacetic acid	HMDB_SMPDB	Samples:	24	Pathways:	2	Histidinemia	Histidine Metabolism
Methylimidazoleacetic acid	HMDB_SMPDB	Samples:	24	Pathways:	2	Histidinemia	Histidine Metabolism
Imidazole-4-acetaldehyde	HMDB_SMPDB	Samples:	24	Pathways:	2	Histidinemia	Histidine Metabolism
Methylimidazole acetaldehyde	HMDB_SMPDB	Samples:	24	Pathways:	2	Histidinemia	Histidine Metabolism
4-Imidazolone-5-propanoate	HMDB_SMPDB	Samples:	24	Pathways:	2	Histidinemia	Histidine Metabolism
5-Formiminotetrahydrofolate	HMDB_SMPDB	Samples:	43	Pathways:	6	Methotrexate Action Pathway	Histidine Metabolism	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Histidinemia	Folate Metabolism	Folate malabsorption, hereditary
beta-Alanyl-N(pi)-methyl-L-histidine	HMDB_SMPDB	Samples:	42	Pathways:	6	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Histidine Metabolism	Histidinemia	GABA-Transaminase Deficiency
Imidazole-4-acetate	HMDB_SMPDB	Samples:	24	Pathways:	2	Histidinemia	Histidine Metabolism
N(pi)-Methyl-L-histidine	HMDB_SMPDB	Samples:	42	Pathways:	6	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Histidine Metabolism	Histidinemia	GABA-Transaminase Deficiency
N-Formimino-L-glutamate	HMDB_SMPDB	Samples:	24	Pathways:	2	Histidinemia	Histidine Metabolism
N-Methylhistamine	HMDB_SMPDB	Samples:	24	Pathways:	2	Histidinemia	Histidine Metabolism
Urocanate	HMDB_SMPDB	Samples:	42	Pathways:	3	Ammonia Recycling	Histidinemia	Histidine Metabolism
Roxatidine acetate	HMDB_SMPDB	Samples:	6	Pathways:	1	Roxatidine acetate Action Pathway
Acetylcholine	HMDB_SMPDB	Samples:	6	Pathways:	14	Cimetidine Action Pathway	Betazole Action Pathway	Esomeprazole Action Pathway	Roxatidine acetate Action Pathway	Lansoprazole Action Pathway	Omeprazole Action Pathway	Famotidine Action Pathway	Nizatidine Action Pathway	Rabeprazole Action Pathway	Gastric Acid Production	Metiamide Action Pathway	Ranitidine Action Pathway	Pirenzepine Action Pathway	Pantoprazole Action Pathway
S-Lactoylglutathione	HMDB_SMPDB	Samples:	57	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Malonyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	10	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Propanoate Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
D-Lactic acid	HMDB_SMPDB	Samples:	57	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Acetylphosphate	HMDB_SMPDB	Samples:	57	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Propylene glycol	HMDB_SMPDB	Samples:	57	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
D-Lactaldehyde	HMDB_SMPDB	Samples:	57	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
S-Acetyldihydrolipoamide-E	HMDB_SMPDB	Samples:	57	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Acetyl adenylate	HMDB_SMPDB	Samples:	57	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
(R)-Lactaldehyde	HMDB_SMPDB	Samples:	57	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
(R)-Lactate	HMDB_SMPDB	Samples:	57	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
(R)-S-Lactoylglutathione	HMDB_SMPDB	Samples:	57	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
(S)-Lactaldehyde	HMDB_SMPDB	Samples:	57	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
[Dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine	HMDB_SMPDB	Samples:	57	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Acetyl phosphate	HMDB_SMPDB	Samples:	57	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Propane-1,2-diol	HMDB_SMPDB	Samples:	57	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Clopidogrel	HMDB_SMPDB	Samples:	5	Pathways:	2	Clopidogrel Pathway	Clopidogrel Metabolism Pathway
2-Oxoclopidogrel	HMDB_SMPDB	Samples:	5	Pathways:	2	Clopidogrel Pathway	Clopidogrel Metabolism Pathway
Ureidopropionic acid	HMDB_SMPDB	Samples:	42	Pathways:	4	Ureidopropionase deficiency	Beta-Alanine Metabolism	GABA-Transaminase Deficiency	Carnosinuria, carnosinemia
Dihydrouracil	HMDB_SMPDB	Samples:	42	Pathways:	4	Ureidopropionase deficiency	Beta-Alanine Metabolism	GABA-Transaminase Deficiency	Carnosinuria, carnosinemia
Uracil	HMDB_SMPDB	Samples:	42	Pathways:	4	Ureidopropionase deficiency	Beta-Alanine Metabolism	GABA-Transaminase Deficiency	Carnosinuria, carnosinemia
3-Ureidopropionate	HMDB_SMPDB	Samples:	42	Pathways:	4	Ureidopropionase deficiency	Beta-Alanine Metabolism	GABA-Transaminase Deficiency	Carnosinuria, carnosinemia
5,6-Dihydrouracil	HMDB_SMPDB	Samples:	42	Pathways:	4	Ureidopropionase deficiency	Beta-Alanine Metabolism	GABA-Transaminase Deficiency	Carnosinuria, carnosinemia
Dihydrofolate	HMDB_SMPDB	Samples:	43	Pathways:	4	Methotrexate Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
Betaxolol	HMDB_SMPDB	Samples:	8	Pathways:	2	Betaxolol Action Pathway	Betaxolol Pathway
Estrone	HMDB_SMPDB	Samples:	1	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Estrone sulfate	HMDB_SMPDB	Samples:	1	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Estrone 3-sulfate	HMDB_SMPDB	Samples:	1	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Olmesartan	HMDB_SMPDB	Samples:	16	Pathways:	1	Olmesartan Action Pathway
Pristanic acid	HMDB_SMPDB	Samples:	52	Pathways:	3	Phytanic Acid Peroxisomal Oxidation	Oxidation of Branched Chain Fatty Acids	Refsum Disease
Phytanic acid	HMDB_SMPDB	Samples:	52	Pathways:	3	Phytanic Acid Peroxisomal Oxidation	Oxidation of Branched Chain Fatty Acids	Refsum Disease
Propionylcarnitine	HMDB_SMPDB	Samples:	50	Pathways:	1	Oxidation of Branched Chain Fatty Acids
2-Hydroxyphytanoyl-CoA	HMDB_SMPDB	Samples:	52	Pathways:	3	Phytanic Acid Peroxisomal Oxidation	Oxidation of Branched Chain Fatty Acids	Refsum Disease
Phytanoyl-CoA	HMDB_SMPDB	Samples:	52	Pathways:	3	Phytanic Acid Peroxisomal Oxidation	Oxidation of Branched Chain Fatty Acids	Refsum Disease
Pristanal	HMDB_SMPDB	Samples:	52	Pathways:	3	Phytanic Acid Peroxisomal Oxidation	Oxidation of Branched Chain Fatty Acids	Refsum Disease
Pristanoyl-CoA	HMDB_SMPDB	Samples:	50	Pathways:	1	Oxidation of Branched Chain Fatty Acids
Formyl-CoA	HMDB_SMPDB	Samples:	52	Pathways:	3	Phytanic Acid Peroxisomal Oxidation	Oxidation of Branched Chain Fatty Acids	Refsum Disease
4,8 Dimethylnonanoyl carnitine	HMDB_SMPDB	Samples:	50	Pathways:	1	Oxidation of Branched Chain Fatty Acids
4,8-Dimethylnonanoyl-CoA	HMDB_SMPDB	Samples:	50	Pathways:	1	Oxidation of Branched Chain Fatty Acids
3-Oxopristanoyl-CoA	HMDB_SMPDB	Samples:	50	Pathways:	1	Oxidation of Branched Chain Fatty Acids
O-Propanoylcarnitine	HMDB_SMPDB	Samples:	50	Pathways:	1	Oxidation of Branched Chain Fatty Acids
Phytanate	HMDB_SMPDB	Samples:	52	Pathways:	3	Phytanic Acid Peroxisomal Oxidation	Oxidation of Branched Chain Fatty Acids	Refsum Disease
Acetaminophen	HMDB_SMPDB	Samples:	5	Pathways:	1	Acetaminophen Metabolism Pathway
Levomethadyl Acetate	HMDB_SMPDB	Samples:	28	Pathways:	1	Levomethadyl Acetate Action Action Pathway
Levomethadyl acetate	HMDB_SMPDB	Samples:	28	Pathways:	1	Levomethadyl Acetate Action Action Pathway
Propionic acid	HMDB_SMPDB	Samples:	50	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
Hydroxypropionic acid	HMDB_SMPDB	Samples:	50	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
Malonyl-CoA semialdehyde	HMDB_SMPDB	Samples:	50	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
Acrylyl-CoA	HMDB_SMPDB	Samples:	50	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
Propinol adenylate	HMDB_SMPDB	Samples:	50	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
3-Hydroxypropionyl-CoA	HMDB_SMPDB	Samples:	50	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
2-Hydroxybutanoic acid	HMDB_SMPDB	Samples:	50	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
3-Hydroxypropanoate	HMDB_SMPDB	Samples:	50	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
3-Oxopropionyl-CoA	HMDB_SMPDB	Samples:	50	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
Propanoate	HMDB_SMPDB	Samples:	50	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
Propenoyl-CoA	HMDB_SMPDB	Samples:	50	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
Propionyladenylate	HMDB_SMPDB	Samples:	50	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
Bendroflumethiazide	HMDB_SMPDB	Samples:	44	Pathways:	2	Bendroflumethiazide Pathway	Bendroflumethiazide Action Pathway
Fosinopril	HMDB_SMPDB	Samples:	16	Pathways:	2	Fosinopril Pathway	Fosinopril Action Pathway
Amiodarone	HMDB_SMPDB	Samples:	8	Pathways:	1	Amiodarone Action Pathway
Gamma-Aminobutyric acid	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Nicotinic acid adenine dinucleotide	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Succinic acid semialdehyde	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Carbonic acid	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
4-Aminobutanoate	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Deamino-NAD+	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Succinate semialdehyde	HMDB_SMPDB	Samples:	28	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
4-Trimethylammoniobutanoic acid	HMDB_SMPDB	Samples:	24	Pathways:	1	Carnitine Synthesis
N6,N6,N6-Trimethyl-L-lysine	HMDB_SMPDB	Samples:	24	Pathways:	1	Carnitine Synthesis
4-Trimethylammoniobutanal	HMDB_SMPDB	Samples:	24	Pathways:	1	Carnitine Synthesis
3-Hydroxy-N6,N6,N6-trimethyl-L-lysine	HMDB_SMPDB	Samples:	24	Pathways:	1	Carnitine Synthesis
4-Trimethylammoniobutanoate	HMDB_SMPDB	Samples:	24	Pathways:	1	Carnitine Synthesis
Fluorouracil	HMDB_SMPDB	Samples:	7	Pathways:	2	Capecitabine Metabolism Pathway	Capecitabine Pathway
Teniposide	HMDB_SMPDB	Samples:	7	Pathways:	3	Teniposide Action Pathway	Teniposide Pathway	Teniposide Metabolism Pathway
Methyclothiazide	HMDB_SMPDB	Samples:	44	Pathways:	2	Methyclothiazide Pathway	Methyclothiazide Action Pathway
Benazepril	HMDB_SMPDB	Samples:	16	Pathways:	2	Benazepril Action Pathway	Benazepril Pathway
Phenylacetic acid	HMDB_SMPDB	Samples:	34	Pathways:	1	Phenylacetate Metabolism
Alpha-N-Phenylacetyl-L-glutamine	HMDB_SMPDB	Samples:	34	Pathways:	1	Phenylacetate Metabolism
Phenylacetyl-CoA	HMDB_SMPDB	Samples:	34	Pathways:	1	Phenylacetate Metabolism
Phenylacetylglutamine	HMDB_SMPDB	Samples:	34	Pathways:	1	Phenylacetate Metabolism
Isradipine	HMDB_SMPDB	Samples:	8	Pathways:	1	Isradipine Pathway
Candesartan	HMDB_SMPDB	Samples:	16	Pathways:	1	Candesartan Action Pathway
Oxybuprocaine	HMDB_SMPDB	Samples:	28	Pathways:	1	Oxybuprocaine Pathway
Quinolinic acid	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
Quinolinate	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
1,3-Diaminopropane	HMDB_SMPDB	Samples:	42	Pathways:	4	Ureidopropionase deficiency	Beta-Alanine Metabolism	GABA-Transaminase Deficiency	Carnosinuria, carnosinemia
Anserine	HMDB_SMPDB	Samples:	42	Pathways:	4	Ureidopropionase deficiency	Beta-Alanine Metabolism	GABA-Transaminase Deficiency	Carnosinuria, carnosinemia
3-Aminopropionaldehyde	HMDB_SMPDB	Samples:	42	Pathways:	4	Ureidopropionase deficiency	Beta-Alanine Metabolism	GABA-Transaminase Deficiency	Carnosinuria, carnosinemia
3-Aminopropanal	HMDB_SMPDB	Samples:	42	Pathways:	4	Ureidopropionase deficiency	Beta-Alanine Metabolism	GABA-Transaminase Deficiency	Carnosinuria, carnosinemia
Hydrochlorothiazide	HMDB_SMPDB	Samples:	44	Pathways:	2	Hydrochlorothiazide Action Pathway	Hydrochlorothiazide Pathway
L(-)-Nicotine	HMDB_SMPDB	Samples:	36	Pathways:	1	Nicotine Pathway
Bopindolol	HMDB_SMPDB	Samples:	8	Pathways:	1	Bopindolol Action Pathway
Iodotyrosine	HMDB_SMPDB	Samples:	43	Pathways:	2	Tyrosine Metabolism	Thyroid hormone synthesis
Thyroxine	HMDB_SMPDB	Samples:	43	Pathways:	2	Tyrosine Metabolism	Thyroid hormone synthesis
Liothyronine	HMDB_SMPDB	Samples:	43	Pathways:	2	Tyrosine Metabolism	Thyroid hormone synthesis
3,5-Diiodo-L-tyrosine	HMDB_SMPDB	Samples:	43	Pathways:	2	Tyrosine Metabolism	Thyroid hormone synthesis
Caproic acid	HMDB_SMPDB	Samples:	51	Pathways:	3	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Beta Oxidation of Very Long Chain Fatty Acids	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids
Hexanoic acid	HMDB_SMPDB	Samples:	51	Pathways:	2	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids
Torasemide	HMDB_SMPDB	Samples:	44	Pathways:	1	Torsemide Pathway
Remifentanil	HMDB_SMPDB	Samples:	28	Pathways:	2	Remifentanil Pathway	Remifentanil Action Pathway
Imipramine	HMDB_SMPDB	Samples:	28	Pathways:	2	Imipramine Pathway	Imipramine Action Pathway
Desipramine	HMDB_SMPDB	Samples:	28	Pathways:	4	Desipramine Pathway	Imipramine Pathway	Desipramine Action Pathway	Imipramine Action Pathway
2-hydroxyimipramine	HMDB_SMPDB	Samples:	28	Pathways:	1	Imipramine Pathway
Caprylic acid	HMDB_SMPDB	Samples:	51	Pathways:	2	Beta Oxidation of Very Long Chain Fatty Acids	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids
Capric acid	HMDB_SMPDB	Samples:	26	Pathways:	1	Beta Oxidation of Very Long Chain Fatty Acids
Ethacrynic acid	HMDB_SMPDB	Samples:	44	Pathways:	1	Ethacrynic Acid pathway
Fluoxetine	HMDB_SMPDB	Samples:	28	Pathways:	1	Fluoxetine Pathway
Fluoxetine glucuronide	HMDB_SMPDB	Samples:	28	Pathways:	1	Fluoxetine Pathway
Ethanol	HMDB_SMPDB	Samples:	55	Pathways:	3	Disulfiram Action Pathway	Ethanol Degradation	Disulfiram Pathway
Dicumarol	HMDB_SMPDB	Samples:	7	Pathways:	3	Dicoumarol Action Pathway	Dicumarol Action Pathway	Dicumarol Pathway
Reduced Vitamin K	HMDB_SMPDB	Samples:	14	Pathways:	23	Tranexamic Acid Action Pathway	Fondaparinux Action Pathway	Aminocaproic Acid Action Pathway	Phenindione Action Pathway	Ardeparin Action Pathway	Dicumarol Action Pathway	Warfarin Action Pathway	Aprotinin Action Pathway	Anistreplase Action Pathway	Heparin Action Pathway	Lepirudin Action Pathway	Argatroban Action Pathway	Alteplase Action Pathway	Ximelagatran Action Pathway	Dicoumarol Action Pathway	Phenprocoumon Action Pathway	Urokinase Action Pathway	Bivalirudin Action Pathway	Tenecteplase Action Pathway	Streptokinase Action Pathway	Acenocoumarol Action Pathway	Enoxaparin Action Pathway	Reteplase Action Pathway
Vitamin K1 epoxide	HMDB_SMPDB	Samples:	14	Pathways:	23	Tranexamic Acid Action Pathway	Fondaparinux Action Pathway	Aminocaproic Acid Action Pathway	Phenindione Action Pathway	Ardeparin Action Pathway	Dicumarol Action Pathway	Warfarin Action Pathway	Aprotinin Action Pathway	Anistreplase Action Pathway	Heparin Action Pathway	Lepirudin Action Pathway	Argatroban Action Pathway	Alteplase Action Pathway	Ximelagatran Action Pathway	Dicoumarol Action Pathway	Phenprocoumon Action Pathway	Urokinase Action Pathway	Bivalirudin Action Pathway	Tenecteplase Action Pathway	Streptokinase Action Pathway	Acenocoumarol Action Pathway	Enoxaparin Action Pathway	Reteplase Action Pathway
Amlodipine	HMDB_SMPDB	Samples:	8	Pathways:	2	Amlodipine Action Pathway	Amlodipine Pathway
(2E)-Dodecenoyl-CoA	HMDB_SMPDB	Samples:	51	Pathways:	3	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids
Heparin	HMDB_SMPDB	Samples:	14	Pathways:	2	Heparin Action Pathway	Heparin Pathway
DG(16:0/16:0/0:0)	HMDB_SMPDB	Samples:	3	Pathways:	1	Glycerolipid Metabolism
Ubiquinol 8	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Electron Transport Chain
Dezocine	HMDB_SMPDB	Samples:	28	Pathways:	1	Dezocine Action Pathway
Mexiletine	HMDB_SMPDB	Samples:	8	Pathways:	2	Mexiletine Pathway	Mexiletine Action Pathway
Buprenorphine	HMDB_SMPDB	Samples:	28	Pathways:	1	Buprenorphine Action Pathway
2-Aminoacrylic acid	HMDB_SMPDB	Samples:	10	Pathways:	1	Thyroid hormone synthesis
Iodide	HMDB_SMPDB	Samples:	10	Pathways:	1	Thyroid hormone synthesis
3-Iodo-L-tyrosine	HMDB_SMPDB	Samples:	10	Pathways:	1	Thyroid hormone synthesis
Dehydroalanine	HMDB_SMPDB	Samples:	10	Pathways:	1	Thyroid hormone synthesis
Triiodothyronine	HMDB_SMPDB	Samples:	10	Pathways:	1	Thyroid hormone synthesis
Fosphenytoin	HMDB_SMPDB	Samples:	8	Pathways:	2	Fosphenytoin (Antiarrhythmic) Action Pathway	Fosphenytoin (Antiarrhythmic) Pathway
Betaine aldehyde	HMDB_SMPDB	Samples:	39	Pathways:	2	sarcosine oncometabolite pathway 	Betaine Metabolism
Trandolapril	HMDB_SMPDB	Samples:	16	Pathways:	1	Trandolapril Pathway
N-Desmethyltamoxifen	HMDB_SMPDB	Samples:	1	Pathways:	3	Tamoxifen Action Pathway	Tamoxifen Metabolism Pathway	Tamoxifen Pathway
Tamoxifen	HMDB_SMPDB	Samples:	1	Pathways:	3	Tamoxifen Action Pathway	Tamoxifen Metabolism Pathway	Tamoxifen Pathway
Tamoxifen N-oxide	HMDB_SMPDB	Samples:	1	Pathways:	3	Tamoxifen Action Pathway	Tamoxifen Metabolism Pathway	Tamoxifen Pathway
4-Hydroxytamoxifen	HMDB_SMPDB	Samples:	1	Pathways:	2	Tamoxifen Metabolism Pathway	Tamoxifen Pathway
Norendoxifen	HMDB_SMPDB	Samples:	1	Pathways:	2	Tamoxifen Metabolism Pathway	Tamoxifen Pathway
Tamoxifen-N-glucuronide	HMDB_SMPDB	Samples:	1	Pathways:	2	Tamoxifen Metabolism Pathway	Tamoxifen Pathway
4-Hydroxytamoxifen sulfate	HMDB_SMPDB	Samples:	1	Pathways:	2	Tamoxifen Metabolism Pathway	Tamoxifen Pathway
Endoxifen sulfate	HMDB_SMPDB	Samples:	1	Pathways:	2	Tamoxifen Metabolism Pathway	Tamoxifen Pathway
alpha-Hydroxytamoxifen	HMDB_SMPDB	Samples:	1	Pathways:	2	Tamoxifen Action Pathway	Tamoxifen Metabolism Pathway
Endoxifen	HMDB_SMPDB	Samples:	1	Pathways:	2	Tamoxifen Action Pathway	Tamoxifen Metabolism Pathway
Hydroxytamoxifen	HMDB_SMPDB	Samples:	1	Pathways:	2	Tamoxifen Action Pathway	Tamoxifen Metabolism Pathway
Nisoldipine	HMDB_SMPDB	Samples:	8	Pathways:	2	Nisoldipine Action Pathway	Nisoldipine Pathway
Phenprocoumon	HMDB_SMPDB	Samples:	7	Pathways:	1	Phenprocoumon Pathway
Selenocysteine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Phosphoroselenoic acid 	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Selenomethionine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Adenylylselenate	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Se-Methylselenocysteine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Selenohomocysteine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Selenocystine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Selenocystathionine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Selenophosphate	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Gamma-Glutamyl-Se-methylselenocysteine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
3-Phosphoadenylylselenate	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Hydrogen selenide	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Se-Adenosylselenohomocysteine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Se-Adenosylselenomethionine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Selenite	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
3'-Phosphoadenylylselenate	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
gamma-Glutamyl-Se-methylselenocysteine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
L-Selenocystathionine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
L-Selenocysteine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
L-Selenomethionine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Se-Adenosyl-L-selenohomocysteine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Se-Methyl-L-selenocysteine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Selenophosphoric acid	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Butyric acid	HMDB_SMPDB	Samples:	49	Pathways:	1	Butyrate Metabolism
Malonic acid	HMDB_SMPDB	Samples:	1	Pathways:	1	Aspartate Metabolism
(R)-3-Hydroxybutanoate	HMDB_SMPDB	Samples:	6	Pathways:	2	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Ketone Body Metabolism
Butanoic acid	HMDB_SMPDB	Samples:	49	Pathways:	1	Butyrate Metabolism
Penbutolol	HMDB_SMPDB	Samples:	8	Pathways:	2	Penbutolol Pathway	Penbutolol Action Pathway
Valsartan	HMDB_SMPDB	Samples:	16	Pathways:	1	Valsartan Action Pathway
2-hydroxydesipramine	HMDB_SMPDB	Samples:	28	Pathways:	1	Desipramine Pathway
Quinethazone	HMDB_SMPDB	Samples:	44	Pathways:	2	Quinethazone Pathway	Quinethazone Action Pathway
Hydromorphone	HMDB_SMPDB	Samples:	28	Pathways:	2	Hydromorphone Action Pathway	Hydromorphone Pathway
Nalbuphine	HMDB_SMPDB	Samples:	28	Pathways:	1	Nalbuphine Action Pathway
Pantoprazole	HMDB_SMPDB	Samples:	6	Pathways:	2	Pantoprazole Pathway	Pantoprazole Action Pathway
Artemether	HMDB_SMPDB	Samples:	22	Pathways:	1	Artemether Metabolism Pathway
Quinidine	HMDB_SMPDB	Samples:	8	Pathways:	2	Quinidine Pathway	Quinidine Action Pathway
Sulfite	HMDB_SMPDB	Samples:	1	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Ramipril	HMDB_SMPDB	Samples:	16	Pathways:	1	Ramipril Pathway
Meprobamate	HMDB_SMPDB	Samples:	7	Pathways:	2	Capecitabine Metabolism Pathway	Capecitabine Pathway
Capecitabine	HMDB_SMPDB	Samples:	7	Pathways:	3	Capecitabine Action Pathway	Capecitabine Metabolism Pathway	Capecitabine Pathway
Indoleacetic acid	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
Tryptamine	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
5-Hydroxy-L-tryptophan	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
L-Kynurenine	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
Kynurenic acid	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
5-Hydroxyindoleacetic acid	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
Xanthurenic acid	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
L-Tryptophan	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
4-(2-Aminophenyl)-2,4-dioxobutanoic acid	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
2-Aminobenzoic acid	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
Indoleacetaldehyde	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
N'-Formylkynurenine	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
N-Acetylserotonin	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
2-Aminomuconic acid semialdehyde	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
2-Amino-3-carboxymuconic acid semialdehyde	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
Melatonin	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
3-Hydroxyanthranilic acid	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
5-Hydroxyindoleacetaldehyde	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
5-Hydroxykynurenamine	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
4,6-Dihydroxyquinoline	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
Cinnavalininate	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
6-Hydroxymelatonin	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
4-(2-Amino-3-hydroxyphenyl)-2,4-dioxobutanoic acid	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
5-Hydroxy-N-formylkynurenine	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
Formylanthranilic acid	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
5-Methoxyindoleacetate	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
Acetyl-N-formyl-5-methoxykynurenamine	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
N-Methylserotonin	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
N-Methyltryptamine	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
L-3-Hydroxykynurenine	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
5-Hydroxykynurenine	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
Formyl-5-hydroxykynurenamine	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
2-Amino-3-carboxymuconate semialdehyde	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
2-Aminomuconate semialdehyde	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
3-Hydroxy-L-kynurenine	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
3-Hydroxyanthranilate	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
4-(2-Amino-3-hydroxyphenyl)-2,4-dioxobutanoate	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
4-(2-Aminophenyl)-2,4-dioxobutanoate	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
4-Hydroxy-2-quinolinecarboxylic acid	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
5-Hydroxyindoleacetate	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
5-Hydroxytryptophan	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
Anthranilate	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
Formyl-N-acetyl-5-methoxykynurenamine	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
Formylanthranilate	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
Indole-3-acetaldehyde	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
Indole-3-acetate	HMDB_SMPDB	Samples:	36	Pathways:	1	Tryptophan Metabolism
Superoxide	HMDB_SMPDB	Samples:	1	Pathways:	1	Degradation of Superoxides
O2.-	HMDB_SMPDB	Samples:	1	Pathways:	1	Degradation of Superoxides
Proparacaine	HMDB_SMPDB	Samples:	28	Pathways:	2	Proparacaine Pathway	Proparacaine Action Pathway
Eplerenone	HMDB_SMPDB	Samples:	44	Pathways:	2	Eplerenone Pathway	Eplerenone Action Pathway
Hydrocodone	HMDB_SMPDB	Samples:	28	Pathways:	2	Hydrocodone Action Pathway	Hydrocodone Pathway
Ranitidine	HMDB_SMPDB	Samples:	6	Pathways:	1	Ranitidine Pathway
Chlorothiazide	HMDB_SMPDB	Samples:	44	Pathways:	2	Chlorothiazide Action Pathway	Chlorothiazide Pathway
Rescinnamine	HMDB_SMPDB	Samples:	16	Pathways:	2	Rescinnamine Pathway	Rescinnamine Action Pathway
Atenolol	HMDB_SMPDB	Samples:	8	Pathways:	1	Atenolol Pathway
Acebutolol	HMDB_SMPDB	Samples:	8	Pathways:	2	Acebutolol Pathway	Acebutolol Action Pathway
Spirapril	HMDB_SMPDB	Samples:	16	Pathways:	1	Spirapril Pathway
Ibutilide	HMDB_SMPDB	Samples:	8	Pathways:	2	Ibutilide Pathway	Ibutilide Action Pathway
Eprosartan	HMDB_SMPDB	Samples:	16	Pathways:	1	Eprosartan Action Pathway
N,N-Didesmethyltramadol	HMDB_SMPDB	Samples:	15	Pathways:	1	Tramadol Metabolism Pathway
N,N,O-Tridesmethyl-tramadol	HMDB_SMPDB	Samples:	15	Pathways:	1	Tramadol Metabolism Pathway
N,O-Didesmethyltramadol	HMDB_SMPDB	Samples:	15	Pathways:	1	Tramadol Metabolism Pathway
L-Threonine	HMDB_SMPDB	Samples:	53	Pathways:	2	Threonine and 2-Oxobutanoate Degradation	Glycine and Serine Metabolism
Warfarin	HMDB_SMPDB	Samples:	7	Pathways:	2	Warfarin Pathway	Warfarin Action Pathway
S-6-Hydroxywarfarin	HMDB_SMPDB	Samples:	7	Pathways:	1	Warfarin Pathway
Nadolol	HMDB_SMPDB	Samples:	8	Pathways:	1	Nadolol Pathway
1-Methylhistidine	HMDB_SMPDB	Samples:	24	Pathways:	1	Histidine Metabolism
Sapropterin	HMDB_SMPDB	Samples:	35	Pathways:	3	Catecholamine Biosynthesis	Aromatic L-Aminoacid Decarboxylase Deficiency	Tyrosine hydroxylase deficiency
7a,12a-Dihydroxy-5b-cholestan-3-one	HMDB_SMPDB	Samples:	33	Pathways:	1	Bile Acid Biosynthesis
7 alpha,24-Dihydroxy-4-cholesten-3-one	HMDB_SMPDB	Samples:	33	Pathways:	1	Bile Acid Biosynthesis
Verapamil	HMDB_SMPDB	Samples:	8	Pathways:	2	Verapamil Action Pathway	Verapamil Pathway
O-Desmethylverapamil (D-702)	HMDB_SMPDB	Samples:	8	Pathways:	1	Verapamil Pathway
Propoxyphene	HMDB_SMPDB	Samples:	28	Pathways:	1	Propoxyphene Action Pathway
Cyclothiazide	HMDB_SMPDB	Samples:	44	Pathways:	2	Cyclothiazide Action Pathway	Cyclothiazide Pathway
(R)-3-Hydroxybutyric acid	HMDB_SMPDB	Samples:	6	Pathways:	2	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Ketone Body Metabolism
Acetone	HMDB_SMPDB	Samples:	6	Pathways:	2	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Ketone Body Metabolism
Phenol	HMDB_SMPDB	Samples:	1	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Chondroitin	HMDB_SMPDB	Samples:	1	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Chondroitin 4-sulfate	HMDB_SMPDB	Samples:	1	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Propyl alcohol	HMDB_SMPDB	Samples:	1	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Adenosine phosphosulfate	HMDB_SMPDB	Samples:	1	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Molybdenum	HMDB_SMPDB	Samples:	1	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Phenol sulphate	HMDB_SMPDB	Samples:	1	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Adenylyl sulfate	HMDB_SMPDB	Samples:	1	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Aryl sulfate	HMDB_SMPDB	Samples:	1	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Propane-1-ol	HMDB_SMPDB	Samples:	1	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
D-1-Piperideine-2-carboxylic acid	HMDB_SMPDB	Samples:	56	Pathways:	1	Lysine Degradation
S-Glutaryldihydrolipoamide	HMDB_SMPDB	Samples:	56	Pathways:	1	Lysine Degradation
Fondaparinux sodium	HMDB_SMPDB	Samples:	14	Pathways:	1	Fondaparinux Pathway
Nitrendipine	HMDB_SMPDB	Samples:	8	Pathways:	2	Nitrendipine Action Pathway	Nitrendipine Pathway
Pentazocine	HMDB_SMPDB	Samples:	28	Pathways:	1	Pentazocine Action Pathway
Triamterene	HMDB_SMPDB	Samples:	44	Pathways:	1	Triamterene Pathway
5,10-Methenyltetrahydrofolic acid	HMDB_SMPDB	Samples:	43	Pathways:	4	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Methotrexate Pathway	Folate Metabolism	Folate malabsorption, hereditary
Folinic acid	HMDB_SMPDB	Samples:	43	Pathways:	5	Methotrexate Action Pathway	Methotrexate Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
N-Formyl-L-glutamic acid	HMDB_SMPDB	Samples:	43	Pathways:	4	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Methotrexate Pathway	Folate Metabolism	Folate malabsorption, hereditary
5,10-Methenyltetrahydrofolate	HMDB_SMPDB	Samples:	43	Pathways:	4	Methotrexate Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
Folate	HMDB_SMPDB	Samples:	43	Pathways:	4	Methotrexate Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
N-Formyl-L-glutamate	HMDB_SMPDB	Samples:	43	Pathways:	4	Methotrexate Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
THF-polyglutamate	HMDB_SMPDB	Samples:	43	Pathways:	4	Methotrexate Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
Lactaldehyde	HMDB_SMPDB	Samples:	57	Pathways:	1	Pyruvate Metabolism
2-(a-Hydroxyethyl)thiamine diphosphate	HMDB_SMPDB	Samples:	57	Pathways:	1	Pyruvate Metabolism
5-Amino-2-oxopentanoic acid	HMDB_SMPDB	Samples:	44	Pathways:	1	Fatty Acid Elongation In Mitochondria
2-trans-Dodecenoyl-CoA	HMDB_SMPDB	Samples:	44	Pathways:	2	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria
Oxymorphone	HMDB_SMPDB	Samples:	28	Pathways:	2	Oxymorphone Pathway	Oxymorphone Action Pathway
Celecoxib	HMDB_SMPDB	Samples:	21	Pathways:	3	Celecoxib Metabolism Pathway	Celecoxib Pathway	Celecoxib Action Pathway
Hydroxycelecoxib	HMDB_SMPDB	Samples:	21	Pathways:	2	Celecoxib Metabolism Pathway	Celecoxib Pathway
Carboxycelecoxib	HMDB_SMPDB	Samples:	21	Pathways:	2	Celecoxib Metabolism Pathway	Celecoxib Pathway
Naloxone	HMDB_SMPDB	Samples:	28	Pathways:	1	Naloxone Action Pathway
Disulfiram	HMDB_SMPDB	Samples:	54	Pathways:	2	Disulfiram Action Pathway	Disulfiram Pathway
Naltrexone	HMDB_SMPDB	Samples:	28	Pathways:	1	Naltrexone Action Pathway
Gefitinib	HMDB_SMPDB	Samples:	2	Pathways:	1	Gefitinib Pathway
Acenocoumarol	HMDB_SMPDB	Samples:	7	Pathways:	1	Acenocoumarol Pathway
Anileridine	HMDB_SMPDB	Samples:	28	Pathways:	1	Anileridine Action Pathway
Ropivacaine	HMDB_SMPDB	Samples:	28	Pathways:	2	Ropivacaine Action Pathway	Ropivacaine Pathway
(R)-lipoic acid	HMDB_SMPDB	Samples:	52	Pathways:	2	Ammonia Recycling	Glycine and Serine Metabolism
Bevantolol	HMDB_SMPDB	Samples:	8	Pathways:	1	Bevantolol Action Pathway
Ethylmorphine	HMDB_SMPDB	Samples:	28	Pathways:	1	Ethylmorphine Action Pathway
Valproic acid glucuronide	HMDB_SMPDB	Samples:	50	Pathways:	1	Valproic Acid Metabolism Pathway
Valproic acid	HMDB_SMPDB	Samples:	50	Pathways:	1	Valproic Acid Metabolism Pathway
Pentanoyl-CoA	HMDB_SMPDB	Samples:	50	Pathways:	1	Valproic Acid Metabolism Pathway
4-ene-Valproic acid	HMDB_SMPDB	Samples:	50	Pathways:	1	Valproic Acid Metabolism Pathway
5-Hydroxyvalproic acid	HMDB_SMPDB	Samples:	50	Pathways:	1	Valproic Acid Metabolism Pathway
3-Hydroxyvalproic acid	HMDB_SMPDB	Samples:	50	Pathways:	1	Valproic Acid Metabolism Pathway
4-Hydroxyvalproic acid	HMDB_SMPDB	Samples:	50	Pathways:	1	Valproic Acid Metabolism Pathway
2-ene-Valproic acid	HMDB_SMPDB	Samples:	50	Pathways:	1	Valproic Acid Metabolism Pathway
2-Propyl-2,4-pentadienoic acid	HMDB_SMPDB	Samples:	50	Pathways:	1	Valproic Acid Metabolism Pathway
2-n-Propyl-2-pentenoic acid	HMDB_SMPDB	Samples:	50	Pathways:	1	Valproic Acid Metabolism Pathway
2-n-Propyl-4-oxopentanoic acid	HMDB_SMPDB	Samples:	50	Pathways:	1	Valproic Acid Metabolism Pathway
2-n-Propyl-4-pentenoic acid	HMDB_SMPDB	Samples:	50	Pathways:	1	Valproic Acid Metabolism Pathway
2-Propylglutaric acid	HMDB_SMPDB	Samples:	50	Pathways:	1	Valproic Acid Metabolism Pathway
3-Oxovalproic acid	HMDB_SMPDB	Samples:	50	Pathways:	1	Valproic Acid Metabolism Pathway
Levobunolol	HMDB_SMPDB	Samples:	8	Pathways:	1	Levobunolol Action Pathway
Ardeparin	HMDB_SMPDB	Samples:	14	Pathways:	1	Ardeparin Pathway
Enoxaparin	HMDB_SMPDB	Samples:	14	Pathways:	2	Enoxaparin Pathway	Ardeparin Pathway
Esmolol	HMDB_SMPDB	Samples:	8	Pathways:	2	Esmolol Pathway	Esmolol Action Pathway
Irbesartan	HMDB_SMPDB	Samples:	16	Pathways:	1	Irbesartan Action Pathway
Stearoylcarnitine	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
3-Oxooctadecanoyl-CoA	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
trans-Octadec-2-enoyl-CoA	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
(S)-Hydroxyoctadecanoyl-CoA	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
(2E)-Octadecenoyl-CoA	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
3-Oxostearoyl-CoA	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
Isoproterenol	HMDB_SMPDB	Samples:	8	Pathways:	1	Isoprenaline Action Pathway
Sotalol	HMDB_SMPDB	Samples:	8	Pathways:	1	Sotalol Action Pathway
Prilocaine	HMDB_SMPDB	Samples:	28	Pathways:	2	Prilocaine Pathway	Prilocaine Action Pathway
Fentanyl	HMDB_SMPDB	Samples:	28	Pathways:	1	Fentanyl Pathway
Nifedipine	HMDB_SMPDB	Samples:	8	Pathways:	2	Nifedipine Pathway	Nifedipine Action Pathway
Hydroflumethiazide	HMDB_SMPDB	Samples:	44	Pathways:	2	Hydroflumethiazide Action Pathway	Hydroflumethiazide Pathway
4-Pyridoxic acid	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin B6 Metabolism	Hypophosphatasia
Pyridoxine	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin B6 Metabolism	Hypophosphatasia
Pyridoxine 5'-phosphate	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin B6 Metabolism	Hypophosphatasia
Pyridoxamine	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin B6 Metabolism	Hypophosphatasia
Pyridoxamine 5'-phosphate	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin B6 Metabolism	Hypophosphatasia
Glycolaldehyde	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin B6 Metabolism	Hypophosphatasia
2-Methyl-3-hydroxy-5-formylpyridine-4-carboxylate	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin B6 Metabolism	Hypophosphatasia
3-Hydroxy-2-methylpyridine-4,5-dicarboxylate	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin B6 Metabolism	Hypophosphatasia
4-Pyridoxate	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin B6 Metabolism	Hypophosphatasia
Pyridoxamine phosphate	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin B6 Metabolism	Hypophosphatasia
Pyridoxine phosphate	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin B6 Metabolism	Hypophosphatasia
Glyburide	HMDB_SMPDB	Samples:	5	Pathways:	2	Glibenclamide Action Pathway	Glibenclamide Pathway
Cilazapril	HMDB_SMPDB	Samples:	16	Pathways:	1	Cilazapril Pathway
L-Octanoylcarnitine	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids
Methadone	HMDB_SMPDB	Samples:	28	Pathways:	2	Methadone Pathway	Methadone Action Pathway
Enalapril	HMDB_SMPDB	Samples:	16	Pathways:	2	Enalapril Pathway	Enalapril Action Pathway
Chloroprocaine	HMDB_SMPDB	Samples:	28	Pathways:	2	Chloroprocaine Action Pathway	Chloroprocaine Pathway
Sorafenib	HMDB_SMPDB	Samples:	3	Pathways:	1	Sorafenib Metabolism Pathway
Sorafenib beta-D-Glucuronide	HMDB_SMPDB	Samples:	3	Pathways:	1	Sorafenib Metabolism Pathway
Sorafenib N-oxide	HMDB_SMPDB	Samples:	3	Pathways:	1	Sorafenib Metabolism Pathway
Mepivacaine	HMDB_SMPDB	Samples:	28	Pathways:	2	Mepivacaine Pathway	Mepivacaine Action Pathway
Indapamide	HMDB_SMPDB	Samples:	44	Pathways:	1	Indapamide Pathway
Betazole	HMDB_SMPDB	Samples:	6	Pathways:	1	Betazole Action Pathway
7-Hydroxygliclazide	HMDB_SMPDB	Samples:	5	Pathways:	1	Gliclazide Pathway
Gliclazide	HMDB_SMPDB	Samples:	5	Pathways:	1	Gliclazide Pathway
Methotrexate	HMDB_SMPDB	Samples:	22	Pathways:	2	Methotrexate Pathway	Methotrexate Action Pathway
Propranolol	HMDB_SMPDB	Samples:	8	Pathways:	2	Propranolol Pathway	Propranolol Action Pathway
Phenindione	HMDB_SMPDB	Samples:	7	Pathways:	1	Phenindione Action Pathway
6-Phosphonoglucono-D-lactone	HMDB_SMPDB	Samples:	56	Pathways:	1	Warburg Effect
D-Glucono-1,5-lactone 6-phosphate	HMDB_SMPDB	Samples:	56	Pathways:	1	Warburg Effect
Hydroxylansoprazole	HMDB_SMPDB	Samples:	6	Pathways:	1	Lansoprazole Pathway
Bisoprolol	HMDB_SMPDB	Samples:	8	Pathways:	2	Bisoprolol Pathway	Bisoprolol Action Pathway
Chlorthalidone	HMDB_SMPDB	Samples:	44	Pathways:	1	Chlorthalidone Pathway
Nimodipine	HMDB_SMPDB	Samples:	8	Pathways:	2	Nimodipine Pathway	Nimodipine Action Pathway
Metolazone	HMDB_SMPDB	Samples:	44	Pathways:	1	Metolazone Pathway
Nebivolol	HMDB_SMPDB	Samples:	8	Pathways:	1	Nebivolol Pathway
Trichlormethiazide	HMDB_SMPDB	Samples:	44	Pathways:	2	Trichlormethiazide Action Pathway	Trichlormethiazide Pathway
Cocaine	HMDB_SMPDB	Samples:	28	Pathways:	2	Cocaine Pathway	Cocaine Action Pathway
Ketobemidone	HMDB_SMPDB	Samples:	28	Pathways:	1	Ketobemidone  Action Pathway
Nizatidine	HMDB_SMPDB	Samples:	6	Pathways:	2	Nizatidine Pathway	Nizatidine Action Pathway
Glycerophosphocholine	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
Vitamin A	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
B-Carotene	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
Retinal	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
2-Ethylacrylic acid	HMDB_SMPDB	Samples:	2	Pathways:	1	Retinol Metabolism
11-cis-Retinaldehyde	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
9-cis-Retinoic acid	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
Retinoyl b-glucuronide	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
Retinyl ester	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
Retinyl palmitate	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
11-cis-Retinol	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
9-cis-Retinol	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
9-cis-Retinal	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
4-Hydroxyretinoic acid	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
4-oxo-Retinoic acid	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
DG(16:1(9Z)/22:0/0:0)	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
PC(24:1(15Z)/15:0)	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
All-trans-13,14-dihydroretinol	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
4-Oxoretinol	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
all-trans-5,6-Epoxyretinoic acid	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
all-trans-18-Hydroxyretinoic acid	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
TG(16:1(9Z)/22:0/16:1(9Z))	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
18-Hydroxyretinoic acid	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
11-cis-Retinal	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
all-trans-13,14-Dihydroretinol	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
all-trans-4-Hydroxyretinoic acid	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
all-trans-4-Oxoretinoic acid	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
all-trans-Retinoyl-beta-glucuronide	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
beta-Carotene	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
Retinoate	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
Retinol	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
sn-Glycero-3-phosphocholine	HMDB_SMPDB	Samples:	2	Pathways:	2	Vitamin A Deficiency	Retinol Metabolism
Escitalopram	HMDB_SMPDB	Samples:	28	Pathways:	1	Escitalopram Pathway
Metiamide	HMDB_SMPDB	Samples:	6	Pathways:	1	Metiamide Action Pathway
Benzocaine	HMDB_SMPDB	Samples:	28	Pathways:	2	Benzocaine Action Pathway	Benzocaine Pathway
Oxprenolol	HMDB_SMPDB	Samples:	8	Pathways:	1	Oxprenolol Pathway
Amiloride	HMDB_SMPDB	Samples:	44	Pathways:	2	Amiloride Pathway	Amiloride Action Pathway
5'-Deoxy-5-fluorouridine	HMDB_SMPDB	Samples:	7	Pathways:	2	Capecitabine Action Pathway	Capecitabine Metabolism Pathway
5-Deoxyribose-1-phosphate	HMDB_SMPDB	Samples:	7	Pathways:	2	Capecitabine Action Pathway	Capecitabine Metabolism Pathway
5-FU	HMDB_SMPDB	Samples:	7	Pathways:	2	Capecitabine Action Pathway	Capecitabine Metabolism Pathway
Polythiazide	HMDB_SMPDB	Samples:	44	Pathways:	2	Polythiazide Action Pathway	Polythiazide Pathway
Aminocaproic acid	HMDB_SMPDB	Samples:	7	Pathways:	1	Aminocaproic Acid Pathway
Dobutamine	HMDB_SMPDB	Samples:	8	Pathways:	1	Dobutamine Action Pathway
Practolol	HMDB_SMPDB	Samples:	8	Pathways:	1	Practolol Action Pathway
Procaine	HMDB_SMPDB	Samples:	28	Pathways:	2	Procaine Action Pathway	Procaine Pathway
Diltiazem	HMDB_SMPDB	Samples:	8	Pathways:	2	Diltiazem Pathway	Diltiazem Action Pathway
Acetaminophen glucuronide	HMDB_SMPDB	Samples:	5	Pathways:	1	Acetaminophen Metabolism Pathway
Paracetamol sulfate	HMDB_SMPDB	Samples:	5	Pathways:	1	Acetaminophen Metabolism Pathway
NAPQI	HMDB_SMPDB	Samples:	5	Pathways:	1	Acetaminophen Metabolism Pathway
Alvimopan	HMDB_SMPDB	Samples:	28	Pathways:	1	Alvimopan Action Pathway
Nateglinide	HMDB_SMPDB	Samples:	5	Pathways:	2	Nateglinide Pathway	Nateglinide Action Pathway
Tranexamic Acid	HMDB_SMPDB	Samples:	7	Pathways:	1	Tranexamic Acid Pathway
Dihydromorphine	HMDB_SMPDB	Samples:	28	Pathways:	1	Dihydromorphine Action Pathway
Telmisartan	HMDB_SMPDB	Samples:	16	Pathways:	1	Telmisartan Action Pathway
Pindolol	HMDB_SMPDB	Samples:	8	Pathways:	2	Pindolol Action Pathway	Pindolol Pathway
4-Hydroxybenzoic acid	HMDB_SMPDB	Samples:	3	Pathways:	1	Ubiquinone Biosynthesis
3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid	HMDB_SMPDB	Samples:	3	Pathways:	1	Ubiquinone Biosynthesis
3-Hexaprenyl-4,5-Dihydroxybenzoic acid	HMDB_SMPDB	Samples:	3	Pathways:	1	Ubiquinone Biosynthesis
Ubiquinone-1	HMDB_SMPDB	Samples:	3	Pathways:	1	Ubiquinone Biosynthesis
3-Hexaprenyl-4-hydroxybenzoic acid	HMDB_SMPDB	Samples:	3	Pathways:	1	Ubiquinone Biosynthesis
2-Hexaprenyl-6-methoxyphenol	HMDB_SMPDB	Samples:	3	Pathways:	1	Ubiquinone Biosynthesis
2-Hexaprenyl-6-methoxy-1,4-benzoquinone	HMDB_SMPDB	Samples:	3	Pathways:	1	Ubiquinone Biosynthesis
2-Hexaprenyl-3-methyl-6-methoxy-1,4 benzoquinone	HMDB_SMPDB	Samples:	3	Pathways:	1	Ubiquinone Biosynthesis
2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone	HMDB_SMPDB	Samples:	3	Pathways:	1	Ubiquinone Biosynthesis
All-trans-hexaprenyl diphosphate	HMDB_SMPDB	Samples:	3	Pathways:	1	Ubiquinone Biosynthesis
2-Hexaprenyl-3-methyl-6-methoxy-1,4-benzoquinone	HMDB_SMPDB	Samples:	3	Pathways:	1	Ubiquinone Biosynthesis
3-Hexaprenyl-4,5-dihydroxybenzoate	HMDB_SMPDB	Samples:	3	Pathways:	1	Ubiquinone Biosynthesis
3-Hexaprenyl-4-hydroxy-5-methoxybenzoate	HMDB_SMPDB	Samples:	3	Pathways:	1	Ubiquinone Biosynthesis
3-Hexaprenyl-4-hydroxybenzoate	HMDB_SMPDB	Samples:	3	Pathways:	1	Ubiquinone Biosynthesis
4-Hydroxybenzoate	HMDB_SMPDB	Samples:	3	Pathways:	1	Ubiquinone Biosynthesis
all-trans-Hexaprenyl diphosphate	HMDB_SMPDB	Samples:	3	Pathways:	1	Ubiquinone Biosynthesis
Ubiquinone-6	HMDB_SMPDB	Samples:	3	Pathways:	1	Ubiquinone Biosynthesis
Timolol	HMDB_SMPDB	Samples:	8	Pathways:	1	Timolol Action Pathway
8-Hydroxycarvedilol	HMDB_SMPDB	Samples:	8	Pathways:	1	Carvedilol Pathway
Carvedilol	HMDB_SMPDB	Samples:	8	Pathways:	2	Carvedilol Action Pathway	Carvedilol Pathway
Venlafaxine	HMDB_SMPDB	Samples:	5	Pathways:	1	Venlafaxine Metabolism Pathway
N-Desmethylvenlafaxine	HMDB_SMPDB	Samples:	5	Pathways:	1	Venlafaxine Metabolism Pathway
Arbutamine	HMDB_SMPDB	Samples:	8	Pathways:	1	Arbutamine Action Pathway
Flecainide	HMDB_SMPDB	Samples:	8	Pathways:	2	Flecainide Pathway	Flecainide Action Pathway
Pirenzepine	HMDB_SMPDB	Samples:	6	Pathways:	2	Pirenzepine Pathway	Pirenzepine Action Pathway
Captopril	HMDB_SMPDB	Samples:	16	Pathways:	1	Captopril Pathway
Lamivudine	HMDB_SMPDB	Samples:	2	Pathways:	1	Lamivudine Metabolism Pathway
Lamivudine sulfoxide	HMDB_SMPDB	Samples:	2	Pathways:	1	Lamivudine Metabolism Pathway
Ximelagatran	HMDB_SMPDB	Samples:	7	Pathways:	1	Ximelagatran Pathway
Repaglinide	HMDB_SMPDB	Samples:	5	Pathways:	2	Repaglinide Action Pathway	Repaglinide Pathway
Diphenoxylate	HMDB_SMPDB	Samples:	28	Pathways:	1	Diphenoxylate Action Pathway
Famotidine	HMDB_SMPDB	Samples:	6	Pathways:	1	Famotidine Pathway
Tocainide	HMDB_SMPDB	Samples:	8	Pathways:	2	Tocainide Pathway	Tocainide Action Pathway
Enalaprilat	HMDB_SMPDB	Samples:	16	Pathways:	1	Enalapril Action Pathway
NPC	HMDB_SMPDB	Samples:	1	Pathways:	1	Irinotecan Action Pathway
SN-38	HMDB_SMPDB	Samples:	1	Pathways:	1	Irinotecan Action Pathway
6-Aminohexanoate	HMDB_SMPDB	Samples:	7	Pathways:	1	Aminocaproic Acid Action Pathway
Tranexamic acid	HMDB_SMPDB	Samples:	7	Pathways:	1	Tranexamic Acid Action Pathway
Linamarin	HMDB_SMPDB	Samples:	6	Pathways:	1	Lansoprazole Action Pathway
Procaterol hydrochloride	HMDB_SMPDB	Samples:	8	Pathways:	1	Atenolol Action Pathway
L-(-)-1-Butyl-2',6'-pipecoloxylidide	HMDB_SMPDB	Samples:	28	Pathways:	1	Levobupivacaine Action Pathway
Morphine-3-glucuronide	HMDB_SMPDB	Samples:	8	Pathways:	1	Morphine Action Pathway
Morphine-6-glucuronide	HMDB_SMPDB	Samples:	8	Pathways:	1	Morphine Action Pathway
2-Ethyl-5-methyl-3,3-diphenyl-1-pyrroline	HMDB_SMPDB	Samples:	28	Pathways:	1	Methadone Action Pathway
Citalopram aldehyde	HMDB_SMPDB	Samples:	44	Pathways:	1	Citalopram Action Pathway
Citalopram N-oxide	HMDB_SMPDB	Samples:	44	Pathways:	1	Citalopram Action Pathway
Citalopram propionic acid	HMDB_SMPDB	Samples:	44	Pathways:	1	Citalopram Action Pathway
Demethylcitalopram	HMDB_SMPDB	Samples:	44	Pathways:	1	Citalopram Action Pathway
Didemethylcitalopram	HMDB_SMPDB	Samples:	44	Pathways:	1	Citalopram Action Pathway
(R,S)-Nicotine	HMDB_SMPDB	Samples:	36	Pathways:	1	Nicotine Action Pathway
